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SUMMARY
I e v a lua ted  t h a l l lu m - 2 0 1  c h l o r i d e  as a tumour imaging agent .
I s tu d ie d  the t ime course o f  T I -201  uptake in va r io u s  tumours in order  to  es­
t a b l i s h  the best  t ime fo r  imaging tumours f o l lo w in g  i n j e c t i o n  o f  the t r a c e r .  
The r e s u l t s  show th a t  uptake occurs r a p i d l y  in tumours w i th  a peak va lue  ob­
ta in e d  8 to  20 minutes p o s t - i n j e c t I o n  in var ious  tumours s tu d ie d .  The mean 
t ime o f  tumour uptake (+SD) was 11 .2  ( + 3 . 3 4 )  minutes fo r  lung carcinoma, 11.21  
( + 1 . 8 8 )  minutes fo r  breas t  carcinoma and 11 .76  ( + 3 . 2 5 )  minutes fo r  lymphoma. 
There were no s i g n i f i c a n t  d i f f e r e n c e s  in d i f f e r e n t  tumour types .
Tumour to  background r a t i o s  a ls o  r a p i d l y  a t t a i n e d  peak va lues  and remained 
r e l a t i v e l y  constant  over the hour f o l lo w in g  i n j e c t i o n .  The mean (+SD) t ime of  
maximal tumour/background a c t i v i t y  was assessed and found fo r  lung cancer to  
be 18 .3  ( + 0 . 5 9 )  minutes,  breast  cancer 13 .0  ( + 1 . 1 6 )  minutes,  and lymphoma 16 .7  
( + 1 . 0 4 )  minutes.  The mean tumour to  background r a t i o s  d id  not change s i g ­
n i f i c a n t l y  over the f i r s t  hour once the peak va lue was obta in ed  at  around ten 
minutes .
The tumour to  background r a t i o s  were a ls o  compared in the e a r l y  and four hours 
delayed ten minutes and found to  be mean (+SD) 1 .8  ( + 0 . 3 0 )  f o r  the i n i t i a l
image and 1 .6 7  ( + 0 . 3 3 )  fo r  the delayed image. These values  are  not s i g ­
n i f i c a n t l y  d i f f e r e n t .
13
From these data I concluded th a t  tumour imaging w i th  T I -2 01  is best  performed  
20 to 60 minutes post I n j e c t i o n .  I d id not f i n d  any evidence th a t  delayed  
four hour imaging was advantageous because tumour to  background was not s i g ­
n i f i c a n t l y  changed and the count in tumour decreased.
I s tu d ied  the mechanism o f  tumour uptake o f  T I -201  by in v iv o  and in v i t r o  
s t u d ie s .
In a s e r i e s  o f  p a t i e n t s  w i th  lung cancer ( n * 5 0 ) ,  b reast  cancer ( n = 2 4 ) ,  and 
m ed ia s t in a l  lymphoma ( n - 1 3 ) ,  the t ime course o f  tumour uptake o f  T I -20 1  p a r a l ­
le le d  t h a t  In the myocardium w i th  almost id e n t i c a l  t imes being obta ined  in 
tumours and myocardium. The t ime from i n j e c t i o n  to  peak myocardial  a c t i v i t y  
ranged from 8 to  20 minutes.  The mean t ime to  peak myocardial  a c t i v i t y  C+SD) 
was 11.61 (+ 3 . 2 5 ) .  The mean (+SD) washout of  T I -201  from the tumour over  
four hours post i n j e c t i o n  was 25 .4  (+ 3 3 . 5 )  percent  o f  the a c t i v i t y  present  in 
the e a r l y  s t a t i c  image. The mean washout o f  T I - 201  from the myocardium over  
four hours was 2 9 .7  ( + 1 6 . 7 ) .
In a p a t i e n t  w ith  hep a t ic  metastases from c o lo n ic  cancer undergoing  
laparotomy,  TC labeled  microspheres and T I -201  were In je c t e d  in to  the
h e p a t ic  a r t e r y  and b io ps ie s  o f  m e t a s t a t i c  and normal l i v e r  t i s s u e  obta in ed .  
The tumour to  normal l i v e r  t i s s u e  a c t i v i t y  r a t i o s  f o r  T I -201  were o n e - te n th  of  
those fo r  TC®®m microspheres.
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Measurement o f  T I -201  act  i vIty^junder contro l  cond11ions Rafter  d ig o x in  i n t e r ­
ven t io n  in non-smal l  c e l l  lung cancer l in e  SK-MTS. The c e l l s  were incubated  
fo r  30 minutes w i th  T I -2 01  and w ithout  the a d d i t i o n  o f  d i g o x in ,  which ac ts  as 
a sodium-potassium pump b lo c k e r .  The c e l l s  exposed to  d igox in  showed markedly 
decreased uptake o f  T I -20 1  compared to  the c e l l s  not exposed.
Results  of  the s tu d ie s  in d ic a t e  t h a t  T I -2 01  uptake in tumours in not a p ure ly  
f low  dependent process.  The mechanism o f  i n t r a c e l l u l a r  uptake o f  T I -201  
demonstrates the v i a b i l i t y  and m etabol ic  a c t i v i t y  o f  the p a t h o lo g ic a l  c e l l s .  
I t  appears to  be s i m i l a r  to  the myocardium by s u b s t i t u t i o n  o f  T I -2 01  fo r  
potassium in the ATP-ase dependent sodium-potassium pump.
I c a r r i e d  out a c l i n i c a l  e v a lu a t io n  o f  T I -201  c h lo r id e  in the diagnosis  and 
st ag in g  o f  var io u s  common mal ig nanc ies .
I eva lu a ted  the a b i l i t y  o f  T I -20 1  c h lo r id e  to  de tec t  pr imary  lung cancer  
(n - 1 4 7 )  and to  demonstrate m ed ias t in a l  spread of  the d isease .  Tha l l ium-201  
images were compared w i th  the r e s u l t s  o f  CT Scanning and su r g ic a l  med ias t in a l  
e x p l o r a t i o n .  Tha l l ium-201  was accura te  In lo c a t in g  126 o f  147 o f  the pr imary  
lung tumours (86%) but d is a p p o in t in g  in d e t e c t in g  m ed ia s t in a l  tumour spread 
(16%).
Ten p a t i e n t s  w i th  benign iung disease were examined. T I -201  c h lo r id e  was also  
found to  concentr a te  in a c t i v e  sarco id o s is  (one case)  and a c t i v e  TB (two 
c ases ) .  The s p e c i f i c i t y  o f  70 percent  was o b ta in ed .  F o r t y - f i v e  p a t i e n t s  with  
h i s t o l o g i c a l l y  proven lung cancer underwent T I -201  and Ga-67 s tu d ie s .
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T h i r t y - n i n e  (87%) showed p o s i t i v e  uptake o f  T I -2 01  in to  the pr imary  tumour,  
w h i le  36 (80%) had p o s i t i v e  Ga-67 uptake In the tumour. Ga-67 was su perior
over T I -2 01  In d e t e c t in g  m e d ia s t in a l  spread o f  the disease in 16 out  o f  28 
(58%) p a t i e n t s  w i th  m ed ia s t in a l  g a l l iu m  uptake ,  w h i le  f i v e  out  o f  28 (18%) 
p a t i e n t s  showed p o s i t i v e  T i -20 1  uptake .  I concluded t h a t  T I -20 1  c h l o r i d e  con­
c e n t r a t e s  In both mal ignant  and benign a c t i v e  m etabo l ic  t i s s u e .  T I -2 01  is 
h ig h ly  s e n s i t i v e  in lo ca t in g  pr imary  lung cancer but lacks s e n s i t i v i t y  in 
determ in ing  m ed ias t in a l  spread o f  the disease .
I ev a lu a ted  T I -2 0 1  c h l o r i d e  in p a t i e n t s  w i th  b reast  cancer (n»26)  and In 
p a t i e n t s  w i th  mal ignant  lymphoma ( n - 1 5 ) ,  and found th a t  T I -201  is h ig h ly  sen­
s i t i v e  in d e t e c t in g  pr imary  tumours and d isa p p o in t in g  in d e t e c t i n g  nodal 
spread o f  the d isease .
Tha l l iu m-201  was a lso  eva lu a te d  in p a t i e n t s  w i th  bone and s o f t  t i s s u e  tumours 
( n * 9 ) , b r a in  tumours and in p a t i e n t s  w i th  mass les ions o f  the l i v e r .
Tha l l iu m-201  was found to  be usefu l  In d e t e c t in g  bone and s o f t  t i s s u e  tumours 
(100% s e n s i t i v i t y ) ,  b r a in  tumours (100%) and was not a f f e c t e d  by s t e r o i d  
therapy .  Th a l l ium-201  was found to be e q u a l ly  usefu l  to  g a l l i u m - 6 7  fo r  imag­
ing pr imary  hepatomas. I t  surpasses g a l l iu m - 6 7  imaging in d i s t i n c t i o n  of  
pseudotumours o f  the l i v e r .  In a d d i t i o n ,  I t  has the advantage over g a l l iu m - 6 7  
of  e a r l y  imaging.
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F i n a l l y ,  se quent ia l  T I -201  scans were found to be use fu l  in e v a lu a t in g  
p a t i e n t s  w i th  mal ignant  disease and determin ing  local  tumour response a f t e r  
ant  I - tumour th e rap y ,  e s p e c i a l l y  when the scan was p o s i t i v e  p r e - t r e a t m e n t .  
There was a good c o r r e l a t i o n  between the changes In T I -2 0 1  uptake and the 
change In the pr imary tumour s i z e  a f t e r  t reatment  as determined r a d io g r a p h i -  
c a l l y .
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CHAPTER I
A HISTORICAL REVIEW OF THE APPLICATION OF 
THALLIUM-2011 IN VIVO
1(1) In t r o d u c t Io n
The f i r s t  a p p l i c a t i o n  o f  r a d i o a c t i v e  t r a c e r s  In man was in the f i e l d  of  
ca rd io vas c u la r  d isease ,  when Blumgart and co l leagues  in 1927 i n je c te d  
radium C in to  the ve in  o f  an arm to  measure the t r a n s i t  t ime through the 
hear t  to  an a r t e r i a l  s i t e  in the o ther  arm. The a r r i v a l  o f  the t r a c e r  
was d etected  w i th  a cloud chamber A longer than normal c i r c u l a t i o n
t ime was found in p a t i e n t s  w ith  a u r i c u l a r  f i b r i l l a t i o n  or "myocardial  
degenerat ion"  ^ .
Fo l lowing  the development of  the f i r s t  c y c lo t r o n  by Lawrence and 
L iv i n g s t o n ,  1932 ( 3 )  and I t s  l a t e r  improvement by Lawrence and Cooksey
1936 Hamil ton ,  1938 descr ibed the a r t i f i c i a l  rad io iso to p e
potasslum-42 which was s u i t a b l e  fo r  b i o l o g i c a l  use Three years
la t e r  Noonan, Fenn and Haege demonstrated ra p id  accumulat ion of  
potasslum-42 in the myocardium o f  r a t s  f o l lo w in g  i n t r a p e r i t o n e a I  i n j e c ­
t i o n
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In the e a r l y  1 9 5 0 's ,  work by Burch and h is  assoc ia tes  demonstrated that  
w h i le  r a d i o a c t i v e  rubidium and potassium do not have i d e n t i c a l  k i n e t i c s  
they a re  s u f f i c i e n t l y  s i m i l a r  to  a l lo w  rubidium to be used in making 
g e n e r a l i s a t i o n  concerning c e r t a i n  aspects o f  K a l i o k i n e t i c  phenomena in 
man. The two t r a c e r s  behaved s i m i l a r l y  during the 120 minutes f o l lo w in g  
int ravenous a d m i n i s t r a t i o n .  The p a r t i t i o n i n g  o f  potassium-42 and 
rub id lum-86  in the i n t r a -  and e x t ra v a s c u la r  compartments a lso  was 
s i m i l a r  S i m i l a r  p r o p e r t i e s  were a ls o  found fo r  r a d i o a c t i v e
caesium-134 ^  .
The s tu d ie s  o f  Burch and his  co l leag ues which in d ica ted  rap id  uptake of  
rub id ium-86  by the myocardium suggested the p o s s i b i l i t y  o f  demonstrat ing  
the myocardium by photoscanning a f t e r  a d m i n is t r a t io n  o f  t h i s  
r a d i o i s o t o p e .  Carr and h is  assoc ia tes  showed the f e a s i b i l i t y  of  
demonstrat ing the myocardium o f  the beat ing  heart  o f  l i v i n g  dogs by t h i s  
techniq ue .  Furthermore ,  in photosc in t igrams they found 'c o ld  are as '  of  
r e l a t i v e l y  decreased uptake o f  rubid ium-86  in h ear ts  p r e v io u s ly  sub­
j ec ted  to  coronary a r t e r y  l i g a t i o n ,  but these d e fec ts  could only  be 
i d e n t i f i e d  r e l i a b l y  a f t e r  ex c is io n  o f  the hear t  They, t h e r e f o r e ,
considered t h i s  Isotope u n s u i ta b le  fo r  in vivo  imaging o f  the myocardium 
and turned t h e i r  a t t e n t i o n  to caesium-131. Using a r e c t i l i n e a r  scanner 
and in t ravenous ly  In je c te d  caesium-131,  they repor ted  the f i r s t  success­
fu l  r a d io is o to p e  imaging o f  the human myocardium in v iv o ,  and they were 
ab le  to  demonstrate decreased isotope uptake corresponding to  areas of
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i n f a r c t e d  myocardium. In the same p u b l i c a t i o n  they a ls o  reported  that  
Ischaemic t i s s u e  in dogs showed an uptake o f  caesium less than th a t  of  
normal t i s s u e  but g re a t e r  than th a t  of  i n f a r c t e d  t i s s u e  d O ) .
Over the next  ten years a number of  d i f f u s i b l e  monovalent c a t i o n i c  e x -  
t r a c t a b l e  i n d ic a t o r s  were used c l i n i c a l l y  as myocardial  imaging agents,  
n otab ly  potassium-42 and potass ium-43,  rubidium-81 and rub id ium -82 ,  
caesium-129 and caesium-131,  and n i t r o g e n - 1 3  labeled  ammonia. None of  
them ever became a v a i l a b l e  fo r  widespread use and they d id  not reach the  
c l i n i c a l  a rena.  These ra d io n u c l id e s  had major disadvantages as myocar­
d i a l  Imaging agents ,  namely, t h e i r  low myocardial  e x t r a c t i o n ,  low t a r ­
get  organ/background r a t i o ,  and high photon e n e rg ie s ,  which made imaging 
w ith  a convent ional  gamma camera d i f f i c u l t  (12 )  j ^ e  s i t u a t i o n  was
changed by the in t ro d u c t io n  o f  th a l l iu m -2 0 1  in 1974 ( 13) .  This
r a d io n u c l id e  has been e x t e n s i v e ly  eva lu a ted  in both c l i n i c a l  and 
l a b o ra to ry  s tu d ie s  and has been ap p l ie d  p a r t i c u l a r l y  in asymptomatic and 
symptomatic p a t i e n t s  Tha l l ium-201  c u r r e n t l y  has replaced the
other  r a d io n u c l id e s  as the myocardial  imaging agent o f  choice .
R ad ionuc l ides  fo r  myocardial  imaging are g e n e r a l l y  in je c te d  as the 
c h lo r id e  s a l t  in the ionic  s t a t e .  The b i o l o g i c a l  behaviour o f  the 
rad io n u c l id e s  o f  potassium, rubidium, caesium and t h a l l i u m  vary in 
d e t a i l  w i th  respect  to  dosimetry ,  blood c le a ran c e ,  d u ra t io n  o f  uptake in 
t a r g e t  organ,  and t a r g e t  to  n o n - ta rg e t  r a t i o s .  D i f f e r e n t  r a d io n u c l id e s  
o f  a s p e c i f i c  e lement ,  such as potassium, demonstrate the same b i o l o g i ­
cal  behav io ur.  However, r a d io n u c l id e s  o f  a given  element w i l l  not have
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the same dosimetry because each ra d io n u c l id e  has d i f f e r e n t  decay charac­
t e r i s t i c s .  A l l  o f  the elements mentioned tend to  l o c a l i s e  in v ia b le  
t i s s u e ,  e . g . ,  the myocardium, r e s u l t i n g  in cold spot images o f  i n f a r c t e d  
or ischaemic areas ( 14 ) .  The pro p er ty  is dependent on broadly  s i m i l a r  
p h y s io lo g ic a l  behaviour between potassium and o ther  elements ,  which are  
viewed as potassium analogues.
Potassium is a major c a t i o n i c  c o n s t i tu e n t  o f  the body. The i n t r a c e l ­
l u l a r  content  o f  potassium ion is much higher than th a t  in the e x t r a c e l ­
l u l a r  spaces. This  g ra d ie n t  is mainta ined  by an energy expending  
process which is oxygen dependent,  and even t r a n s i e n t  per iods  o f  hypoxia  
lead to  immediate loss of  i n t r a c e l l u l a r  ion i f  t h i s  e f f l u x  could
be measured, a very s e n s i t i v e  method fo r  the rap id  d e t e c t i o n  o f  the  
re g io na l  hypoxia would be provided .  Of course,  the label would have to  
be in the c e l l  p r i o r  to the hypoxic i n s u l t .  Radiopotassium has only  
been used as a reg iona l  f low i n d i c a t o r .  On a s in g le  passage through the 
h e a r t ,  over 70 percent  o f  a v a i l a b l e  K+ ions in the plasma w i l l  en ter  
myocardial  c e l l s  d ® ) .  An equal number o f  I n t r a c e l l u l a r  ions w i l l  leave 
the c e l l ,  but as the co n cen t ra t io n  of  i n t r a c e l l u l a r  K+ to  e x t r a c e l l u l a r  
K + is very la rg e ,  the turnover r a t e  o f  the r a d i o a c t i v e  ions is slow
enough to  permit  a c q u i s i t i o n  o f  an Image th a t  i n i t i a l l y  represents  the  
d i s t r i b u t i o n  o f  reg iona l  blood f lo w .  Over a per iod  o f  several  hours,  
the r a d i o a c t i v e  and non-  r a d i o a c t i v e  potassium w i l l  come in to  equ i­
l ib r iu m ,  and the d i s t r i b u t i o n  o f  the r a d io a c t i v e  potassium then r e f l e c t s
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the potassium p oo l ,  not reg iona l  p e r f u s io n .  The most r e l i a b l e  d e t e r ­
min at ion  o f  reg io na l  p e r fu s io n  w i l l  be obta ined  In the f i r s t  few minutes  
f o l l o w in g  I n j e c t i o n
I (2 )  The phys ical  and b i o l o g i c a l  p r o p e r t i e s  o f  Tha l l lum-201
I ( 2 ) ( a )  Physical  P ro p e r t ie s
In 1861,  the Engl ish  chemist W i l l i a m  Crookes noted the occurence o f  a 
b r i l l i a n t  green l in e  in the spectrum o f  some selenium residues  w h i l s t  
examining them fo r  t e l l u r i u m .  He conf irmed t h a t  the green l i n e  was due 
to  a new element,  probably a higher member o f  the su lp h u r ,  selenium and 
t e l l u r i u m  group,  possessing wel l  de f in ed  c h a r a c t e r s .  He proposed fo r  i t
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the name o f  T h a l l iu m  (Symbol T l ) ,  from the Greek or L a t in  t ha I —
lus,  "a budding twig -  a word which is f r e q u e n t l y  employed to express  
the b e a u t i f u l  green t i n t  o f  young v e g e t a t i o n ,  and which I chose on ac­
count o f  the green l in e  which i t  communicated to  the spectrum r e c a l l i n g  
w ith  p e c u l i a r  v iv id n es s  the f resh  colour o f  e a r l y  spr ing" d 8 )
T h a l l iu m  (atomic number 81)  is a m e t a l l i c  element o f  group I I I A  o f  the  
p e r i o d ic  t a b l e .  I t  belongs to  a d i f f e r e n t  element group from potassium,  
rubidium and caesium.
The use o f  r a d io t h a I  IIum in nuclear  medicine was f i r s t  suggested by 
Kawana e t  a l ,  1970 ( W .  Using t h a l l l u m - 1 9 9  they demonstrated the pos­
s i b i l i t y  o f  imaging the human myocardium, but the images they obta ined
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were o f  poor q u a l i t y  because o f  contaminat ing high energy gamma rays 
causing e x c i t a t i o n  of  the lead In the c o l l i m a t o r  and they suggested tha t  
t h a l l lu m - 2 0 1  might be a more s u i t a b l e  rad io ph a rm ace ut ic a l .  Workers at  
Brookhaven Nat io na l  Laboratory  in the U.S.A.  developed a method for  
producing the ra d io n u c l id e  in a form s u i t a b l e  fo r  human use 0 3 )
Tha l l lum -201  was produced by i r r a d i a t i n g  a n a tu ra l  t h a l l i u m  t a r g e t  in 
the e x te rn a l  beams o f  the Brookhaven cy c lo t ro n  w i th  31 MeV protons.  The 
nuclear  r e a c t io n  is 203TI ( P>3n) — > 201 Pb> Lead-21 has a h a l f - l i f e  of
9 . 4  hours and is the parent  o f  201 T l - The th a l l iu m -2 0 1  is separated  
from the lead by a process in vo lv in g  d i s s o lv in g  the t a r g e t  in n i t r i c  
ac id  and passing the s o l u t io n  through severa l  r e s in  exchange column 
stages 0 3 ) .  Tha l l ium-201  has a phys ical  h a l f - l i f e  o f  73 hours,  and 
decays by e l e c t r o n  cap tu re ,  e m i t t i n g  a small y i e l d  o f  gamma rays (135 to  
167 keV) in ten per cent t o t a l  abundance. In a d d i t i o n ,  the daughter  
n u c l id e  mercury-201 emits X- rays  w ith  an energy o f  69 to  83 keV. These 
X - rays  occur In 98 percent  of  th a l l iu m -2 0 1  d i s i n t e g r a t i o n s  0 3 )  -p^g 
t h a l l iu m - 2 0 1  is contaminated w i th  a small amount of  t h a l l i u m - 2 0 2  ( ha I f — 
I I f e  288 hours)  ( 2 1 ) .
The gamma rays em it ted  by th a l l iu m -2 0 1  have s u i t a b l e  energ ie s  fo r  s c in ­
t i l l a t i o n  camera Imaging, but as they are not s i g n i f i c a n t l y  abundant the 
mercury daughter  X -rays  are u s u a l ly  u t i l i z e d .  A tk in s  e t  a I found that  
the X- rays  gave count r a t e s  dur ing myocardial  imaging which were seven 
t imes g r e a t e r  than those from the gamma rays ( 22 ) .  Because o f  the in­
herent  low energy o f  the X -rays  u t i l i z e d  fo r  t h a l l lu m -2 0 1  Images, the 
energy s ig na l  Is poorly  determined s t a t i s t i c a l l y  by the s c i n t i l l a t i o n
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camera and t h i s  r e s u l t s  in r e l a t i v e l y  poor s p a t i a l  and co n t ra s t  re s o lu ­
t i o n  in the image. Cont rast  r e s o l u t io n  is f u r t h e r  degraded by the Com­
pton s c a t t e r e d  photons from the gamma ray f r a c t i o n .  The h a l f - v a l u e  
layer  in t i s s u e  e q u iv a le n t  of  Hg-201 X - rays  is about 4 cm. so th a t  about 
50 percent  to  70 percent  of  the em i t te d  photons are absorbed in 
p a t i e n t s ^ 23 ) . Tissue a t t e n u a t i o n  can produce t h a l l i u m  d e f e c t s .  An ap­
parent  decrease in r a d i o a c t i v i t y  in the septum or l a t e r a l  wa l l  may occur  
secondary to  b reast  a t t e n u a t i o n  ( 24 ) .  The diaphragm has been shown to  
a t t e n u a t e  photons o r i g i n a t i n g  from the i n f e r i o r  myocardial  segment when 
the p a t i e n t  is in the supine p o s i t io n  fo r  the l e f t  l a t e r a l  v iew.  This  
d i f f i c u l t y  may be overcome by imaging w i th  the p a t i e n t  ly in g  on h is  or  
her r i g h t  s ide  ( 2 5 ) .
I ( 2 ) ( b )  Mechanism o f  c e l l u l a r  uptake o f  t h a l l i u m
In 1960, M u l l i n s  and Moore noted th a t  the c r y s t a l  rad iu s  o f  T l + (1 .44A)  
Is between th a t  o f  K+ (1 .33A )  and Rb+ ( 1 . 4 9 A ) ,  and thus expected that  
T l + would behave as do these a l k a l i n e  ions. Working w i th  the is o la ted  
f rog  s a r t o r i u s  muscle p r e p a r a t i o n ,  they found " r e s u l t s  which were con­
s i s t e n t  w i th  the view tha t  the muscle f i b r e  membrane cannot d i s t i n g u i s h  
between the t o x i c  heavy metal T l + and K+ provided t h a t  the concentra­
t io n s  o f  the former Ion are kept low". The e f f l u x  o f  T l + is increased  
during s t i m u l a t i o n  to  a t  least  the same e x ten t  as is th a t  o f  K+ in 
s t im u la te d  muscle
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The b i o l o g i c a l  s i m i l a r i t i e s  between potassium and t h a l l i u m  were con­
f i rmed by Gehring and Hammond working f i r s t l y  w i th  ra b b i t  
e r y t h r o c y t e s ^ 27) and l a t e r  w it h  b l o d l s t r i b u t I o n  s tu d ie s  in r a t s  and 
dogs^2®) .  They demonstrated th a t  " a c t i v a t i o n  o f  the Na and K a c t i v a t e d  
adenosine t r ip hosphatase  by the s u b s t i t u t i o n s  o f  t h a l l i u m  fo r  potassium 
supports the b e l i e f  th a t  the mechanism involved in the a c t i v e  t ran sp o r t  
of  potassium cannot d i f f e r e n t i a t e  between potassium and t h a l l i u m " .  The 
c e l l u l a r  uptake o f  Tl + was I n h ib i t e d  by ouabain and sodium f j jo r id e ,  
which block the Na+ -  K+ pump (28 )  B r i t t e n  and Blank working in r a b b i t  
kidney a lso  conf irmed tha t  the c e l l u l a r  uptake o f  t h a l l i u m  is due to ac­
t i v a t i o n  o f  the sodium-potassium ATP-ase system, but t h e i r  r e s u l t s  sug­
gested th a t  the mechanism o f  uptake was not id e n t i c a l  w i th  t h a l l i u m
bind in g  on two s i t e s  in the enzyme system compared to  one fo r  potassium 
( 2 9 ) .
G i l b e r t  and co-workers ,  1976,  in ves t ig a ted  myocardial  uptake o f  Tl + 
w ith  a canine i n f a r c t  model and reported  th a t  t h a l l iu m -2 0 1  co n cen t ra t io n  
in myocardial  b io p s ie s  c o r r e l a t e d  w ith  both p e r fu s io n  and reg iona l  ATP- 
ase a c t i v i t y  ( 3 0 ) .  This has led o ther  In v e s t ig a t o r s  to  p o s t u la t e  tha t  
the reduct io n  o f  t h a l l i u m  uptake in ischaemic myocardium is p r i m a r i l y  
due to  a decrease in ATP-ase a c t i v i t y  (®1 ) (32 )
Several  s tu d ie s  have shown tha t  the d i s t r i b u t i o n  o f  t h a l l i u m  is a f lo w -  
dependent process (®3) (34 )  (35 )  j 0 assess the r o l e  o f  ATP-ase in
t h a l l i u m  uptake ,  s tu d ies  were performed in a r r e s t e d  dog h ear ts  a f t e r  In­
troduc ing  ouabain.  The coronary sinus blood t h a l l i u m  a c t i v i t y  was in­
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creased approaching a r t e r i a l  a c t i v i t y ,  and the myocardial  e x t r a c t i o n  
r a t i o  f e l l  markedly.  i t  was concluded th a t  myocardial  t h a l l i u m  uptake  
is  mediated by ATP-ase * 35 ) . The myocardial  d i s t r i b u t i o n  o f  potassium 
analogues is  a ls o  dependent on reg iona l  blood f lo w .  Prokop e t  a l ,  1974,  
compared the re g iona l  d i s t r i b u t i o n  o f  io n ic  potassium-43 w i th  th a t  of  
r a d i o a c t i v e  microspheres admin is tered  in to  the l e f t  a t r ium  in th ree  
groups o f  dogs as an In d ic a to r  o f  blood f lo w .  The reg iona l  myocardial  
d i s t r i b u t i o n  o f  potassium was s i m i l a r  to  th a t  o f  microspheres under nor­
mal c o n d i t io n s ,  during exper imental  ischaemia and a f t e r  complete coro­
nary a r t e r i a l  occ lu s io n s .  These data suggest th a t  the major determinant  
o f  io n ic  t r a c e r  d i s t r i b u t i o n  is blood f low  C3®) .  S i m i la r  in v e s t ig a t i o n  
has been performed w i th  t h a l l i u m .  Strauss e t  a l ,  1975 <37 ) ,  and N ie lsen  
e t  a l ,  1980 ^3® ) ,  demonstrated tha t  the d i s t r i b u t i o n  o f  t h a l l i u m  in the 
canine myocardium f o l lo w in g  intravenous a d m i n is t r a t io n  is p ro p o r t io n a l  
to  the reg iona l  f low as measured w i th  labeled microspheres although the  
r e l a t i o n s h i p  to  blood f lo w  is not l in e a r  over a l l  f low r a t e s .  
S i m i l a r l y ,  Welch e t  a l ,  1977 C33 ) ,  found th a t  the i n i t i a l  e x t r a c t i o n  of  
t h a l l i u m  in canine h ear ts  is p ro p o r t io n a l  to  myocardial  blood f lo w .
Many o f  the c u r re n t  methods fo r  measuring blood f lo w  w i th  r a d io a c t i v e  
t r a c e r s  a re  based on the f r a c t i o n a t i o n  p r i n c i p l e  o f  S a p l r s t e i n  ( 39>, or  
on th e  reco rd in g  o f  myocardial  washout o f  d i f f u s i b l e  in d ic a t o rs  in je c te d  
in to  a coronary a r t e r y  .
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According to the S a p i r s t e l n  f r a c t i o n a t i o n  p r i n c i p l e ,  i f  an in d ic a t o r  is 
u n i fo rm ly  mixed w i th  blood at  the l e f t  v e n t r i c u l a r  o u t l e t  the f r a c t i o n  
o f  the adm in is te red  dose d i s t r i b u t e d  to  the myocardium du ring  the f i r s t  
c i r c u l a t i o n  equa ls  the f r a c t i o n  of  c a rd ia c  output  t h a t  perfuses  card iac  
muscle.  T h is  a p p l ie s  both to  p a r t i c u l a t e  in d ic a t o r s  t h a t  do not re ­
c i r c u l a t e  <4 1 ) ,  and to  r e - c i r c u l a t i n g  in d ic a t o r s  w i th  high e x t r a c t i o n  
r a t e s  during the f i r s t  c i r c u l a t i o n ,  such as potassium and o ther  c a t i o n i c  
t r a c e r s  as long as the amount o f  n o n -e x t rac ted  i n d ic a t o r  leav ing the 
myocardium is e x a c t l y  balanced by the amount t h a t  r e - e n t e r s  the coronary  
a r t e r i e s  w i th  r e - c i r c u l a t i o n  ( 4 2 ) .  Under these c o n d i t io n s ,  when the 
f r a c t i o n  o f  the in d ic a t o r  in the myocardium can be measured as a f r a c ­
t i o n  o f  the i n j e c t a t e ,  one can c a l c u l a t e  t o t a l  myocardial  blood f low  (or  
the f r a c t i o n  o f  c a rd iac  output  t h a t  per fuses the myocardium) ( 40 ) .
According to  the "Washout p r i n c i p l e ” , one can c a l c u l a t e  myocardial  biood  
f lo w  per u n i t  mass o f  myocardium, when the mean washout t ime o f  the in­
d ic a t o r  can be determined ,  the space o f  d i s t r i b u t i o n  o f  the in d ic a t o r  is 
confined  to  the myocardium and i t s  t i s s u e /b lo o d  p a r t i t i o n  c o e f f i c i e n t  is 
known ( 4 3 ) .  Nishiyama e t  a l ,  1982 ( 44 ) ,  s tud ied  myocardial  uptake and 
washout o f  t h a l l iu m -2 0 1  in an exper imental  dog model,  and found that  
t h a l l i u m  uptake and washout was d i r e c t l y  r e l a t e d  to  blood f lo w .  With 
r e a c t i v e  hyperaemia,  there  was a rap id  and absolu te  increase in uptake  
fo l low ed  by rap id  washout; w i th  ischaemia,  there  was slow and decreased  
uptake fo l lo w ed  by a slow washout. They found s i g n i f i c a n t  d i f f e r e n c e s  
In washout s lopes ,  compared to  contro l  dogs a f t e r  r e a c t i v e  hyperaemia,  
and a f t e r  t r a n s i e n t  ischaemia,  w i th  hal f -washout t imes o f  5 . 3  hours,  3 . 4
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hours and 11 .0  hours r e s p e c t i v e l y .  These data suggest th a t  both the 
I n i t i a l  excess in the hyperaemic area and the decreased uptake in the 
Ischaemic area  are co r rec ted  by d i f f e r e n t  washout r a t e s  o f  ischaemic and 
hyperaemic c e l l s  dur ing r e - d i s t r i b u t i o n  ( 4 4 ) .
In c l i n i c a l  p r a c t i c e ,  myocardial  blood f low is l i k e l y  to be the main 
determinant  o f  reg iona l  myocardial  d i s t r i b u t i o n  of  t h a l l i u m - 2 0 1 ,  but  
some exper imenta l  data suggest th a t  t h a l l i u m  accumulat ion becomes abnor­
mal o n ly  when decreased per fu s io n  r e s u l t s  in myocardial  ischaemia,  that  
is d isordered  metabol ism C4 5 ) .  Experimental animal s tu d ies  have 
demonstrated t h a t  the myocardial  d i s t r i b u t i o n  of  in t raven o u s ly  in je c te d  
t h a l l iu m -2 0 1  r e f l e c t s  myocardial  blood f low (37K The r e l a t i o n s h i p ,  
however, is not l i n e a r ,  w i th  increase in p e r fu s io n  producing a propor­
t i o n a l l y  smal le r  augmentation o f  t r a c e r  accumulat ion (37 )  ( 46)  Trap­
ping of  the t h a l l iu m -2 0 1  w i t h i n  the myocardial  c e l l  involves a dynamic 
process of  Na-K pump (30 )  The p r0 cess cons is ts  o f  cont inuous e x t r a c ­
t i o n  and re le a s e  o f  ion ic  t h a l l i u m  by v i a b l e  myocardial  c e l l s  ( 4 7 ) .  The 
changes in the t h a l l i u m  d i s t r i b u t i o n  observed on s e r i a l  images r e f l e c t  
both reg iona l  p e r fu s ion  and myocardial  c e l l  metabolism ( 11^. Though 
myocardial  blood f low is u s u a l ly  the main determinant  o f  the i n i t i a l  
d i s t r i b u t i o n  o f  t h a l l i u m - 2 0 1 ,  any process causing an abnorm al i ty  o f  the 
Na-K pump could Impair myocardial  uptake o f  th a l l lu m -2 0 1  ( 11^.
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I ( 2 ) Cc) B l o d i s t r l b u t Ion o f  th a l I lu m -2 0 1
Fol lowing  Int ravenous a d m i n i s t r a t i o n ,  t h a l I lu m -2 0 1  is d i s t r i b u t e d  to  
the e n t i r e  body, and is e x t r a c t e d  In m u l t i p l e  organs.  Bradley-Moore et  
a l ,  1975 (48 )  f working in goats found t h a t  the g r e a t e s t  co n cen t ra t io n s  
of  th a l I lu m -2 0 1  were in k idney ,  hear t  and l i v e r ,  and t h a t  the a c t i v i t y  
remained high in these organs fo r  at  leas t  two hours.  Maximum myocar­
d i a l  and renal  uptake were achieved by ten minutes.  The organ d i s t r i b u ­
t i o n  o f  t h a l l i u m  in animal species has been repor ted  to  be s i m i l a r  in 
mice ( 37 ) ,  in goats (48 )  f j n r a t s ancj <j0gs (49 )  f ancj | n man (22 )  (50 )
The r a t e  o f  blood disappearance is ext rem ely ra p i d .  Bradiey-Moore e t  
a l ,  1975 ( 4 8 ) f working w i th  goats found the h a l f - t i m e  c learance  from
blood o f  In travenous ly  in je c te d  t h a l l i u m  was less than one minute.  
S i m i l a r  rap id  ra t e s  o f  c learance  were reported  by She lber t  e t  al (1976)
(49 )  and by Strauss and P i t t  (1977 )  ( 5 1 ) .  Nishlyama e t  a l ,  1976 ( 5 2 ) , 
working w i th  dogs, found s l i g h t l y  slower c learance  which occurred in 
b ie x p on e n t ia l  fash ion wi th  the h a l f - t i m e  o f  the f a s t  component being 2 .9  
minutes.  A tk in s  e t  a l ,  1977 ( 22 ) ,  a lso  in v e s t ig a te d  the blood clea rance  
In humans, and reported  that  at  f i v e  minutes a f t e r  intravenous ad­
m i n i s t r a t i o n  on ly  f i v e  to  e ig h t  percent o f  the in je c te d  a c t i v i t y
remained in the blood.  A b iexp o n ent ia l  disappearance curve was obta ined  
w ith  9 1 .5  percent  o f  the blood r a d i o a c t i v i t y  disappearing  w i th  a h a l f -
t ime o f  about f i v e  minutes.  The remainder had a h a l f - t i m e  o f  about 40
hours. The m a j o r i t y  o f  the slower c le a r i n g  component was w i t h i n  the red
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blood c e l l s ,  the plasma f r a c t i o n  vary in g  from 28 percent  to 50 
p erc en t^22 ) .  St rauss and P i t t ,  1977 ( 5 1 ) f found t h i s  re s id u a l  blood  
c o n c e n t ra t io n  is in e q u i l i b r i u m  between red c e l l s  (33%) and plasma 
(66%).  The whole body r e t e n t i o n  o f  th a l I lu m -2 0 1  was measured in three  
v o lu n te e rs  by A tk ins  e t  a l ,  1977 ( 22 ) ,  using a whole body counter .  They 
found a mean whole body disappearance h a l f - t i m e  o f  9 . 8  days (range 7 . 4  -
12 .4  days ) .  A repeat  study w i th  potassium loading showed no s i g n i f i c a n t  
change, the h a l f - t i m e  being 11 .0  days (range 8.1 -  15.1 days) .
Bradley-Moore e t  al  reported  th a t  the maximum uptake o f  th a l l iu m -2 0 1  by 
the myocardium was approximately 3 . 7  percent  o f  the in je c t e d  dose at  
10-25 minutes ( 4 8 ) t a f in d i n g  subsequently conf irmed by o th e r s ^ 5 0 ) ( 4®) 
( 5 3 ) .  S che lber t  e t  a l ,  1976 ( 4 9 ) ,  demonstrated t h a t  myocardial  uptake  
in r a t s  was s i g n i f i c a n t l y  higher fo r  t h a l l i u m  than fo r  rubid ium. The 
t h a l l i u m  c o n cen t ra t io n  in the l i v e r  and blood were e i t h e r  lower or f e l l  
more r a p i d l y  than those of  rubidium r e s u l t i n g  in higher ta r g e t  to back­
ground r a t i o s  ( 4 9 ) .  Nishiyama e t  a l ,  1976, found both K-43 and T I —201 
surpass Cs-129 in terms o f  r a p i d i t y  o f  rad io n u c l id e  c o n cen t ra t io n  in the 
myocardium. Furthermore,  T I —201 is superio r  to Cs-129 and K-43 in t a r ­
get  to  n o n - ta r g e t  r a t i o  ( 52  ^ C5 4 ) .  A tk in s  e t  a l ,  1977 ( 22 ) ,  found that  
the myocardial  uptake o f  th a l l iu m -2 01  d id  not s i g n i f i c a n t l y  change from 
f i v e  to 60 minutes a f t e r  i n j e c t i o n  in human s u b je c t s .  Throughout t h i s  
p eriod  the blood a c t i v i t y  is s u f f i c i e n t l y  low to enable myocardial  
lmaging(22 ) .  Bradley-Moore e t  a l ,  1976 ( 4Q) ,  reported  t h a t  the loss of  
th a l l iu m -2 0 1  from the myocardium had two components w i th  h a l f - t i m e s  of
4 . 4  hours (78%) and 40 hours (22%) r e s p e c t i v e l y .
30
Abbate,  M a s e r I , B la g in l  e t  a l ,  1977 ( 5 5 > est im ated  the f i r s t  pass 
myocardial  e x t r a c t i o n  o f  th a l I lu m -2 0 1  to  be 83 percent  w h i l s t  P i t t  and 
Strau s s ,  1976 (®4 ) ,  quote a f i r s t  pass e x t r a c t i o n  o f  85 percent  o f  the 
t r a c e r .  Grunwald e t  al  (1981 )  ( 34  ^ In v e s t ig a te d  myocardial  e x t r a c t i o n  
e f f i c i e n c y  o f  T I —201 at  vary in g  coronary a r t e r y  p e r fu s io n  pressures and 
concluded th a t  the e x t r a c t i o n  of  t h a l l i u m  by the myocardium is not s i g ­
n i f i c a n t l y  a l t e r e d  at  var io us  le v e ls  o f  f lo w  re duct ion  <34 ) .
Myocardial  d i s t r i b u t i o n  o f  th a l l iu m -2 0 1  is uneven. This  was f i r s t  ob­
served in the goat hear t  ( 4Q) .  S im i la r  reg iona l  d i f f e r e n c e s  in myocar­
d i a l  t h a l l i u m  co n ce n t ra t io n  were found in the dog h e a r t ,  h igher con­
c e n t r a t i o n  being found in the f re e  LV wal l  and in the i n t r a v e n t r i c u l a r  
septum than in the f r e e  RV wal l  ( 4 9 >. Strauoret al ( 5 6 ) ,  1977,  working
in ca ts  found th a t  the highest  th a l l iu m -2 01  co n cen t ra t io n  per gram of  
muscle weight  was in the inner LV layer  and in the LV p a p i l l a r y  muscle,  
the out layer  c on ta in in g  ten to 15 percent  less r a d i o a c t i v i t y  per gram 
than the inner la y e r .  The t o t a l  RV t h a l l i u m  accumulation was found to  
be 40 percent  less than th a t  in the whole o f  the l e f t  v e n t r i c l e  (56 )  
Hamilton e t  a l ,  1978 (50 )  f found th a t  r i g h t  v e n t r i c u l a r  a c t i v i t y  was 
about 75 percent  o f  l e f t  v e n t r i c u l a r  a c t i v i t y .  These d i f f e r e n c e s  are  
l i k e l y  to  r e f l e c t  d i f f e r e n c e s  In reg ional  myocardial  p er fu s ion  since  
they correspond c l o s e ly  to the d i s t r i b u t i o n  o f  r a d io io d in a t e d  macroal -  
bumln p a r t i c l e s  The lower t h a l l i u m  c o nc en t ra t io n  in the RV
myocardium e x p la in s  why the t h i n  w a l led  RV o f t e n  is not v i s u a l i z e d  on 
s c i n t  igraphy.
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Drugs may a l t e r  the t i s s u e  d i s t r i b u t i o n  and, In p a r t i c u l a r ,  the myocar­
d i a l  uptake o f  t h a l l i u m - 2 0 1 .  Dipyr idamole f o l lo w i n g  Intravenous ad­
m i n i s t r a t i o n  can Increase coronary blood f low  to  th re e  to  four t imes  
r e s t i n g  le v e ls  w i th  a 60 percent  Increase in myocardial  t h a l l i u m -
201 c o n c en t ra t io n  (50 )  (46 )  Gould e t  a l ,  1978,  concluded th a t  myocar­
d i a l  images equal in q u a l i t y  to  those obtained when t h a l l iu m -2 0 1  was ad­
m in is te r e d  during t r e a d m i l l  s t r e s s  could be obta ined  using Dipyridamole  
in fus ion  ( 5 9 ) .  The opt imal  technique comprised o f  intravenous  
Dipyridamole at  a dose o f  0 .142  mg/Kg for  four minutes w i th  the  
th a l l iu m -2 0 1  in je c te d  in the t h i r d  and fo u r th  minute a f t e r  complet ion of  
the in f u s io n ,  w i th  the p a t i e n t  u p r i g h t ,  walking  in p la c e .  In a group of  
p a t i e n t s  who had both e x e rc is e  and Dipyr idamole imaging performed,  the 
s e n s i t i v i t y  and s p e c i f i c i t y  o f  the two techniques fo r  d e t e c t io n  o f  coro­
nary a r t e r y  disease was i d e n t ic a l  The s a t i s f a c t o r y  s e n s i t i v i t y
and s p e c i f i c i t y  o f  Dipyr idamole imaging have been conf irmed by H a r r i s  et  
a l ,  1980 Thus, "pharmacological  s t ress "  imaging w i th  Dipyr idamole
has p o t e n t i a l  c l i n i c a l  va lu e ,  e s p e c i a l l y  In p a t i e n t s  who are unable or  
u n w i l l i n g  to  e x e r c is e  adequate ly .
Digoxin and propranolo l  produce a small reduct io n  in l e f t  v e n t r i c u l a r  
th a l l iu m -2 0 1  c o n c e n t ra t io n ,  but t h i s  does not seem to  a f f e c t  the q u a l i t y  
of  Image obta ined  ( 5 ° ) .  Acidosis and hypoxia both induced a f a l l  in ex­
t r a c t i o n  e f f i c i e n c y  in p a r a l l e l  w i th  an increase In coronary blood f low  
( 47 )
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Sodium b icarbonate  has been shown to enhance the myocardial  concentra ­
t i o n  of  t h a l I lu m -2 0 1  In r a b b i t s  and goats ( 6 2 ) .  The suggest ion that  
t h i s  could be used c l i n i c a l l y  to  Improve the q u a l i t y  o f  myocardial  
images has not been attempted.
Renal uptake occurs r a p i d l y  being maximal 10 minutes a f t e r  in j e c t i o n  
in to  goats ( 4 3  ^ and between ten and 20 minutes a f t e r  i n j e c t i o n  in 
m i c e ^ 7 ^. Four hours a f t e r  i n j e c t i o n  o f  the t r a c e r ,  the r a t i o  o f  renal  
to  background a c t i v i t y  is reduced from th a t  s h o r t l y  a f t e r  i n j e c t i o n  but 
some accen tu a t io n  o f  renal  uptake can s t i l l  be seen on Images performed  
f i v e  days a f t e r  I n j e c t i o n  ( 2 2 ) .  The renal  e x c r e t i o n  r a t e s  fo r
t h a l l iu m -2 0 1  are low ( 4 9  ^ (22 )  Faecal e x c r e t io n  has a lso  been found to  
be i n s i g n i f i c a n t  ( 2 2 ) .
The uptake In the abdominal organs was approximately 20 percent  o f  the  
i n je c te d  dose. The large bowel shows cons iderab le  uptake o f  t h a l l i u m -  
201 and, as in the k idneys,  there  is prolonged r e t e n t i o n  of
act  I v I t y ( 2 2 ) . L iv e r  uptake Is marked when the t r a c e r  Is In je c te d  into  
animals at  res t  ( 49  ^ ( 49 )   ^ bUt | n c l i n i c a l  s tu d ies  l i v e r  uptake can be 
cons id erab ly  reduced by i n j e c t i n g  the ra d io n u c l id e  w ith  the p a t i e n t  
standing and f a s t i n g  ( 2 2 ) .  C o lo n ic ,  hepat ic  and s p ^ len lc  uptake are
reduced by I n j e c t i n g  the t r a c e r  during e x e r c is e ,  which a lso  produces a 
b e t t e r  myocardial  to  lung a c t i v i t y  r a t i o  (®3  ^ ( 2 1 ) .  T e s t i c u l a r  t i s s u e  
was found to  accumulate 0 .1 5  percent o f  the in je c t e d  dose in man.
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Studies  on a female beagle showed the t o t a l  amount In o v a r ie s  and uteru s  
was 0 . 2  percent  o f  the i n j e c t e d ,  but in human o v a r ie s  the uptake could  
not be est im ated  due to  high uptake in the gut and p e l v i c  organs 2^2K
The t h y r o id  accumulates 0 . 2  percent  o f  the in je c te d  dose, but t h i s  ac­
t i v i t y  disappears w i t h i n  24 hours (22K
Two mechanisms have been p o s tu la te d  fo r  the co n ce n t ra t io n  o f  t h a l l i u m  in 
the t h y r o i d .  F i r s t ,  the fo rmation  o f  a complex an ion,  t h a l l o u s  
d i c h l o r i d e  (T l  C12 - )  which could behave as an iodide analogue (based on 
i t s  p o s tu la ted  ion ic  rad ius  and ch arg e ) ,  or secondly,  the s u b s t i t u t i o n  
o f  t h a l l i u m  for  potassium in the sodium-potassium ATP-ase pump in which 
case the t h y r o id  d i s t r i b u t i o n  o f  t h a l l i u m  should p a r a l l e l  blood f low  
r a t h e r  than iodide con cen t ra t ion  (64)
The changes In t h y r o id a l  iodide con c en t ra t io n  in p e r c h lo ra t e  t r e a t e d  
r a t s  w i th  l i t t l e  change in the t h a l l i u m  c o n ce n t ra t ion  (®4 ) ,  and the in­
verse r e l a t i o n s h i p  between serum potassium level  and t h y r o id a l  t h a l l i u m  
uptake (65 )  a | |  suggest tha t  t h y r o id a l  t h a l l i u m  uptake r e f l e c t s  the
s t a t e  o f  sodium-potassium ATP-ase system -  the c a t i o n i c  side  o f  the pump 
-  r a t h e r  than an io n ic  s id e .
Pulmonary e x t r a c t i o n  f r a c t i o n  of  th a l l iu m -20 1  dur ing the f i r s t  t r a n s i t  
was es t im ated  to  be about nine percent  o f  the i n je c te d  dose (6® ) .  i n i ­
t i a l l y  the lung a c t i v i t y  rece ived  scant a t t e n t i o n  In the I n t e r p r e t a t i o n  
of  t h a l I lu m -2 0 1  s t u d ie s ,  a l though t h i s  c o n t r ib u t e s  a cons id erab le  p o r -
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t i o n  of  the background a c t i v i t y  o f  the heart  (®7 ) .  Increased pulmonary 
th a l l iu m -2 0 1  c o nc en t ra t io n  has been observed in e x e r c is e  s t re s s  t h a l l i u m  
p e r fu s io n  Imaging in p a t i e n t s  w ith  coronary a r t e r y  disease  ^7 0 ^
(69 )  (68 )  (71 )  This increased lung uptake a f t e r  s t r e s s  has been as­
so c ia ted  w i th  the presence o f  severe coronary a r t e r y  disease
The exact  mechanism o f  increased lung th a l l iu m -2 0 1  uptake f o l l o w in g  ex­
e r c i s e  is incomplete ly understood ^7 1 ^. Boucher e t  a l ,  1980, showed a 
d i r e c t  r e l a t i o n  between e xerc is e - in d u c ed  increased in pulmonary c a p i l ­
la ry  wedge pressure and increased lung th a l l iu m -2 0 1  uptake in p a t i e n t s  
w ith  s i g n i f i c a n t  coronary a r t e r y  disease in a d d i t i o n ,  Bingham et
a l ,  (1978)  ( 7 2 ) ,  using an open chest dog model, showed th a t  increased  
e x t r a c t i o n  o f  th a l l iu m -2 0 1  in the lung can r e s u l t  from increases in l e f t  
a r t e r i a l  pressure .  I t  may be p o s tu la ted  th a t  increased th a l l iu m -2 0 1  
lung a c t i v i t y  r e s u l t s  from t r a n s i e n t ,  exerc is e - in d u ced  l e f t  v e n t r i c u l a r  
dysfunct ion  w i th  a concomitant  increase in i n t e r s t i t i a l  lung w a te r .  Be­
cause t h a l l i u m  is in je c te d  in t ravenously  and i n i t i a l l y  t rav e rs e s  the  
pulmonary vascular  bed during a per iod  when l e f t  v e n t r i c u l a r  f i l l i n g  
pressure is e l e v a t e d ,  t ransudat io n  of  water  w i th  r a d i o t r a c e r  in to  the  
i n t e r s t i t i a l  compartment would occur ( 7° ) .
Increased lung uptake o f  th a l l iu m -2 0 1  is l i k e l y  to  r e s u l t  from l e f t  
v e n t r i c u l a r  dysfunct ion  o f  any cause, Includ in g  cardiomyopathy as wel l  
as v a l v u l a r  and congeni ta l  hear t  disease ^7 1 ^, and the c a l c u la t e d  in -
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dices  o f  increased t h a l l iu m -2 0 1  lung uptake and lung c learan ce  have been 
suggested as useful  Ind ices fo r  assessing the s e v e r i t y  o f  e x e r c i s e -  
induced l e f t  v e n t r i c u l a r  dysfunct io n  ( 7 3 >.
There is co n s id erab le  t h a l l i u m  uptake by the s k e l e t a l  muscles i f  
th a l l iu m -2 0 1  is In je c t e d  during e x e rc is e  ( 21 ) ,  and leg muscle uptake 
during walk ing  on a t r e a d m i l l  has been a p p l ie d  to  the assessment of  
p a t i e n t s  w i th  a r t e r i a l  disease C7 4 ) . Th is  technique has not found 
general  c l i n i c a l  a p p l i c a t i o n .
1 C2 ) Cd) R ad ia t io n  Dosimetry
The whole body r a d i a t i o n  dose from th a l l iu m -2 0 1  has been v a r i o u s ly  es­
t im ated  as 0 .0 7  to 0 .2 4  rads per m i l l i c u r i e  ^7^  ^ 3 ) ( 4®) ( 7®) ( 7 7 ^. 
The c r i t i c a l  organ fo r  r a d i a t i o n  exposure is the kidney w i th  an average
• f
r a d i a t i o n  dose ^  0 .5 2  rads per m i l l i c u r i e .  The renal  medul la  where 
t h a l l i u m  concentra tes  re ce ive s  a dose o f  1.1 rads per m i l l i c u r i e  ( 4 3 ) .  
This  dose Is u n l i k e l y  to  cause renal  damage as no s i g n i f i c a n t  long term 
f u n c t io n a l  or anatomical  e f f e c t s  were observed in dog kidneys i r r a d i a t e d  
w ith  400 rads <49 ) .
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1 ( 2 ) ( e )  Toxicology o f  Tha l l ium
In common w i th  o ther  heavy m eta ls ,  t h a l l i u m  is p o t e n t i a l l y  t o x i c .  The 
main e f f e c t s  are seen on the g a s t r o i n t e s t i n a l  t r a c t  and nervous 
system*7 8 * *7 8 * * 8 0 * .
The minimum f a t a l  dose of  t h a l l i u m  for  man is thought to  be 8 to 12 m i l ­
l igram per ki logram body weight  *8 1 * ,  or a t i s s u e  c o n ce n t ra t io n  o f  0 .5  
mg percent  e lementa l  t h a l l i u m  * 4 9 * .  T o x i c i t y  in higher animals and man
has been repor ted  at  a dose of  0 .1 m i l l i g r a m  per k i logram * 4 8 * .  Sch e l -
ojAm j (u *  .
b e r t  e t  a I c a l c u l a t e d  the dose adnri-n i s t  ra ted  in d iag n o s t ic  s tu d ies  using  
two m i l l i c u r i e s  to be o f  order 0 .0 7  to 0 .1 5  r?anogram per k i logram body 
w eig h t ,  and blood le v e ls  averaged 0.0017  nanogram per 100 ml * 4 9 * .  Even 
fo r  minimal t o x i c i t y ,  the re qu ired  dose of  t h a l l i u m  is about 10.000  
t imes g r e a t e r  than the dose o f  t h a l l i u m  given as r a d io ­
p h a rm a ceu t ica l *4 8 * .  As y e t ,  there  have been no re p o r ts  o f  i l l  e f f e c t s  
fo l l o w in g  a d m i n is t r a t io n  o f  the radiopharmaceut ical  o f  t h a l l i u m  as a 
d ia g n o s t ic  Imaging agent e i t h e r  In animal s tu d ie s  or fo r  human use.
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1 (3 )  Thai I lum-201 myocardial  Imaging
1 ( 3 ) ( a )  In t r o d u c t Io n
The main use o f  T I -201  imaging u n t i l  now has been in the d e t e c t i o n  of  
coronary a r t e r y  d isease .  In t h i s  a p p l i c a t i o n ,  s t r e s s  myocardial  imaging 
is e s p e c i a l l y  impor tant .  Var ious  s tu d ies  have shown th a t  reg iona l  
myocardial  p e r fu s io n  may not be s i g n i f i c a n t l y  changed a t  r e s t  in s p i t e  
o f  coronary a r t e r y  disease (CAD) (®2 ) (®2 ) (31 )
In 1973, Zaret  e t  al  (®4 ) reported  th a t  the a d m i n is t r a t i o n  of  
potassium-43 at  peak e x e rc is e  to  detect  e x e rc is e - in d u ce d  per fu s io n  
d e fec ts  in 28 o f  34 p a t i e n t s  w ith  coronary a r t e r y  d isease .  No de fec ts  
were seen in 12 out  of  12 p a t i e n t s  without  CAD. Strauss e t  a l ,  1973,  
demonstrated t h a t  Images obtained a f t e r  i n j e c t i o n  of  potassium-43 during  
e x e rc is e  were abnormal in CAD p a t i e n t s  w it h  normal re s t  s tu d ies  ( Q5 ) .  
CAD is t y p i c a l l y  a segmental disease with  vary ing  degrees o f  o b s t ru c t io n  
in d i f f e r e n t  coronary a r t e r i e s .  During e x e r c i s e ,  increased myocardial  
oxygen consumption req u i res  an increase in coronary blood f lo w .  In 
s i t u a t i o n s  o f  increased myocardial  oxygen demand or dur ing pharmacologi­
cal hyperaemia,  the coronary f low increases in non-obst ructed  coronary  
a r t e r i e s  but does so to  a lesser ex te n t  in a r t e r i e s  w it h  s i g n i f i c a n t  
s te n o s is .  This impairment w ith  s t re s s  hyperaemia was seen d i s t a l  to oc­
c lu s io n s  o f  50 percent  or more o f  the luminal diameter  ( 5 9 ) .  i f  
th a l l iu m -2 0 1  is in je c te d  at  peak e x e r c i s e ,  the increased f low  in normal
38
vesse ls  leads to g r e a t e r  t h a l I lu m -2 0 1  c on c en t ra t io n  In t h e i r  t e r r i t o r y .  
At the same t ime,  areas perfused by diseased vesse ls  do not rec e iv e  such 
an Increase In f lo w ,  and a d i f f e r e n c e  in t r a c e r  co n cen t ra t io n  
r e s u l t s ^ 37 ) .
At r e s t ,  areas o f  decreased myocardial  T I —201 uptake have been shown to  
c o r r e l a t e  u s u a l l y  w i th  myocardial  f i b r o s i s  or necrosis (8 ® ) .  This has 
lead to  the c l a s s i f i c a t i o n  o f  T I -201  de fec ts  as f i x e d  or i r r e v e r s i b l e .  
Areas o f  abnormal t r a c e r  uptake on the s t re s s  study not seen on the res t  
study,  " r e v e r s i b l e  d e f e c t s " ,  are taken to in d ic a ted  v i a b l e  but ischaemic 
myocardium, w h i le  d e fec ts  which are unchanged from re s t  to  s t r e s s  " f ix e d  
d e fec ts "  are taken to in d ica ted  n o n -v iab le  t i s s u e  (®7 ) (88 )  (®9 ) (90 )
In 1977, Pohost et  al observed th a t  c e r t a i n  zones o f  decreased myocar­
d i a l  t h a l l i u m  uptake present  on immediate p o s t - s t r e s s  images reso lved ,  
w h i le  o th er  d e fec ts  p e r s is t e d .  The t r a n s ie n t  de fec ts  appeared to cor­
respond to  zones o f  t r a n s i e n t  ischaemia, w h i le  the p e r s i s t e n t  d e fects  
appeared to  correspond to zones of  previous myocardial  i n f a r c t i o n  ( 4 7 ) .  
The mechanism o f  r e d i s t r i b u t i o n  appears to be a combinat ion o f  uptake of  
t h a l l i u m  from the blood pool by the p re v io u s ly  ischaemic zone and a loss 
of isotope from the non- ischaemic area which has an est imated  b i o lo g ic  
h a l f - t i m e  o f  4 . 5  and seven hours (®1) (47 )  The r e s u l t i n g  Image re p re ­
sents the net e f f e c t  o f  th a l l i u m  uptake by the p re v io u s ly  ischaemic zone 
and loss from the non- ischaemic zone (®2 ) .  Th is was confirmed in ex­
per imenta l  s tu d ie s  by Grunwald e t  a l ,  1981 (®3 ) , who measured the 
i n t r i n s i c  myocardial  washout r a t e  o f  t h a l l i u m  In the absence o f  systemic
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r e c i r c u l a t i o n .  At anyt ime a f t e r  l . v .  I n j e c t i o n  of  the t r a c e r  the 
myocardial  c o n ce n t ra t io n  of  th a l l iu m -2 0 1  depends upon the net  balance  
between con t in u in g  myocardial  e x t r a c t i o n  from low le v e ls  o f  r e c i r c u l a t ­
ing t h a l l i u m  in the blood compartment and the net  r a t e  o f  e f f l u x  of  
t h a l l i u m  from the myocardium in to  the e x t r a c a r d i a c  blood pool .
Experimental s tu d ies  were performed by Khan, S t rauss ,  Pohost e t  a l ,  
1983,  in animals w i th  acute coronary occ lu s io n  to  compare the d i s t r i b u ­
t i o n  o f  r a d i o la b e l e d  ant imyosin ant ibody (AM-Fab) w i th  immediate and 
delayed d i s t r i b u t i o n  o f  t h a l l i u m - 2 0 1 .  Cardiac m y o s in - s p e c i f i c  an­
t i b o d i e s  labeled  w i th  iod ine-125  l o c a l i z e  in n e c r o t i c  myocytes and are  
h ig h ly  s p e c i f i c  markers fo r  myocardial  i n f a r c t i o n .  Tha l l ium-201  d i s ­
t r i b u t i o n  c o r r e l a t e d  c l o s e ly  with  microsphere regional  blood f lo w ,  but 
an inverse exponential  r e l a t i o n  to io dine-125  ant imyosin ant ibody (AM- 
Fab) uptake was found. They concluded tha t  immediate t h a l l iu m -2 0 1  d i s ­
t r i b u t i o n  at  f i v e  minutes a f t e r  i n j e c t i o n  is f l o w - l i m i t e d  and an in­
d ic a t o r  o f  r e l a t i v e  blood f lo w .  Delayed th a l l iu m -2 01  d i s t r i b u t i o n  
r e f l e c t s  c e l l  v i a b i l i t y  and Is f low independent
The a b n o r m a l i t i e s  observed in e a r l y  post s t re s s  images can be due to  
e i t h e r  e xe rc is e - in d u ced  in homogenity of  p er fus io n  or to  previous areas  
of  myocardial  s c a r r in g  or i n f a r c t s .  A second study is necessary to 
determine whether the area wi th  decreased p er fus io n  is i r r e v e r s i b l y  
damaged (scar  t i s s u e )  or is ischaemic but v i a b l e .  Since the h a l f - l i f e  
o f  th a l I lu m -2 0 1  Is 74 hours, a repeat  study should be done f i v e  to seven 
days l a t e r  a t  r e s t .  I f  the images are s i m i l a r  dur ing e x e rc is e  and r e s t ,
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a d iagnosis  o f  o ld  scar  is made. IF the images are abnormal during ex­
e r c i s e  but normal at  r e s t ,  the diagnos is  o f  e xe rc is e - in d u ced  perfus ion  
abnorm al i ty  Is made. The need fo r  two sep arate s tu d ie s  Is uncomfortable  
f o r  the p a t i e n t  and adds to  both the r e d l a t l o n  dose and the expense of  
the t e s t  0 5 )  (11 )  (12 )  Pohost e t  a l ,  1977 C4 7 ) ,  have shown t h a t  the  
p e r fu s io n  abnorm al i ty  w i l l  tend to normal ize  i f  a repeat  study is done 
th re e  to  s ix  hours a f t e r  the i n i t i a l  e xe rc is e  images. This  is termed a
r e d i s t r i b u t i o n  (de layed)  study,  or the s in g le  dose technique.
I t  is now g e n e r a l l y  accepted fo r  c l i n i c a l  purposes, s t r e s s  and 
r e d i s t r i b u t i o n  imaging r a th e r  than sep arate s t r e s s  and r e s t  s tu d ie s  is 
s a t i s f a c t o r y  C12) .
1 ( 3 ) ( b )  A c q u is i t io n  o f  myocardial  images
Three types o f  myocardial  imaging are mainly used in c l i n i c a l  p r a c t i c e ,  
namely, ( 1 )  r e s t ,  ( 2 )  e xe rc is e  or s t r e s s ,  and (3 )  r e d i s t r i b u t i o n  images. 
Some s tu d ie s  are combined with  dypyridamole v a s o d i l a t io n
R ec en t ly ,  there  has been marked Improvement In the te ch n ic a l  aspects of
t h a l l iu m - 2 0 1  myocardial  imaging e s p e c i a l l y  in imaging systems, computer 
a p p l i c a t i o n ,  tomographic techniques and q u a n t i t a t i v e  a n a ly s is  of  
t h a l l iu m - 2 0 1  d i s t r i b u t i o n .
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1 ( 3 ) ( b ) ( 1 ) ThaI I lum-201 Imaging at  res t
Rest s tu d ie s  a re  performed by I n j e c t i n g  the t r a c e r  as a bolus
intravenous I n j e c t i o n  in a standard dose o f  1 .5  to  two mCl a f t e r  the
p a t i e n t  has been s i t t i n g  q u i e t l y  fo r  some t im e .  The s p le n ic  uptake can
be minimized by having the p a t i e n t  fa s t  p r i o r  to  the in j e c t i o n  
( 12).
1 ( 3 ) ( b ) ( 2 ) Exerc is e  myocardial  thalMum-201 imaging
Stress  T I -201 imaging should always be performed by a phys ic ian  who is 
experienced In e x e rc is e  t e s t i n g .  Any c o n t r a - i n d i c a t i o n  to  e xerc is e  
t e s t i n g  such as ar rhy thm ia s ,  unstab le  angina decompensated card iac  
f a i l u r e  and severe ,  u n c o n t ro l le d  hyper tension should be excluded by h is ­
to ry  and examin at ion .  Whenever p o s s ib le ,  n i t r a t e s  are w i th h e ld  fo r  at  
least  four hours p r i o r  to  the t e s t .  The other  card iac  medicat ions such 
as b e t a - b l o c k e r s ,  calcium an ta g o n is ts ,  o ther  v a s o d i l a t o r s ,  d i g i t a l i s ,  
d i u r e t i c s ,  or a n t la r r h y t h m ic  drugs are not d iscont inued  r o u t i n e l y .  I t  
must be kept  in mind th a t  the a d m in is t r a t io n  o f  b e ta -b lo c k e rs  w i l l  f r e ­
qu e n t ly  r e s u l t  in suboptima I exe rc is e  t e s t  r e s u l t s  because o f  lesser  
hear t  r a t e  Increases,  and t h i s  may decrease the s e n s i t i v i t y  o f  the  
test^12) .
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A f t e r  d e t a i l e d  e x p la n a t io n  o f  e xe rc is e  procedures to the p a t i e n t ,  a 
medium-sized ang io ca th e te r  is secured to an a n t e c u b i t a l  ve in  and a t ­
tached to  a s o l u t io n  o f  dextrose  and w a te r .  A 1 2 - le ad  ECG is recorded  
at  r e s t .
For the e x e r c is e  t e s t  a Bruce m u l t is ta g e  t r e a d m i l l  e x e r c is e  protocol  or 
b i c y c l e  ergom etr ic  exe rc is e  may be used. Blood pressure is measured 
w ith  sphygmomanometer at the midpoint  of  each s tage.  At peak exerc is e  
l e v e l ,  a dose o f  1 .5  to two mCi of  th a l l o u s  c h l o r i d e  T I —201 is in jec ted  
in t ravenous ly  and f lushed  w i th  dextrose and w ater .  The p a t i e n t  is r e ­
quested to  cont inue e x e r c is in g  fo r  30 to 60 seconds more. An ECG is re ­
corded immediately upon te rm in a t io n  in the standing  and supine p o s i t io n .  
The p r e c o rd ia l  leads are removed, the p a t i e n t  is p o s i t io n ed  under the
gamma camera, and a c q u i s i t i o n  is u s u a l ly  s t a r t e d  w i t h i n  two to th ree
minutes o f  te rm in a t io n  of  e x e r c is e .
The method o f  t h a l l i u m  a d m in is t r a t io n  and t im ing of  s c in t ig r a p h y  are im­
p o r tan t  in d e t e c t in g  s t ress - in d u ced  myocardial  ischaemia. I f  exerc is e  
is not mainta ined  a f t e r  th a l l i u m  a d m in i s t r a t io n ,  the d i s t r i b u t i o n  o f  the 
r a d io n u c l id e  may not r e f l e c t  the he te rog e n e i ty  of  e xe rc is e  induced per ­
fus io n  a b n o r m a l i t i e s .  I f  the exerc is e  is submaximal ( l e s s  than 85% of  
p r e d ic te d  maximal hear t  r a t e )  there may be i n s u f f i c i e n t  d i f f e r e n c e s  in 
myocardial  per fu s io n  to be detected by s c in t ig r a p h y  (23 )  McLaughlin et
a l ,  1977 (®®),  have demonstrated th a t  o f  the th a l l i u m  p er fus io n  d e fects
seen a f t e r  maximal e x e r c is e ,  on ly  53 percent  were present  a f t e r  sub-  
maximal e x e r c is e .
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The Images c o l l e c t e d  s h o r t l y  a f t e r  e x e rc is e  are r e p r e s e n t a t i v e  o f  the 
myocardial  p e r fu s io n  during s t r e s s .  I f  s c i n t i g r a p h y  is delayed or 
prolonged a f t e r  e x e r c i s e ,  the d i s t r i b u t i o n  o f  t h a l l i u m  In the myocardium 
may be in f luenced by a r e d i s t r i b u t i o n  o f  the r a d i o n u c l i d e ,  and the image 
obta ined  does not r e f l e c t  myocardial  p er fu s ion  during e x e r c is e ,  and 
s t re s s - in d u c e d  a b n o rm a l i t i e s  may be missed C47) .
1 ( 3 ) ( b ) ( 3 ) R e d i s t r i b u t i o n  Images
Pohost e t  a l ,  1977, demonstrated th a t  fo l lo w in g  e x e r c is e  i n j e c t i o n  of  
t h a l l i u m - 2 0 1 ,  delayed imaging In p a t i e n t s  w ithout  i n f a r c t i o n  but w it h  
e x e r c is e  induced ischaemia revea led  disappearance o f  i n i t i a l  p er fu s io n  
d e f e c t s .  These authors observed th a t  p i c t u r e s  taken two to  four hours 
ap a r t  in dogs w i th  complete coronary l i g a t i o n  were s i m i l a r .  On the 
o th er  hand, when p i c t u r e s  were taken two to four hours a f t e r  the re le ase  
th e re  was a s u b s t a n t ia l  d i f f e r e n c e  w ith  a " r e d i s t r i b u t i o n "  or " f i l l i n g  
in" in the regions d is p la y in g  per fus io n  defect  in the e a r l y  images. 
This  method o f  the s in g l e  dose" was c l i n i c a l l y  useful  e s p e c i a l l y  in the  
d i s t i n c t i o n  between ischaemia and i n f a r c t i o n  t 47 ) .
I t  was i n i t i a l l y  b e l ie v e d  that  r e d i s t r i b u t i o n  o f  t h a l I i u m  might be 
secondary to  r e a c t i v e  hyperaemia in p re v io u s ly  ischaemic areas fo l lo w in g  
e x e r c i s e .  However, r e d i s t r i b u t i o n  has a ls o  been observed a f t e r  in je c ­
44
t i o n  a t  r e s t  In p a t i e n t s  w ith  severe f i x e d  coronary s tenos is  without  In­
f a r c t i o n  and w ithout  evidence o f  In te rn a l  changes in myocardial  p e r fu ­
s ion between the t ime o f  I n j e c t i o n  and delayed imaging 0 7 )  (98)^
1 ( 3 ) ( b ) ( 4 ) Imaging system
Thai I lum-201 images can be recorded w i th  e i t h e r  a r e c t i l i n e a r  scanner or  
s c i n t i l l a t i o n  camera but the l a t t e r  is almost u n i v e r s a l l y  used now. The 
energy window o f  choice fo r  c l i n i c a l  t h a l l i u m  imaging is a 20 per cent  
window centered on the abundant 69 -83  keV mercury X - ray  photopeak 0 2 )  # 
In systems w i th  m u l t i - p u l s e  height  a n a ly z e rs ,  the use in a d d i t io n  fys- the  
less abundant 135 and 167: keV photopeaks may be d e s i r a b le  in order to
improve counting s e n s i t i v i t y  and s p a t i a l  r e s o l u t i o n .  Gamma cameras wi th  
at  least  37 p h o t o m u l t ip l i e r  tubes are used, p r e f e r a b l y  those w ith  1 /4  
inch t h i c k  c r y s t a l s  w ith  s i g n i f i c a n t  improvement in i n t r i n s i c  and system 
r e s o l u t i o n  and n e g l i g i b l e  loss in s e n s i t i v i t y .
Standard f i e l d  o f  view cameras are most commonly f i t t e d  w i th  a low 
energy a l l  purpose or high s e n s i t i v i t y  c o l l i m a t o r .  A high r e s o lu t io n  
c o l l i m a t o r  may be used, but myocardial  motion and degradat ion of  the 
image by t i s s u e  absorpt ion tend to cancel any gain In r e s o l u t i o n .  A 
converging c o l l i m a t o r  w i l l  magnify the s i z e  of  the myocardial  image but 
may produce d i s t o r t i o n  of  the image and loss of  c o n t r a s t ,  and so have 
not gained wide acceptance except when a wide f i e l d  o f  view camera is 
being used O D  0 3 )  O D .  To adequately d e l in e a t e  the l e f t  v e n t r i c u l a r  
myocardium m u l t i p l e  p r o je c t io n s  are taken,  u s u a l ly  a n t e r i o r ,  one or more
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l e f t  a n t e r i o r  o b l iq u e  (LAO) Images and a l e f t - l a t e r a l .  The p rec ise  
anatomical areas seen In each p r o je c t io n  w i l l  depend somewhat on the 
o r i e n t a t i o n  o f  the hear t  ( 25 ) .  in th a l I lu m -2 0 1  images, the areas o f  the 
l e f t  v e n t r i c u l a r  myocardium best seen In any p r o j e c t io n  are those per­
p en d ic u la r  to  the f r o n t  o f  the camera face ( 6 1 ) .
The computer p lays  an important  r o le  in th a l l i u m  a c q u i s i t i o n ,  processing  
and d i s p l a y .  The g a t in g  o f  T I —201 Image a c q u i s i t i o n  may improve the 
q u a l i t y  o f  the images by removing the b l u r r i n g  induced by ca rd iac  motion
(50 )  (9 9 )  bUt | S doubt ful  i f  t h i s  s i g n i f i c a n t l y  improves d ia g n o s t ic
y i e l d (1 0 ° ) .
Tomographic techniques have been u t i l i z e d  fo r  d is p la y in g  the rad ioac ­
t i v i t y  in a s e c t io n  of  the myocardium at a given depth.
Vogel e t  a l ,  1979, have described the use o f  a 7 -p in h o le  c o l l im a t o r  to 
produce myocardial  tomograms w ith  t h a l l i u m - 2 0 1 .  In a s e r ie s  of  65 
p a t i e n t s  In whom both 7 -p in h o le  and planar  Images were ob ta ined ,  they 
demonstrated improvement in accuracy o f  d e te c t io n  o f  coronary a r t e r y  
disease  over non-tomographic methods ( 1 0 1 ) .  S im i la r  r e s u l t s  were 
repor ted  by Francisco e t  a l ,  1979 ( 1 0 3 ) .  However, R i t c h i e  e t  a l ,  1981 
( 1 0 4 ) ,  found t h a t  7 - p i n h o l e  c o l l im a t o r  tomography had no advantage over  
planar imaging fo r  d e te c t in g  p r i o r  myocardial  i n f a r c t i o n .
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S in g le  photon emission tomography w ith  a r o t a t i n g  gamma camera does give  
tomographic s l i c e s  w it h  l i t t l e  in t e r p la n a r  propagat ion (105)  (106)
Tamaki e t  a l ,  1981,  ( 1 ° 7 ) ,  found th a t  the s e n s i t i v i t y  o f  diagnosing
p r i o r  myocardial  i n f a r c t i o n s  by th a l l iu m -2 01  s i n g le  photon emission  
tomography (SPECT) was 96 percent  compared w i th  75 percent  by standard  
pla nar  imaging. Maublant e t  a l ,  1981 d ° 8 ) ,  a ls o  found th a t  SPECT in­
creased the s e n s i t i v i t y  fo r  diagnosing p r io r  myocardial  i n f a r c t i o n .  
Nohara e t  a l ,  1984 ( 1 0 9 ) ,  compared exe rc is e  SPECT w ith  planar  s c i n t i g ­
raphy in p a t i e n t s  with  CAD. The s e n s i t i v i t y  and s p e c i f i c i t y  of  SPECT 
In d e t e c t in g  disease in each coronary a r t e r y  was 96 and 87 percent  fo r  
the r i g h t  coronary ,  88 and 89 percent fo r  LAD, and 78 and 199 percent  
fo r  LC a r t e r i e s .  Those are higher than the corresponding f i g u r e s  fo r  
planar  imaging (85 and 87% for  r i g h t  coronary a r t e r y ,  73 and 89% for  
LAD, and 39 and 100% for  L C ) .
1 ( 3 ) ( c )  I n t e r p r e t a t i o n  o f  myocardial  Images
The aim o f  using d i f f e r e n t  techniques in t h a l l i u m  s c in t ig r a p h y  is to  
enhance the s e n s i t i v i t y  and s p e c i f i c i t y  or o v e r a l l  accuracy in diagnos­
ing coronary a r t e r y  disease by minimiz ing the d i f f e r e n c e s  in image con­
t r a s t ,  and the r o l e  o f  the observer  In i n t e r p r e t a t i o n .  Computer 
processing  o f  t h a l l i u m  images has been d i re c t e d  toward image enhancement 
and q u a n t i t a t i o n .  Two types of  image enhancement are mainly used,  
namely background s u b t ra c t io n  and image f i l t e r i n g .
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U n t i l  now, there  is no g e n e r a l l y  accepted method fo r  background sub-
s t r a c t lo n .  In some studies no background subtract ion was u s e d d 10)
( 111) ( 112)
Two methods of background correction commonly being used are e i th er  
simple threshold subtract ion d ”*3) (44) (114) ,  or b i l in e a r  in te rp o la t Iv e  
background substraction d 1 6 )  (116) .
The f i n a l  th a l l iu m -2 0 1  myocardial  images are s t i l l  most commonly
ana lyzed v i s u a l l y .  Leaners et  a l ,  1977 ( 1 1 7 ) f used a combined v isua l  
and q u a n t i t a t i v e  technique by generat ing  myocardial  isocount l i n es  and 
considered areas f a l l i n g  below the 75 percent level  as abnormal.
F le t c h e r  e t  a l ,  1978 ( 1 1 0 ) ,  der ived  an index o f  "perfus ion  in
homogen I t y "  by computer an a ly s is  of  the a c t i v i t y  in each m atr ix  element  
occupied by the myocardial  image. Wainwright  et  a l ,  1977 d 1 8 ) f used a 
re g io na l  count den s i ty  p r o f i l e  to analyze the image. Meade et  a l ,  1978 
d 1 9 ) ,  Burrow e t  a l ,  1979 d 1 2 ) f and McKI I lop et  a l ,  1978 d 2 0 ) f
descr ibed  d i f f e r e n t  versions of  producing c i r c u m f e r e n t ia l  a c t i v i t y  
p r o f i l e s  on t h a l l i u m  images. McKI I lop et  a l ,  1980 ( ”*16) f compared the 
v is u a l  and semi-quant  I t a t  Ive a n a lys is  o f  s t res s  tha l l iu m -201  myocardial  
images in 79 p a t i e n t s  with suspected coronary a r t e r y  d isease.  With the 
semi-quant I  t a t  Ive method they achieved the highest  accuracy fo r  the 
c l a s s i f i c a t i o n  o f  p a t i e n t s  as e i t h e r  having or not having coronary  
a r t e r y  d isease .  Garc ia et  a l ,  1981 ( 1 2 1 ) ,  and Maddahi e t  a l ,  1981
d 2 2 ) f using a computer-mapping technique th a t  combined c i r c u m f e r e n t ia l
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a c t i v i t y  p r o f i l e s  between s t r e s s  and r e d i s t r i b u t i o n  demonstrated in­
creased s e n s i t i v i t y  w i th  coronary a r t e r y  d isease ,  p a r t i c u l a r l y  in 
p a t i e n t s  w i th  m u l t i p l e  vessel d isease.
Var io us  q u a n t i t a t i v e  methods and s e m i - q u a n t i t a t i v e  techniques have been 
found to have g re a te r  accuracy fo r  the d e te c t io n  o f  coronary a r t e r y  d is ­
ease than v isua l  a n a ly s is  of  the same image ( H 7 ) (123)  (124 )  (116)  
( 12 ) .  However, Gould, 1982 ( 125) ,  rev iewing the l i t e r a t u r e  on q u a n t i t a ­
t i v e  Imaging In nuclear  card io logy  concluded th a t  w h i le  these com­
p u t e r i z e d  mapping techniques may add i m p a r t i a l i t y  and ease o f  i n t e r ­
p r e t a t i o n  to these s t u d ie s ,  they have not been proven yet  to improve 
d ia g n o s t ic  accuracy^125^ .
I n t r a -  and in terobserver  v a r i a t i o n  in f luence  the i n t e r p r e t a t i o n  o f  t h a l ­
lium s c i n t i g r a p h y ,  and thus the accuracy of  d e tec t in g  coronary a r t e r y  
disease .  Hamilton e t  a l ,  1977 ( 1 2 6 )  ^ reported 90 percent  complete 
in t ra o b serv er  agreement in 30 rest  t h a l l iu m  sc in t igrams and in the other  
ten percent  on ly  minor disagreement.  The same was reported  by B o tv in ic k  
et  a l ,  1978 ( 127>, when exerc is e  and re s t  scans were compared in 50
p a t l e n t s .
Several  s tu d ie s  have repor ted in terobserver  v a r i a b i l i t y  in th a l l i u m  scan 
I n t e r p r e t a t i o n  <8 8 > <9 0 > (117)  (128 )  (126)  (129 )  (130 )  ( 1 0 0 ) . The I n -  
cldence o f  disagreement var ie d  between 11 percent  and 21 percent .
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The i n t e r  observer  v a r i a t i o n  is acceptable and Is no worse than repor ted  
fo r  in the I n t e r p r e t a t i o n  of  coronary angiogram (131)  ( 1 3 2 ) .  chest  
X - r a y d 33) ;  and l i v e r  scan (134)
IC3 ) ( d ) S e n s i t i v i t y  and s p e c i f i c i t y  In the diagnosis  o f  coronary a r t e r y  
disease
S e n s i t i v i t y  is de f ined  as p a t i e n t s  w it h  t ru e  p o s i t i v e  r e s u l t s  d iv id ed  by 
a l l  p a t i e n t s  w i th  coronary a r t e r y  d isease ,  and s p e c i f i c i t y  as p a t i e n t s  
w ith  t r u e  neg a t ive  r e s u l t s  d iv id ed  by a l l  p a t i e n t s  without  coronary d is ­
ease.  A rev iew ( 1 3 5 ) f summarizing data on 1 ,817  p a t i e n t s  inc luding most 
o f  the repor ted  s e r ie s  wi th  exerc is e  th a l l iu m -20 1  s c in t ig r a p h y  shows a 
range o f  s e n s i t i v i t y  (f rom 66 to 100%) and s p e c i f i c i t y  (75 to 100%).  
The average values fo r  the 24 publ ished s e r ie s  were 82 percent  sen­
s i t i v i t y  and 90 percent s p e c i f i c i t y .  With in  these s e r i e s ,  the o v e r a l l  
s e n s i t i v i t y  and s p e c i f i c i t y  of  the e le c t ro c a r d io g r a p h ic  exerc is e  tes t  
fo r  coronary a r t e r y  disease was 60 percent  and 81 percent  
respect  I v e l y d 3® ) . The th a l l iu m -2 01  e xerc is e  study has been found par­
t i c u l a r l y  usefu l  in p a t i e n t s  with  equivocal  e le c t r o c a r d io g r a p h ic  t e s t s  
because o f  h y p e r v e n t i l a t i o n ,  drug e f f e c t ,  v e n t r i c u l a r  hypertrophy,  
I n t r a v e n t r i c u l a r  conduct ion delay and bundle branch b lo ck ,  p r e -  
e x c i t a t i o n  syndrome or previous myocardial  i n f a r c t i o n  d 27 ) (136)
The s e n s i t i v i t y  o f  tha l l ium -201  exerc is e  t e s t  fo r  coronary disease in­
creases w i th  increasing extent  o f  diseased vesse ls and increas ing  
s e v e r i t y  o f  s tenos is  d 23 ) d 28 ) .  The s c i n t i g r a p h i c  s e n s i t i v i t y  Is a lso
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high f o r  l e f t  main coronary a r t e r y  disease but s i m i l a r  appearances may 
be seen w i th  o th er  coronary a r t e r y  lesions <137) .  S e n s i t i v i t y  decreases  
In the presence o f  coronary c o l l a t e r a l  vessels  <138) and in p a t i e n t s  
talcing propranolo l  w i th  a n egat ive  e le c t r o c a r d io g r a p h ic  exe rc is e  
testC139).
G e n e r a l l y ,  th e re  is an Inverse r e l a t i o n s h i p  between the s e n s i t i v i t y  and 
s p e c i f i c i t y .  An Increase In s e n s i t i v i t y  which can be achieved by less 
s t r i n g e n t  c r i t e r i a  Is fo l lowed  by a decrease in s p e c i f i c i t y  (more ' f a l s e  
p o s i t i v e '  cases are r e p o r t e d ) .  An Increase in s p e c i f i c i t y  (which can be 
achieved by using more s t r in g e n t  c r i t e r i a )  is u s u a l ly  accompanied by a 
decrease in s e n s i t i v i t y ;  fewer " f a ls e  p o s i t i v e "  cases w i l l  r e s u l t
1 ( 3 ) ( e )  Tha l l ium -201  imaging In p r e d i c t io n  of  the ex ten t  o f  coronary  
a r t e r y  disease
There is a f a i r l y  constant  anatomic r e l a t i o n  between ind iv idu a l  coronary  
a r t e r i e s  and myocardial  reg ions.  The a n t e r i o r ,  a n t e r o l a t e r a l  and septal  
regions are predominant ly perfused by the l e f t  a n t e r i o r  descending 
a r t e r y .  The i n f e r i o r  and p o s te r io r  w a l ls  are perfused by the l e f t  an­
t e r i o r  descending a r t e r y .  The i n f e r i o r  and p o s t e r io r  w a l l s  are perfused  
by the p o s t e r i o r  descending a r t e r y  which is a branch o f  the r i g h t  coro­
nary a r t e r y  in the remaining ten percent .  The p o s t e r o - l a t e r a l  wal l  is 
per fused by the c i rcumf lex  a r t e r y  ( 12) .
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In p a t i e n t s  w i th  coronary a r t e r y  disease ,  the number of  vessels  Involved  
is p r o g n o s t l e a l l y  s i g n i f i c a n t  ( 14° ) .  Because mortaI  I t y  from coronary  
a r t e r y  disease  Is associated d i r e c t l y  w ith  the magnitude and ex ten t  of  
dis ea se ,  p a t i e n t s  w i th  t r i p l e  vessel disease or occ lusions o f  the main 
l e f t  coronary a r t e r y  have an e s p e c i a l l y  bad prognosis.  A number of  in­
v e s t i g a t o r s  have examined the use of  s t re ss  tha l l iu m -2 01  imaging for  
i d e n t i f y i n g  such high r i s k  in d i v id u a l s .  Rigo e t  a l ,  1980 ( 141) ,
repor ted  t h a t  the s e n s i t i v i t y  fo r  d e te c t io n  of  in d iv id u a l  involved a r ­
t e r i e s  d imin ishes as the number of  vesse ls involved increases.  With 
s in g l e - v e s s e l  d isease ,  80 percent  o f  the l e f t  a n t e r i o r  descending, 54 
percent  o f  the r i g h t  coronary a r t e r y ,  and 33 percent  o f  the c ircum f lex  
lesions were d e tec ted .  In p a t i e n t s  wi th  t r i p l e  vessel  disease ,  only 63 
percent  o f  the l e f t  a n t e r i o r  descending, 50 percent  of  the r i g h t  coro­
nary a r t e r y  and 16 percent  of  the c ircum f lex  a r t e r i e s  were i d e n t i f i e d .  
S i m i l a r l y ,  Leaners,  1979 (142)^ detected disease o f  the l e f t  a n t e r i o r  
descending coronary a r t e r y  in 83 percent of  cases, the r i g h t  coronary  
a r t e r y  in 63 p e rcen t ,  and the l e f t  c ircumflex  coronary a r t e r y  in 48 per ­
cent  o f  cases. S im i la r  r e s u l t s  were reported by McKiI lop e t  a l ,  1979 
( 124) ,  and Massle e t  a l ,  1979 | n each o f  these s e r i e s ,  high
grade stenoses o f  90 to 100 percent  were more commonly de tected  than 
were stenoses o f  lesser magnitude. Dash et  a l ,  1979 ( 143) ,  in a small  
s e r i e s  o f  p a t i e n t s  wi th  l e f t  main coronary disease and a la rg er  s e r ie s  
o f  p a t i e n t s  w i th  three vessel coronary a r t e r y  disease showed on ly  43 
percent  o f  p a t i e n t s  wi th  t r i p l e - v e s s e l  or l e f t  main coronary a r t e r y  d is ­
ease,  were I d e n t i f i e d  as such. Leppo e t  a l ,  1979 <128) ,  s tud ied  a group
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of  30 p a t i e n t s  w it h  three  vessel coronary disease and exerc ise  
e l e c t r o c a r d io g r a p h i c  signs of  ischaemia and showed th a t  only two t h i r d s  
of  t h i s  subset had p er fus io n  a b n o r m a l i t i e s .
Recent s tu d ie s  employing semi-quant  I t a t i v e  computerized an a ly s is  of  
t h a l l iu m - 2 0 1  washout In the four to s ix  hours a f t e r  Isotope I n j e c t io n  
suggest th a t  the accuracy of  d e te c t io n  of  In d iv id u a l  s t e n o t i c  a r t e r i e s  
is improved ( 144) ( 1 4 5 ) )  Maddahi e t  a l ,  1981 ( 122) ,  using computerized  
q u a n t i t a t i v e  a n a ly s is  of  both p er fus io n  de fec ts  and r e d i s t r i b u t i o n  
images, were ab le  to detect  64 percent  of  the involved a r t e r i e s  in 
p a t i e n t s  w i th  double-vessel  disease and 84 percent  o f  the involved ves­
s e ls  in p a t i e n t s  w i th  t r i p l e - v e s s e l  disease .  They found, o v e r a l l ,  the 
q u a n t i t a t i v e  an a ly s is  de tected 70 percent o f  vessels w i th  s tenos is  be­
tween 50 and 75 percent  of  vesse ls w ith  stenos is  g r e a te r  than 75 per ­
c e n t .  Thus, computer mapping, s e m i - q u a n t i t a t i v e  techniques and quan­
t i t a t i o n  techniques wi th  the use of  computer ized tomographic methods are  
promising and may a l lo w  more frequent  i d e n t i f i c a t i o n  o f  the anatomic 
s i t e  o f  each les ion enab l ing d e tec t io n  of  high r i s k  p a t i e n t s .
I ( 3 ) ( f ) Coronary A r t e r y  Spasm
Coronary a r t e r i a l  spasm has been recognized as a very important  
phenomenon, capable o f  leading to severe myocardial  ischaemia in some 
p a t i e n t s ,  w i th  or without  under ly ing a t h e r o s c l e r o t i c  coronary lesions.  
During a spontaneous a t t a c k ,  there Is t r a n s i e n t  t ransmural  reduct ion  of  
myocardial  blood f low which can be demonstrated using tha l l iu m -201  imag-
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Ing (146 )  <147) .  F u l l e r  et  a l ,  1980 ( 148) ,  have a lso  demonstrated T l -  
201 p er fu s io n  d e fe c ts  and abnormal rad io n u c l id e  vent r icu lograms during  
e x e r c is e  in p a t i e n t s  w ith  a n g io g r a p h ic a l ly  proven exerc is e - induced  coro­
nary a r t e r y  spasm. S im i la r  reduct ion In myocardial  per fu s io n  can be 
demonstrated when a t ta c k s  are Induced in a f f e c t e d  subjects  by the ad­
m i n i s t r a t i o n  o f  the vasospast ic  agent ergonovine maleate,  and t h a l l i u m -  
201 Imaging has been used to e va lu a te  p a t i e n t s  suspected of  having coro­
nary spasm and to  assess the value o f  proposed th e rap ie s  Because
of  the p o t e n t i a l  hazard of  coronary spasm, drug provocat ion  t e s t s  are  
u s u a l l y  conf ined  to  the c a t h e t e r i z a t i o n  la b o ra to ry .
I ( 3 ) ( g )  Th a l l iu m  sc in t ig ram s In acute and o ld  myocardial  I n f a r c t i o n
Th al l ium -201  imaging has been proposed as an a d d i t io n a l  method of  as­
sessing p a t i e n t s  w i th  a suspected acute myocardial  i n f a r c t i o n  d 4 9 ) .
Wackers e t  a l ,  1976 (®7 ) ,  have demonstrated that  res t  th a l l ium -2 01  s c in ­
t igrams have high s e n s i t i v i t y  fo r  the demonstrat ion of  acute myocardial  
i n f a r c t i o n .  This s e n s i t i v i t y  appears to be extremely  dependent on the 
t ime when the Images are done. With in  six  hours o f  the onset of  
symptoms, image d e fects  were demonstrated In a i l  44 p a t i e n t s  s tu d ie d .  
When imaging was delayed more than 24 hours from the onset o f  symptoms, 
only  72 percent  o f  p a t i e n t s  had an abnormal r e s u l t .  The frequency of  
f a l s e  n eg at ive  s tud ies  was g rea te r  in p a t i e n t s  with  non-transmuraI or 
b io ch em ica l ly  small I n f a r c t i o n s .  Because o f  the very high s e n s i t i v i t y  
In the e a r l y  hours of  myocardial  I n f a r c t i o n ,  th a l l iu m -201  may be used
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when d ec id in g  whether or not to admit a p a t i e n t  suspected of  having 
acute myocardial  I n f a r c t i o n  to a coronary care u n i t ,  s ince a negat ive  
t h a l l iu m - 2 0 1  s c in t ig ra m  In t h i s  s e t t i n g  Is strong evidence aga inst  the 
d iagnosis  o f  myocardial  i n f a r c t i o n  such a p o l i c y ,  however, has
not been w id e ly  employed due to the d i f f i c u l t i e s  and expense of  having 
radiopharm aceut ic a l  c o n s tan t ly  a v a i l a b l e .  There are also  problems when 
t h a l l iu m - 2 0 1  images are obta ined  some days a f t e r  admission in an at tempt  
to  c l a r i f y  equivocal  E.C.G.  and enzyme r e s u l t s .  In t h i s  s e t t i n g ,  a pos i­
t i v e  s c i n t i g r a p h i c  study does not d is t in g u is h  between recent  and remote 
myocardial  i n f a r c t i o n ,  w h i le  a normal study does not exclude sm al l ,  or 
p o s s ib ly  even a moderate s iz ed  in f a r c t  (120)
T ha l l iu m -201  Imaging, a lthough q u i t e  s e n s i t i v e  fo r  the prooon*  o f  acute 
myocardial  i n f a r c t i o n ,  is not s p e c i f i c  because one cannot d is t in g u is h  
o ld  s c a r r i n g  r e s u l t i n g  from o ld  I n f a r c t i o n  or cardiomyopathies from 
recent  n ecro s is .  In a d d i t i o n ,  some p a t i e n t s  with  angina wi thout  in f a r c ­
t i o n  may a ls o  have an abnormal re s t  scan O 7 ) .
T h a l l ium-201  imaging has an important c o n t r ib u t io n  in the d e l i n e a t i o n  of  
prognosis in p a t i e n t s  at high r i s k  fo l lo w in g  recent  myocardial  i n f a r c ­
t i o n .  Si lverman e t  a l ,  1980 ( 1 5 1 ) ,  examined 42 p a t i e n t s  w ith  acute in­
f a r c t i o n  w i th  15 hours o f  the onset o f  symptoms. P a t ie n t s  w it h  shock or  
f ran k  pulmonary-oedema were excluded. The s i t e  o f  the th a l l iu m -20 1  
d e fe c ts  was determined In three p r o je c t io n s  and expressed as a summed
55
d efec t  score .  During the i n - p a t i e n t  ho sp i ta l  stay  and a mean fo l lo w  up 
of  nine months, the th a l l iu m -201  score was a potent  In d ica to r  of  short  
and mid term prognosis.
The use o f  t h a l l iu m -2 0 1  imaging to i d e n t i f y  in d iv id u a ls  at high r i s k  
a f t e r  recovery from acute i n f a r c t i o n  was also  eva luated  by Turner et  a l ,  
1980 ^ 5 2 )  | n a group of  32 p a t i e n t s  e xerc is e  and r e d i s t r i b u t i o n ,  
t h a l l iu m - 2 0 1  Imaging were performed three weeks a f t e r  acute i n f a r c t i o n .  
Each p a t i e n t  a ls o  underwent coronary angiography and b ip lan e  cine l e f t  
v e n t r ic u lo g r a p h y  at  the same t ime.  The s c i n t i g r a p h i c  study proved much 
more r e l i a b l e  than c l i n i c a l  f in d in g s  in id e n t i f y i n g  p a t i e n t s  as being at  
high r i s k  due to  the presence of  m u l t i - v e s s e l  coronary a r t e r y  disease  
and res id u a l  jeopard ized  myocardium.
The re por ted  Incidence o f  p o s i t i v e  th a l l iu m -201  scans w it h  previous  
myocardial  i n f a r c t i o n  v a r ie s  from 37 percent  to 91 p ercent .  Hamilton et  
a l ,  1977 repor ted  p o s i t i v e  res t  scans in ten out o f  11 p a t i e n t s
w i th  o ld  in f a r c t i o n s  who had res t  and exerc is e  s c in t ig r a p h y .  Verani  et  
a l ,  1979 observed complete " f i l l i n g  in" of  e xerc is e - in duced  per­
fu s ion  d e fe c ts  at  delayed imagihg in only f i v e  out of  27 p a t i e n t s  and, 
In 22 p a t i e n t s ,  the remote i n f a r c t i o n  was s t i l l  demonstrable.  Blood et  
a l ,  1978 ( 9° ) ,  found perfusion defects  in 15 res t  s tud ies  and 26
r e d i s t r i b u t i o n  s t u d ie s ,  each performed In 28 p a t i e n t s  w ith  p r i o r  in­
f a r c t s .  Wackers e t  a l ,  1979 ( 15° ) ,  obta ined  p o s i t i v e  res t  scans in nine  
o f  24 p a t i e n t s  w it h  o ld  In f a r c t i o n .
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Th al l ium -201  Imaging Is of  l im i t e d  va lue  in the d iagnosis  of  o ld  in f a r c ­
t i o n .  Not in f r e q u e n t l y ,  the images re tu rn  to a normal p a t t e r n  a v a r i ­
ab le  t ime a f t e r  hea l in g  occurs.  This l a t e r  n o rm a l iz a t io n  o f  sc in t igrams  
may be more common w it h  i n f e r i o r  in f a r c t s  and subendocardial  i n f a r c t s .  
The f i n d i n g  o f  a normal th a l l iu m -2 01  scan In p a t i e n t s  known to have had 
a myocardial  i n f a r c t i o n  may s t i l l  have important prognost ic  Im p l ic a t io n ,  
e s p e c i a l l y  in e v a lu a t in g  the ex ten t  of  v i a b l e  myocardial  t is su e  remain­
ing The use o f  res t  and r e d i s t r i b u t i o n  imaging fo r  e va lu a t io n  of
myocardial  v i a b i l i t y  has r e c e n t ly  been subjected  to patho lo g ica l  
v e r i f i c a t i o n  d 5 3 )  | n a group of  card ia c  t ra n s p la n t  r e c i p i e n t s ,  
p r e o p e r a t iv e  myocardial  images were compared to p a th o lo g ic a l  examinat ion  
o f  the heart  fo l lo w in g  i t s  removal at the t ime o f  g r a f t i n g .  Fixed res t  
d e fe c ts  were both s e n s i t i v e  and s p e c i f i c  fo r  areas o f  myocardial  
f i b r o s i s .  Some r e v e r s i b l e  re s t  defects  in t h i s  group corresponded to  
areas o f  myocardium showing an admixture of  f i b r o t i c  and v ia b l e  myocar­
dium. These r e s u l t s  conf irmed the usefulness of  res t  w ith  r e d i s t r i b u ­
t i o n  myocardial  Imaging as a non- invasive  method o f  studying myocardial  
v i a b i I  I t y  <153> .
I ( 3 ) (h)  Tha l l iu m-201  sc in t ig ra p h y  In anginal  syndromes
Stress  th a l l iu m -2 0 1  Imaging Is not useful  in most p a t i e n t s  w it h  t y p ic a l  
angina p e c t o r i s .  The group as a whole has a high prevalence o f  coronary  
a r t e r y  disease  (around 90%). So tha l l ium -201  imaging Is d l a g n o s t i c a l l y  
usefu l  In such p a t i e n t s  only I f  I t  r e l i a b l y  p re d ic t s  the ex ten t  o f  coro­
nary a r t e r y  disease ( 124) .
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The p a t i e n t  w it h  a t y p i c a l  angina has a p r o b a b i l i t y  o f  coronary a r t e r y  
disease o f  around 50 p e rcen t ,  and thus,  from Bayesian a n a ly s is ,  is 
p r e c i s e l y  the In d iv id u a l  in whom s t re s s  tha l l iu m -201  Imaging Is v a lu ­
a b l e ,  e s p e c i a l l y  I f  the s t r e s s  e lec t rocard io gram is neg at ive  or e q u i r o -  
cal  ( 11 ) .  Several in v e s t ig a t o r s  found tha t  tha l l iu m -201  imaging during  
an anginal  a t t a c k  would r e s u l t  in a high percentage o f  s c i n t i g r a p h i c  
d e fe c ts  (40 )  ( 8 9 ) ^
However, p o s i t i v e  th a l l iu m -2 01  imaging In p a t i e n t s  w ith  unstab le  angina  
pro v ides  a d d i t i o n a l  in format ion that  acute coronary i n s u f f i c i e n c y  is 
present  and i d e n t i f i e s  p o t e n t i a l  high r i s k  groups. One t h i r d  of  these  
p a t i e n t s  may be at r i s k  fo r  a complicated course ( 47 ) .
( 3 ) ( i ) S t ress  t h a l l iu m - im a g in g  In p a t i e n t s  with  equivocal s t ress  
e le c t ro c ar d io g ra m
In a con s id erab le  number of  p a t i e n t s  the s t ress  e lec t rocardiogra m  may be 
e i t h e r  u n i n t e r p r e t a b l e  or nondiagnost ic .  Inconclusive e xerc is e  ECGs are  
caused by a number o f  fa c to rs  including conduct ion d is turbances^11) .  
Exerc is e  th a l l iu m -2 01  Imaging is useful  in p a t i e n t s  w i th  inconclusive  
e x e r c is e  ECGs. McCarthy et  a l ,  1979 ( 154) ,  have repor ted  the sen­
s i t i v i t y ,  s p e c i f i c i t y  and d iagnost ic  accuracy o f  exe rc is e  imaging In 39 
p a t i e n t s  w it h  inconclusive ECGs to be 81 percent ,  69 percent  and 71 per ­
cent  r e s p e c t i v e l y .  B otv ln lc k  e t  a l ,  1978 (127)  , s tud ied  19 p a t i e n t s  
w ith  Inconclusive  ECGs who underwent both s t re s s  th a l l iu m -2 01  imaging
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and s e l e c t i v e  coronary a r te r io g r a p h y .  The ra d io n u c l id e  images were ab­
normal In a l l  12 p a t i e n t s  w i th  coronary a r t e r y  disease and normal in 
f i v e  o f  seven w i th  no s i g n i f i c a n t  coronary les ions.  S im i la r  s e n s i t i v i t y  
and s p e c i f i c i t y  were reported  by Tweddel,  Pearson, McKiI lop et  a l ,  1980 
(1 55 )  when the r e s u l t s  of  e xe rc is e  imaging are compared with  the d iag­
n o s t i c  r e s u l t s  o f  ex e rc is e  ECGs ( t h a t  is ,  e i t h e r  p o s i t i v e  or n e g a t i v e ) ,  
the s e n s i t i v i t y  o f  both t e s t s  have been found to be equal 0 2 9 )  (156)  
The va lue  o f  exe rc is e  ECGs in p a t i e n t s  with  inconclusive or s l i g h t l y  ab­
normal e x e r c is e  images has not been s tud ied .
I ( 3 ) ( j ) Screening fo r  coronary disease In p a t i e n t s  w it h  v a lv u l a r  heart
d i sease
Data in the l i t e r a t u r e  is c o n f l i c t i n g  about the value o f  th a l l iu m -201  
imaging in m i t r a l  va lve  prolapse 0 5 7 )  These p a t i e n t s  u s u a l ly  ex­
per ie nce  angina-1 Ike chest pain or r e s t in g  ST-segment and T-wave abnor­
m a l i t i e s ;  many have exerc is e - in duced  ST-segment depression.  The exact  
cause o f  chest  pain in these p a t i e n t s  In the absence o f  assoc iated  coro­
nary a r t e r y  disease is not wel l  understood.  P o s i t i v e  s t re s s  t h a l l i u m -  
201 Images In approximately two t h i r d s  o f  p a t i e n t s  w it h  m i t r a l  va lve  
pro lapse  had been reported by some authors 0 5 8 )  0 5 9 )  (160)  Wh i i e 
o th e rs  suggest that  th a l l iu m -201  exerc ise- Induced de fec ts  are r a re  in
such p a t i e n t s  in the absence of  o b s t r u c t iv e  coronary disease 0 6 1 )
( 1 6 2 ) .
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P a t i e n t s  w i th  a o r t i c  s tenos is  may have angina p e c t o r i s .  In t h i s  group 
o f  p a t i e n t s ,  symptomatic and e l e c t r o c a r d io g r a p h ic  e v a lu a t io n  is u n r e l i ­
a b le .  B a i l e y  e t  a l ,  1977 (86 )  f and mcK I I  lop e t  a l ,  1979 ( 124>, found an 
unacceptably  high r a t e  o f  both f a l s e  p o s i t i v e  and f a l s e  negat ive  
r e s u l t s ,  and demonstrated tha t  th a l l iu m -201  ex erc is e  imaging was un­
s u i t a b l e  in p r e d i c t i n g  associated  coronary a r t e r y  disease in p a t i e n t s  
w ith  a o r t i c  s te n o s is .
I ( 3 ) ( l c )  E xerc is e  th a l l iu m -20 1  In e v a lu a t io n  o f  coronary a r t e r y  bypass 
g r a f t  surgery and trans lumina l  coronary ang iop la s ty
Tha l l iu m -201  e x e rc is e  imaging has been stud ied  to eva lu a te  the e a r l y  and 
long-term f o l l o w  up o f  p a t i e n t s  re c e iv in g  coronary a r t e r y  bypass g r a f t  
surg ery .  N o rm al i za t io n  of  p reo pera t ive  perfusion  d e fects  c o r r e la t e s  
h ig h ly  w i th  patent  g r a f t  ( 129)  (163)  (164)  Exercise imaging in the 
post o p e r a t i v e  p a t i e n t  combined with  the r e s u l t s  of  p reo p era t ive  coro­
nary angiograms o f f e r s  a unique non- invas ive and r e l i a b l e  method, espe­
c i a l l y  i f  p re o p e ra t iv e  exerc is e  images are also a v a i l a b l e  fo r  comparison 
(166 )  Veranl  e t  a l ,  1976 0 6 6 )  f found that  70 percent o f  the preopera­
t i v e  underperfused myocardial  segments showed improved per fus ion  post 
o p e r a t i v e l y ,  and 85 percent  of  the p a t ie n t s  who submitted to saphenous 
bypass g r a f t  had marked improvement In reg ional  myocardial  pe r fu s io n .  
A ls o ,  they found that  p a t i e n t s  with  previous myocardial  i n f a r c t i o n  had a 
s l i g h t l y  higher prevalence of  p o s t -o p e ra t iv e  res id ua l  a b n o rm a l i t ie s  In
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t h e i r  p e r fu s io n  scans. Although p a t i e n t s  u s u a l ly  show marked c l i n i c a l  
Improvement p o s t - o p e r a t I v e l y ,  some res idua l  th a l l iu m -2 01  imaging abnor­
m a l i t i e s  are  common.
When co n s id er ing  the post o p e r a t iv e  use of  myocardial  imaging, i t  is 
usual to  compare I t s  r e s u l t s  to a r t e r io g r a p h i c  eva lu a t io n  o f  g r a f t  
patency .  The anatomical  s i t e  o f  the g r a f t  and myocardial  per fus ion  are  
not n e c e s s a r i l y  synonymous. Thus, i t  is possible fo r  patent  g r a f t s  to 
supply areas o f  myocardial  i n f a r c t i o n  ( 1 6 7 )  ^ which could be abnormal on 
myocardial  images. Conversely ,  though a g r a f t  is occluded,  myocardial  
p e r fu s io n  may be maintained  due to c o l l a t e r a l s  e i t h e r  from n a t iv e  ves­
s e ls  or from other  g r a f t s  ( 168) .
Several  in v e s t ig a t o r s  have been less sure of  the value of  tha l l ium -201  
imaging f o l l o w in g  r e v a s c u la r i z a t i o n  of  the myocardium. These s tud ies  
have in d ica ted  th a t  myocardial  imaging is more accurate  in p re d ic t in g  
g r a f t  patency than g r a f t  occ lusion ( 16Q) (170)  (171)  (172)
S i m i l a r l y  to  coronary a r t e r y  bypass surgery,  tha l l iu m -201  imaging has 
been assessed In the ev a lu a t io n  of  t rans luminal  coronary ang io p las ty .  
Although the short  term r e s u l t s  o f  t ransluminal  coronary ang io p las ty  are  
e x c e l l e n t ,  a s i g n i f i c a n t  number o f  r e -s te n o s is  occur w ith  t ime.  
T h al l lu m -201  imaging has a major p o t e n t i a l  c o n t r ib u t io n  in the iden­
t i f i c a t i o n  o f  s i g n i f i c a n t  stenos is  which may occur in asymptomatic 
p a t i e n t s  <173> <174> <1 7 5 ) .
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CHAPTER I I
THALLIUM-201 AS TUMOUR IMAGING AGENT
(1 )  In t r o d u c t io n :  S c i n t ig r a p h i c  techniques for  tumour d e te c t io n
Various  rad io pharm aceut ica ls  have been in ves t ig a ted  fo r  t h e i r  "tumour 
a f f i n i t y " .  There is hope th a t  s p e c i f i c  l o c a l i z a t i o n  in malignant  le­
sions w i l l  be useful  in d e te c t in g  the pr imary tumour, i t s  m e ta s ta t ic  ex­
te ns io n  or to monitor  response to var ious ant i - tumour t h e ra p ie s .  The 
success r a t e  o f  a l l  these radiopharmaceut icals is v a r i a b l e ,  and none has 
been comple tely successful  due to b i o l o g i c a l ,  physical  or economic 
problems.
G a l l iu m -6 7  c i t r a t e ,  the most commonly used radiopharmaceut ical  for  
tumour l o c a l i z a t i o n ,  lacks s p e c i f i c i t y  fo r  mal ignant les ions.  Many 
r e p o r t s  o f  g a l l iu m  uptake 1n benign,  Inf lammatory, granulomatous or 
autoimmune disease have been presented In the l i t e r a t u r e  (176)  (177)
(178 )  ( 1 7 9 ) <
G a l l lu m -6 7  Is cyc lo t ro n  produced by proton bombardment o f  Zn-67 or 
deuteron bombardment of  Zn-66.  Ga-67 decays with  a 7 7 .9  hour h a l f - l i f e
to Zn-67 by e l e c t r o n  c apture .  I t  has four pr imary gamma emissions of  93 
keV (38%),  184 keV (24%),  300 keV (16%), and 393 keV (4%) w it h  no
primary p a r t i c u l a t e  r a d i a t i o n .
The absorbed dose v a r ie s  somewhat in d i f f e r e n t  body t is s u e s .  The ta rg e t  
organ Is the large bowel which rece ives  0 .9  rads/mCi.  The t o t a l  body 
dose Is 0 .2 6  rads/mCi.  The bone marrow dose is est imated  to be 0 .58  
rads /mCi.  Based on the usual dose range of  three to e ig h t  mCi, the to ­
t a l  body and gonadal exposure is 0 .7 8  -  2 .08  rad. The rad iopharmaceut i ­
cal is most commonly used as the c i t r a t e  at  a neutra l  pH. Most prepara­
t i o n s  co n ta in  less than one mg of  c i t r a t e  per cubic cen t im eter .
Numerous imaging methods have been employed with  Ga-67. In the past ,
dual probe r e c t i l i n e a r  scanner wi th  a wide window s e t t i n g  encompassing
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9 11h if  the 184 keV^photopeaks was used for  t o t a l  body imaging. Some 
ce n te rs  have u t i l i z e d  r e c t i l i n e a r  scanners with  summation o f  the output  
of  two pulse he ight  ana lyzers  with  windows set  around the 93 and 184 or
184 and 300 keV photopeaks. Whole body or spot view imaging with  a
gamma camera Is most successful when dual or t r i p l e  pulse height  
a n a lyz e rs  are a v a i l a b l e  so that  a 20 percent window can be set  about 
each p r i n c i p a l  photopeak. A medium energy col I i m a t o r , p r e f e r a b ly  
designed fo r  Ga-67 ra th e r  than 1-131, should be used. With e i t h e r  
camera or r e c t i l i n e a r  scanner, an Information den s i ty  o f  400—600 counts 
per square cent im eter  should be obta ined .
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The normal Ga l l ium scan shows the g re a te s t  accumulat ion o f  the 
rad io pharm aceut ic a l  in the l i v e r  and throughout the ske le ton  and bone 
marrow. S k e l e t a l  l o c a l i z a t i o n  is p a r t i c u l a r l y  notab le  in the spine and 
p e l v i s .  The spleen may show minimal a c t i v i t y  but is f re q u e n t ly  not 
v i s u a l i z e d .  Other organs in which normal accumulat ion can be noted in­
clude the nasopharynx, lacr imal  glands,  s a l i v a r y  glands and e x te rna l  
gen I t a I  la ( 18 0 ) e
Uptake has been noted in the human breast  and breast  m i lk  during preg­
nancy, l a c t a t i o n  and exogenous estrogen a d m in is t ra t io n  d S D .
G a l l iu m -6 7  c i t r a t e  is bound in blood to t r a n s f e r r i n .  With in  24 hours 
a f t e r  the intravenous i n j e c t i o n ,  approximately ten to 20 percent  of  g a l ­
lium is excre te d  through the g a s t r o i n t e s t i n a l  t r a c t ,  mainly through the 
bowel w a l l .  Another approximate ten to 20 percent  is excreted v ia  the 
kidneys ( 1 7 8 )  ^ Clearance o f  a c t i v i t y  from the blood is slow, and the 
background a c t i v i t y  is high r e s u l t i n g  In low ta rg e t  to nontarget  r a t i o s .  
A de lay  o f  48 to 72 hours is necessary p o s t - i n j e c t i o n  before images can 
be o b ta in e d ,  and the p a t i e n t  has to come two or th ree  times to the 
nuclear  medicine department to complete the I n v e s t i g a t io n .
64
In a d d i t i o n  to  t r a n s f e r r i n ,  o ther  i ro n -b in d in g  p ro te in s  in plasma, such 
as l a c t o f e r r l n  and f e r r i t i n ,  have been shown to  bind Ga-67 At
p h y s io lo g ic  pH, l a c t o f e r r l n  has a higher a f f i n i t y  fo r  Ga-67 than t ra n s ­
f e r r i n  0 8 2 )  _ r o |e 0 f  l a c t o f e r r l n  and f e r r i t i n  in the t ran sp o r t  of
Ga-67 In the c i r c u l a t i o n  is not c le a r  0 8 3 )
The l o c a l i z a t i o n  o f  Ga-67 in tumours and abscesses, as wel l  as in most 
normal t i s s u e s ,  appears to occur In at  least  two phases. During the 
e a r l y  phase o f  up to six  hours, the Ga-67 that  has lo c a l i z e d  In the
t i s s u e  can be e x t r a c t e d  by i ro n -b in d in g  chelatjs such as Desferal  C184)_
However, when Desferal  is admin is t ra ted  24 hours a f t e r  Ga-67,  i t  is no 
longer capable o f  leaching the ra d io n u c l id e  from most t is sues  0 8 4 )  
This  suggests th a t  Ga-67 lo c a l i z e s  by an e a r ly  weak binding or d i f f u s i o n  
fo l lo w e d  by a f i rm e r  i n t e r c e l l u l a r  binding phase 0 8 5 )
At leas t  th re e  mechanisms by which Ga-67 may lo c a l is e  In in fe c t io n s  have 
been p o s t u la t e d .  These include leukocyte la b e l in g  0 8 6 ) f L a c t o f e r r l n  
bind ing  at  the s i t e  of  i n f e c t io n  0 8 7 ) f and d i r e c t  b a c t e r i a l  uptake  
0 8 8 ) # increased a v a i l a b i l i t y  o f  Ga-67 at  s i t e s  o f  inf lammation can 
e a s i l y  be e xp la in ed  by Increased vessel p e r m e a b i l i t y  at  such s i t e s  
(186 )
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Proposed mechanisms of  Ga-67 l o c a l i z a t i o n  In tumour are c o n t r o v e r s i a l .  
There is some agreement th a t  the h ig h ly  permeable w a l ls  o f  tumour ves­
s e l s ,  combined w i th  the large e x t r a c e l l u l a r  f l u i d  space o f  tumours play  
an Important  r o l e  In the I n i t i a l  l o c a l i z a t i o n  of  Ga-67 at  the s i t e  of  
tumours 0 8 9 )
Hayes e t  a l ,  1976 0 9 0 ) .  1977 0 9 1 ) .  1981 0 9 2 ) .  suggest th a t  Ga-67 
e n t e rs  tumour c e l l s ,  presumably by simple d i f f u s i o n ,  as a r e s u l t  o f  the 
h y p e rp e r m e a b i l i ty  o f  the tumour c e l l  membrane. However, Engl ish e t  a l ,  
1977 C1 9 3 )  ^ have shown th a t  severa l  types of  tumour c e l l s  do not s i g ­
n i f i c a n t l y  accumulate Ga-67 unless the plasma membrane p e r m e a b i l i t y  bar­
r i e r  Is d is ru p ted  as in nonviab le c e l l s .
A n g h l i e r i  e t  a l ,  1971; 0 9 4 ) .  1974 0 9 5 ) .  and A n g h l ie r i  1977 0 9 6 )  sug_ 
gests  a l in k  between Ga-67 l o c a l i z a t i o n  and calcium metabolism in 
tumours, the uptake o f  Ga-67 to calcium and magnesium-binding s i t e s .  
This  theory  c o n f l i c t s  with  the observa t ion  that  Ga-67 uptake and Ca +2 
content  In tumours are not associated 0 8 5 )
H o f fe r  e t  a l ;  1980 0 8 5 ) f proposed that  binding of  Ga-67 by l a c t o f e r r l n  
present  in some tumours is responsible fo r  Ga-67 accumulat ion.  Studies  
of  Sephton and H a r r i s ,  1975 0 9 7 )  p and Larson et  a l ,  1979 0 9 8 )  f sug_ 
gested t h a t  human t r a n s f e r r i n  enhanced Ga-67 uptake by a number of  
tumour c e l l  l in es  and proposed that  Ga-67 accumulat ion in tumours was 
due to  t r a n s f e r r i n  mediated uptake by tumour c e l l s .
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A number o f  In vivo and In v i t r o  stud ies  have been done at tempt ing  to 
e l u c i d a t e  the r o l e  of  t r a n s f e r r i n  on the tumour uptake of  Ga-67,  and to  
determine the i n t r a c e l l u l a r  l o c a l i z a t i o n  of  Ga-67. The r e s u l t s  of  these  
s tu d ie s  are  c o n f l i c t i n g  d " )  (200)  (201)
The exact  mechanism of  g a l l iu m  l o c a l i z a t i o n  in tumours and other  t is sues
Is not p r e c i s e l y  known 0 8 0 )  # j n V |ew 0 f the strong evidence a v a i l a b l e
to  support many o f  the competing th e or ie s  for  g a l l iu m  l o c a l i z a t i o n  In
tumour, i t  is poss ib le  tha t  more than one mechanism is o p era t in g  0 8 5 )  
( 202 ) ^
Since I t s  In t ro d u c t io n  by Edwards and Hayes in 1969 ( 2 0 3 )  ^ Ga-67 has be­
come the most w ide ly  employed tumour imaging agent .  I t  has been most 
usefu l  fo r  head and neck lesions and less e f f e c t i v e  in the abdomen be­
cause o f  i t s  normal exc r e t io n  in to  the g a s t r o i n t e s t i n a l  t r a c t  contents.  
Lymphomas, mal ignant  melanomas, focal leukaemic masses, m e t a s t a t ic  te s ­
t i c u l a r  mal ig nanc ies ,  and Ewing tumours o f t e n  have been wel l  
demonstrated.  I t  has been less r e l i a b l e  for  d e tec t io n  of  b re a s t ,  lung,  
g a s t r o i n t e s t i n a l ,  and u t e r in e  mal ignancies.  In the l i v e r ,  i t  has 
demonstrated hepatomas or lymphomatous masses ( 2 0 4 ) < C l i n i c a l l y  i t  has 
been employed w ide ly  fo r  lymphoma. I t  has detected 70 percent  of  un­
t r e a t e d  Hodgkin's s i t e s ,  50 percent of  i r r a d i a t e d  s i t e s ,  and 48 percent  
of  abdominal s i t e s  ( 2 0 5 ) < j^ e  r e s u l t s  have been poor fo r  Non-Hodgkin's  
lymphoma, on ly  53 percent of  un treated  involved s i t e s  were 
p o s i t I v e ^ 2®6 ^ .
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Gall iu m  imaging cannot be used to r u le  out s i t e  of  mal ignancy,  to  d i f ­
f e r e n t i a t e  benign from mal ignant  les ions,  or to d i s t i n g u i s h  n e o p la s t ic  
from inf lammatory lesions (207)  (208)
Grove e t  a l ,  1974, in ves t ig a ted  the chemotherapeut ic agent bleomycin 
labe led  w i th  Indium-111 fo r  tumour d e te c t io n ,  but the r e s u l t s  were in­
f e r i o r  to  those from Ga-67 c i t r a t e  (209)_ Another group o f  inves­
t i g a t o r s  t r i e d  C o b a l t -57  bleomycin-A2 in doses of  40 MBq fo r  l o c a l i z i n g  
lung carcinoma.  The s e n s i t i v i t y  of  d e tec t ing  lung cancer v a r ied  from 83 
percent  to  96 percent  in d i f f e r e n t  s e r i e s ,  and about 14 percent  of  
benign tumours and non-neoplast ic  lesions produced p o s i t i v e  images 
(210 )  This agent has not been accepted widely  because o f  the long 
physica l  h a l f - l i f e  o f  c o b a l t -5 7  (272 days) .  About 80 percent  of  the ac­
t i v i t y  is excre ted  in the u r ine  by 24 hours, causing a waste disposal  
problem. A lso ,  n o n - ra d lo a c t Iv e  cobal t -bleomycin conjugated with  a 
b i f u n c t i o n a l  c h e la t in g  agent (BLEDTA) labeled with indium-111 has been 
used fo r  tumour l o c a l i z a t i o n ,  but lacks s e n s i t i v i t y  and s p e c i f i c i t y  for  
tumours^211 ) .
Ohta e t  a l ,  1984, developed a pentava lent  p repara t ion  of  dimercaptosuc-  
c i n l c  a c id  labeled with  TC-99m at  pH 8 -  8 .5  with stannous c h lo r id e  and 
sodium b icarbonate  fo r  tumour l o c a l i z a t i o n .  This agent was r a p id ly  ex­
c re te d  In the u r in e  and did not accumulate in the renal  c o r te x .  Images 
were obta in ed  two hours a f t e r  Intravenous in j e c t i o n  o f  370 MBq of  the 
Tc-99m complex. I t  was proposed for  the d e tec t io n  of  medul lary th y ro id
carcinoma <212) .  L a t e r ,  the same group of  In v e s t ig a to rs  claimed the new
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agent d id  not concentra te  In Inflammatory lesions and ob tained  a sen­
s i t i v i t y  o f  90 percent  for  de tec t in g  so f t  t issu e  tumours, most ly s ar ­
comas o f  the limbs and e x t r e m i t i e s  (212)^ Recent work from some groups 
has y ie l d e d  good r e s u l t s  fo r  tumour imaging C214) ,  but o thers  have been 
less successful  ( 215) .
R a d io a c t iv e  Iodine is w ide ly  used In the diagnosis and treatment of  cer ­
t a i n  f u n c t io n in g  th y ro id  tumours ( 21®).
Well d i f f e r e n t i a t e d  p a p i l l a r y  and f o l l i c u l a r  carcinomas represent  75 
percent  o f  a l l  pr imary th y ro id  mal ignancies ( 217) .  The pr imary t r e a t ­
ment f o r  t h y r o id  cancer is surgery.  A f t e r  t o t a l  or subtota l  th y ro id ec ­
tomy, t h y r o i d  hormone replacement is w ithheld for  s ix  weeks. This w i l l  
enhance endogenous t h y r o id - s t im u l a t i n g  hormone s t im u l a t i o n  of  any 
remaining normal th y ro id  t issu e  in the thyro id  bed and any fu nc t io n in g  
m e t a s t a t i c  les io ns .  Whole body images are obtained one to f i v e  days 
a f t e r  the o ra l  a d m in is t r a t io n  of  5 to 10 mCi of  I . Demonstrat ing  
m e t a s t a t i c  uptake of  r a d io a c t iv e  iodine is d i f f i c u l t  when th ere  is a 
s i g n i f i c a n t  amount of  residual  thyro id  t issue  a f t e r  thyroidectomy,  i f  
th e re  Is a s i g n i f i c a n t  amount of  normal t issue  in the th y ro id  bed or 
m e t a s t a t i c  uptake,  the remaining normal t issu e  can be ab la ted  or the 
metastases t r e a t e d  by a the rap eu t ic  dose o f  10 to 150 mCi o f  r a d i o a c t i v e  
I 1 3 1.
In the p a t i e n t  w it h  complete a b la t io n  o f  normal th y ro id  t i s s u e ,  abnormal 
l o c a l i z a t i o n  o f  I 131 Is s p e c i f i c  fo r  fu nc t ion in g  carcinoma ( 213>.
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Rad io Io d In a te d  metalodobenzyIqualdine ( I  ^ 1  m IBG) has proved useful  in 
l o c a l i z i n g  catecholamine producing tumours such as pheochromocytoma, 
neuroblastoma,  as we l l  as adrenomedullary h y p erp la s ia ,  and primary  
m edul la ry  t h y r o id  carcinoma which contained e le va te d  t is s u e  
catecholamines  ( 21^) (220)
Shapiro e t  a l ,  1985, ( 2 1 9 )  ^ reported t h e i r  experience fo r  loca t ing
suspected pheochromocytoma in 400 cases. They have shown that  I 131 
MI BG is a sa fe  and e f f i c a c i o u s  means of  lo c a l i z i n g  a wide range of  
pheochromocytomas. Radio iodinated metalodobenzyIquanid Ine s c in t ig ra p h y  
proved to  be more s e n s i t i v e  than convent ional  X - r a y ,  e s p e c i a l l y  in cases 
of  r e c u r re n t  d isease ,  med iast ina l  tumours and in some malignant  metas­
t a t i c  d isease .  K a l f  e t  a l ,  1982 ( 221) ,  a lso  reported in 22 percent  of  
cases w i th  pheochromocytoma, conventional  imaging techniques had f a i l e d  
to  locate  the lesions which were revealed by s c in t ig ra p h y .
The s p e c i f i c  accumulat ion o f  I 131 MIBG in the tumours suggested the 
t rea tment  by th e r a p e u t ic  doses o f  I 131 MIBG. Such a treatment has been 
rep o r ted  in both pheochromocytoma and neuroblastoma ( 222> (223)
In a d d i t i o n ,  Fieldman et  a l ,  1984, reported that  I 131 MIBG is a ls o  con­
c e n t r a te d  In normal p l a t e l e t s  by neuronal-pump mechanism. This p l a t e l e t
uptake ra is e d  the p o s s l b l I i t y  that  I 131 MIBG might be useful  for
p U M *p
v i s u a l i z i n g  o ther  tumours which have a neuronal <p40=tttr mechanism such as 
c a r c in o i d  tumours ( 2 2 4 ) . Fieldman et  a l ,  1986 ( 2 2 5 ) , repor ted  that  13
70
of  23 p a t i e n t s  (61%) with  carc in o id  tumours were v i s u a l i z e d .  Lewington  
et  a l ,  1987 (226)^ repor ted 84 percent  o v e ra l l  s e n s i t i v i t y  o f  uptake in 
c a r c i n o id  tumours. Three p a t ie n t s  have been t r e a te d  w ith  5 . 5  GBq mlBG, 
symptoms r e l i e f  occurred in one p a t ie n t  and reduct ion o f  f i v e  HIAA 
e x c r e t i o n  in the other  two p a t ie n t s  ( 226 ) .  w h i le  C larke e t  a l ,  1986,  
rep o r te d  t h a t  I 131 MIBG I s an expensive radiopharmaceut ical  w ith  poor 
imaging c h a r a c t e r i s t i c s  and has been shown to be taken up v a r i a b l y  in 
p a t i e n t s  w i th  MCT with  a s i g n i f i c a n t  f a l s e  negat ive r a t e  ( 227) .  Poor 
r e s u l t s  were a ls o  demonstrated by H i l d i t c h  et  a l ,  1986 ( 213) #
Conroy e t  a l ,  1987, compared I 123 MIBG scanning w ith  US and CT in 16 
p a t i e n t s  w i th  neuroendocrine tumours. They found a good c o r r e l a t i o n  be­
tween these imaging m o d a l i t i e s  in de tec t ing  the primary les ions.  I 123 
MIBG imaging demonstrated m eta s ta t ic  lesions not i d e n t i f i e d  by CT or US. 
They suggested that  I 123 MIBG imaging is the more ap p ro p r ia te  , i n i t i a l  
imaging technique and provides more accurate in formation on the s i z e  and
lo c a t io n  o f  o ther  m e t a s t a t ic  lesions p r io r  to surgery ( 228 ) .  m  
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Recent ly  most research on tumour imaging agents has focused on 
r a d io la b e l e d  monoclonal an t ib od ies  (Mabs).
Ant ibody molecules,  or Immunoglobulins, are produced by plasma c e l l s  in 
higher animals in response to the in troduct io n  o f  fo re ig n  substances 
( a n t ig e n s )  th a t  are g en e r a l ly  large molecules o f  1 ,000 dal tons or more. 
Immunoglobulins posses s p e c i f i c  binding regions tha t  recognize the shape 
o f  p a r t i c u l a r  s i t e s ,  or determinants,  on the surface  o f  the an t ig en .
An an t ig e n  may have severa l  determinan ts ,  or ep i to p es ,  each o f  which can 
s t i m u l a t e  one or more B lymphocytes. Each B lymphocyte has the capac ity  
to  d i f f e r e n t i a t e  In to  plasma c e l l s  that  secre te  a s i n g l e ,  s p e c i f i e d  im­
munoglobul in in response to one a n t ig e n ic  determinant ,  and each d i f ­
f e r e n t  an t ibody  is produced by the fam i ly  of  plasma c e l l s  th a t  stems 
from one o f  the B lymphocytes. An t igen ic  cha l lenge thus evokes a 
heterogeneous ant ibody response r e s u l t i n g  from a mix o f  an t ib ody-  
producing plasma c e l l s .
I f  a s u i t a b l e  animal r e c i p i e n t ,  t y p i c a l l y  a mouse or r a b b i t ,  is Im­
munized w i th  an a n t ig e n ic  agent ,  serum taken from the s e n s i t i z e d  host 
w i l l  c o n ta in  a n t ib o d ie s  to d i f f e r e n t  epi topes of  the an t ig en .  Since 
these a n t ib o d ie s  are der ived  from a popula t ion of  s t im u la ted  B lym­
phocytes and t h e i r  daughter plasma c e l l s ,  the term po lyclonal  a n t ib od ie s  
is a p p l i e d .  However, i f  In d iv id ua l  lymphocytes or plasma c e l l s  could be 
e x t r a c t e d  and cloned in t is su e  c u l t u r e ,  each clone would have the poten­
t i a l  to  manufacture a s in g le  species of  ant ibody molecule,  or a 
monoclonal ant ibody ( 22Q) .
Techno logica l  improvement was made by Kohler and M i l s t e i n  who developed 
the monoclonal a n t ib od ies  and hybridoma technique In 1975 ( 230 ) .
Monoclonal a n t ib o d ie s  have la rg e ly  replaced a n t i s e r a  ra is ed  in animals  
aga ins t  human ant igens because the former are h ig h ly  s p e c i f i c ,  
r e p r o d u c ib le ,  and capable o f  being h igh ly  p u r i f i e d  (2 3 1 ) # An extens ive  
search has been made o f  murine Mabs to surface ant igens unique to  tumour
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c e l l s ,  such as ant l -CEA labeled  wi th  I 131 for  d e te c t io n  o f  g a s t ro in t e s ­
t i n a l  tumours ( 2 3 2 ) ;  | 131 a n t l f e r r l t l n  fo r  hepatoma and Hodgkin's d is ­
ease ( 2 3 3 ) .  , 131 an t i  P97 fo r  meianoma ( 2 3 4 ) .  and fo r  choriocarcinoma,  
Tc-99m a n t i  HCG ( 2 3 5 ) .
Monoclonal a n t ib o d ie s  can be labeled with  gamma e m i t t e r s  fo r  tumour itri­
une imaging. Several  alpha and beta e m i t t in g  rad ionucl ides  have poten­
t i a l  fo r  the radioimmunotherapy o f  cancer.  Iodine-131 has most commonly 
been used ( 2 2 9 ) .  B i o d i s t r i b u t i o n  s tud ies  performed with  Mabs have a l ­
lowed a reasonable e s t im at io n  o f  dosimetry,  and c a lc u la te d  that  in a 
p a t i e n t  w i th  good tumour uptake i t  would be possible to d e l i v e r  1000 
rads to  tumour per 70 mCi I 131 labeled fab with  23 rads to marrow and 
205 rads to  l i v e r  (234)
Many labe led  Mabs succ ess fu l ly  image human tumour xenografts in mice,  
but the r e s u l t s  are d isappo in t in g  in human t r i a l s  wi th  poor s e n s i t i v i t y  
In d e t e c t i o n  o f  small tumours (236)  There are many problems in the use 
o f  labe led  Mabs fo r  tumour imaging. Mabs are very expensive to develop 
and screen .  P ro te in  im p u r i t ies  have been found in Mabs p rep ara t io n .  
Most Mabs have been labeled with  I 131 or I 123 , and o f t e n ,  promptly  
d e lo d ln a ted  in v ivo .  Mabs which are labeled wi th  Indium 111 tend to  
have a higher h epat ic  uptake ( 2 3 4 ) .  A i (  Mabs must be screened fo r  con­
t am in a t io n  by murine vi ru ses  before a d m in is t ra t io n  to humans. Using 
s u b t r a c t i o n  techniques,  sometimes a r t i f a c t s  produced by blood a c t i v i t y  
mimicked p o s i t i v e  tumour uptake and f a l s e  p o s i t i v e  r e s u l t s  
o b t a l n e d ( 2 3 7 ) . | n a d d i t io n ,  there are many b io lo g ic a l  problems leading
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to  poor tumour v i s u a l i z a t i o n  (238)_ Mabs may be of  considerable  value  
In the f u t u r e ,  but at  present  are not yet  f u l l y  developed and are a v a i l ­
ab le  on ly  in a few centers for  c l i n i c a l  t r i a l s .
C o n t ro ve rs ies  cont inue between inv es t ig a to rs  regarding c l i n i c a l  research  
in t h i s  f i e l d .  "Whither? back to basics and maybe the fog w i l l  c l e a r " ,  
as p o s t u la t e d  by Bradwell  and Dykes (239) w h o  g a v e  u t t l e
ground o f  encouragement due to many problems in radioimmunoscint igraphy  
(R IS )  and wonder "Whither (or  w i t h e r )  tumour imaging using r a d io la b e le d  
a n t i b o d ie s .  Whi le  B r i t t o n  and Granowsjfa (240)  ^ concluded tha t
each d i s c i p l i n e  of  t h i s  complete technique is r e f i n i n g  and improving i t s  
c o n t r i b u t i o n  to  the methodology and c l i n i c a l  a p p l i c a t io n  o f  radio im­
munoscint igraphy encourages fo r  ser ious work to make (RIS)  a major con­
t r i b u t i o n  o f  nuclear  medicine in c l i n i c a l  p r a c t i c e .
11(2) Potassium analogues as tumour Imaging agents
A p o s s ib le  a l t e r n a t i v e  tumour imaging agent is the potassium analogue 
t h a l l iu m - 2 0 1  c h l o r id e .
Charkes e t  a l ,  1965 (2 4 1 ) f reported that  the potassium analogue caesium 
concentra ted  In tumour and In introducing th a l I i u m —201, Lebowltz e t  a l ,  
1974 ( 13>, suggested th a t  I t  might be u s e f u l ,  fo r  tumour l o c a l i z a t i o n  in 
a d d i t io n  to  I t s  r o le  as a myocardial and renal  imaging agent .
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The f i r s t  d e s c r ip t io n  of  tumour uptake of  tha l l ium -201  was by Cox, B e l -  
f e r  and Van der Pompe In 1976 (241)  They reported concentra t ion  o f  the 
t r a c e r  in the pr imary tumour of  a man with bronchial  carcinoma, and also  
showed t h a t  the n uc l ide  was taken up by rehabdomyosarcoma implants In 
r a t s .  Tonaml, M l c h l g l s h l ,  Bunko et  a l ,  1977 ( 243 ) ,  i n c i d e n t a l l y  found a 
pr imary lung cancer c l e a r l y  v i s u a l i z e d  on tha l l ium -201  sc in t ig rams taken  
fo r  myocardial  e v a l u a t i o n .  This led them to in v es t ig a te  tha l l iu m -201  as 
a tumour imaging agent in man, and compared the de te c t io n  r a t e  of  mal ig ­
nant lesions w ith  Ga l l iu m -67 .  Of the 51 mal ignant  les ions,  36 (71%) 
were v i s u a l i z e d  as p o s i t i v e  with  t h a l l iu m -2 0 1 ,  whereas 13 (72%) of  18 
les ions  were p o s i t i v e l y  de l in ea ted  with Ga l l ium -67 .  In p a t i e n t s  wi th  
t h y r o id  nodules,  14 of  15 (95%) with  th yro id  cancer had a hot spot wi th  
t h a l l i u m - 2 0 1 ,  but only six  of  19 benign adenomas which were cold on 
techn It ium-99m Imaging showed tha l l ium-201  uptake. A l l  of  f i v e  chronic  
t h y r o i d i t i s ,  and a l l  of  three hot nodules showed p o s i t i v e  accumulat ion  
of  t h a l l i u m - 2 0 1 .  In p a t ie n t s  with lung cancer, ten of  14 (72%) were
p o s i t i v e  w i th  t h a l l i u m - 2 0 1 .  Thal l ium-201 accumulation occurred in three  
of  four p a t i e n t s  (75%) with pr imary hepatoma, but none of  e igh t  
p a t i e n t s  w i th  l i v e r  metastas is .  On the basis of  these f i n d in g s ,  Tomami 
et  a l ,  1977,  suggested tha t  tha l l ium-201  imaging might be useful  in d i f ­
f e r e n t i a t i n g  hepatoma and secondary tumour in the l i v e r .  They also  con­
cluded t h a t  i f  a th y ro id  nodule does not accumulate th a l l lu m -201  then 
the p r o b a b i l i t y  o f  malignancy Is very low.
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O c h I , Sawa, Fukuda et  a l ,  1982 ( 2 4 4 )  ^ employed e a r l y  and three  to f i v e  
hours delayed Images of  thal l ium-201  sc in t is cans  In th y ro id  tumour, and 
were ab le  to  d i f f e r e n t i a t e  most malignant thyro id  tumours from those 
which were benign. In 35 of  37 mal ignant  tumours, tha l l iu m -201  accumu­
la te d  In the cold nodule of  the I ^33 thyro id  scan on both e a r l y  and 
delayed scans, and the delayed tha l l ium-201  scans were negat ive  In 35 
out o f  39 benign tumours (244)  Hoefnagel et  a l ,  1985 ( 2 4 5 ) f inves­
t i g a t e d  the r o l e  o f  tha l l iu m -201  t o t a l  body sc in t ig rap h y  in 294 p a t i e n t s  
a f t e r  t o t a l  thyroidectomy for  th yro id  carcinoma. Results were c o r re ­
la ted  w i th  I 131 -  s c in t ig ra p h y  and tumour marker leve ls  (Thyrog lo bu l in  
or c a l c i t o n i n / C E A ) . Thal l ium-201 sc in t ig raphy  c o r r e c t l y  detected tumour 
l o c a l i z a t i o n  in 24 of  30 p a t ie n ts  wi th  I 131 p o s i t i v e ,  metastases.  In 
28 p a t i e n t s ,  tha l l ium -2 01  t o t a l  body s c in t ig raphy  revea led metastases  
which d id  not concentrate I 131 . H is topatho lo g ica l  examinat ion con­
f i rmed t h y r o id  carcinoma metastases in 16 p a t ie n ts  and other  pathology  
in f i v e  cases. Nine of  18 p a t ie n t  with  medul lary th y ro id  carcinoma ( I  
131 n e g a t iv e )  had e le va ted  ca lc i ton in /CEA leve ls .  The tha l l iu m -201  scan 
was p o s i t i v e  in e igh t  of  these p a t ie n t s .  In 196 p a t ie n t s  with  no 
ev idence o f  disease ,  whole body tha l l ium-201  scan was n eg at iv e .  They 
concluded th a t  tha l l iu m -201  t o t a l  body sc in t ig rap h y  is useful  in the 
f o l l o w  up o f  th y ro id  carcinoma, e s p e c i a l l y  when a discrepancy o f  the 
o ther  parameters e x i s t s  and p a r t i c u l a r l y  In medul lary carcinoma. They 
suggested th a t  one could r e ly  upon t h a l l iu m —201 t o t a l  s c in t ig ra p h y  in 
combinat ion w i th  tumour marker assays for  long term fo l lo w  up of  
p a t i e n t s  s u c c e s s fu l ly  t r e a t e d  for  th yro id  carcinoma (245)^
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T e r u l ,  Oyameda, Nishikawa et  a l ,  1984 (246)^ in ves t ig a ted  th a l l iu m -201  
as a tumour scanning agent In six  p a t ie n ts  with  bone tumours (2 w ith  
Ewing's sarcoma, 3 w ith  osteosarcoma and 1 wi th  g ia n t  c e l l  tumour) ,  and 
t h re e  w i t h  s o f t  t i s s u e  sarcomas (1 wi th  liposarcoma and 2 w it h  mal ignant  
f i b r o u s  h is t io c y t o m a ) .  The d i s t r i b u t i o n  of tha l l ium-201  in the tumours 
was s i m i l a r  to  tha t  of  G a l l ium-67 ,  but sometimes d i f f e r e n t  from that  
seen on Tc-99m MDP bone scan. In a l l  p a t ie n ts  wi th  Ewing's '  sarcoma,  
the pr imary and the m e ta s ta t ic  lesions were c l e a r l y  v i s u a l i z e d  wi th  
th a 11 lu m -2 01 . In three  p a t ie n t s  re ce iv in g  e f f e c t i v e  chemotherapy, a 
p o s t - th e r a p y  scan showed reduct ion in tha l l ium-201  uptake which was more 
marked than t h a t  on the Tc-99m bone scan. In a f u r t h e r  p a t i e n t  who had 
no response to  t rea tm en t ,  no changes were seen in the post therapy scan.  
On the b as is  o f  these f ind in gs  they suggested that  th a l l iu m -201  is a 
usefu l  tumour imaging agent ,  and might be of  c l i n i c a l  value in assessing  
the response o f  bone tumours to chemotherapy (246)
Kaplan e t  a l ,  1987, compared bra in  Imaging using th a l l i u m - 2 0 1 ,  
techngt ium-99m glucoheptonate and ga l l iu m -67  c i t r a t e  with  CT and 
neuropatho log lea I data in p a t ie n t s  with gl iomas.  In seven p a t ie n t s  for  
whom autopsy data were a v a i l a b l e ,  tha l l ium-201  o f f e r e d  the most accurate  
c o r r e l a t i o n  w ith  v i a b le  tumour. Gal l ium-67  gave s im i l a r  r e s u l t s  In 
p a t i e n t s  not re c e iv in g  s t e r o id s .  Tc-99m glucoheptonate scans could not 
a c c u r a t e l y  d i f f e r e n t i a t e  tumour from necrosis and oedema. S i m i l a r l y ,  
the CT scan could not d i f f e r e n t i a t e  between f i b r o t l c ,  n o n f i b r o t i c ,  
n e c r o t i c  and n e o p la s t ic  t i s s u e .  In 22 p a t ie n t s  wi thout  autopsy data ,  
T l —201 scans commonly showed smal ler  and more f o c a l l y  abnormal when com-
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pared to  Tc-99m glucoheptonate and Ga-67 c i t r a t e  scans. They concluded 
th a t  th a l l iu m -20 1  scan r e f l e c t e d  v i a b le  tumour burden more a cc u ra te ly  
than o ther  r a d io n u c l id e  s tud ies  of  b ra in  tumours. I t  had the a d d i t io n a l  
advantage th a t  I t  could be performed immediately f o l lo w in g  t r a c e r  ad­
m i n i s t r a t i o n ,  was not a f f e c t e d  by concomitant s t e r o id  a d m in is t r a t io n  and 
compliment the anatomic data obta ined from CT scans <247) .
I I ( 3 )  Aims o f  the present  thes is
The background o f  these iso la ted  repor ts  on TI -201  tumour Imaging led to 
the work described in t h i s  t h e s i s ,  which attempts to eva lu a te  more sys­
t e m a t i c a l l y  the r o l e  of  th a l l ium-201  as a tumour imaging agent in condi­
t io n s  o th er  than th y ro id  carcinoma. The major aims o f  the study were:
( 1 )  To study the time course of  th a l l ium-201  uptake in order to assess 
the opt imal  t ime for  tumour imaging with  T I - 2 0 1 .
( 2 )  To e s t a b l i s h  the s e n s i t i v i t y  and s p e c i f i c i t y  of  tha l l iu m -201  up­
take In a v a r i e t y  of  tumours and to  compare I t  as a means of  
tumour s tag in g  wi th  more standard methods.
( 3 )  To in v e s t ig a t e  changes in tumour uptake fo l lo w in g  chemotherapy and 
rad io therapy  and e s t a b l i s h  whether such changes were he lp fu l  in 
e v a lu a t in g  tumour response to therapy.
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I I ( 4 ) M a t e r f a l s  and equipment fo r  Thal l ium-201 as a tumour imaging 
agents
l l ( 4 ) ( a )  Radlonucl Ide
A l l  s tu d ie s  described in t h i s  th e s is  were performed using t h a l lo u s  
c h lo r id e  ( T I - 2 0 1 )  i n j e c t i o n  suppl ied by Amersham PLC, London. This  
isotope is suppl ied  as a s t e r i l e  iso ton ic  s o lu t io n  in sodium c h lo r id e  at  
a pH o f  f i v e  to seven. At the c a l i b r a t i o n  t ime the s o lu t io n  contains one 
m i l l i c u r i e  (37 MBq) of  a c t i v i t y  per m i l l i l i t r e ,  and is v i r t u a l l y  c a r r i e r  
f r e e  w ith  a s p e c i f i c  a c t i v i t y  o f  more than 500 m i l l i c u r i e s  of  t h a l l iu m .  
Radionuc l ide p u r i t y  is a lso  high wi th  less than one percent  t h a l l iu m -2 0 0  
and less than 0 .5  percent  t h a l l iu m -2 0 2  at the c a l i b r a t i o n  t ime.
Tha l l ium-201  emits a small y i e l d  of  gamma rays (135 to 167 keV in 10% 
t o t a l  abundance) (see Chapter I ) .  In a d d i t i o n ,  the daughter nucl ide  
mercury-201 emits an X -ray  with  an energy of  69 to 85 keV in 98 percent  
of  t h a l l i u m  d i s i n t e g r a t i o n s  d 3 )  These X- rays  are u s u a l ly  u t i l i z e d  for  
imaging. In the s tud ies  of  the t ime-course o f  tha l l ium -201  uptake by 
tumours, X- rays  and both gamma ray photopeaks were used to increase the  
count r a t i o  o b ta in ed .  In s tud ies  o f  Imaging only the X-rays  alone 69 -  
85 keV w it h  a 20 percent  window were used.
79
I I ( 4 ) (b )  Imaging Equipment
Tha i l lu m-201  k i n e t i c s  and tumour images were obta ined  using wide f i e l d  
o f  view gamma cameras (General  E l e c t r i c  400A or General E l e c t r i c  500 
Maxi camera) ,  f i t t e d  w i th  a general  purpose p a r a l l e l  ho le ,  low energy 
col I i m a t o r .
Var ious  q u a l i t y  contro l  checks were c a r r i e d  out d a i l y  including u n i f o r ­
mity  response using a f lood  source, energy s e t t i n g s  o f  pulse height  
an a ly z e r s ,  v is u a l  inspect ion of  image q u a l i t y  and e l e c t r i c a l  and 
mechanical s a f e t y  inspect ions.  In a d d i t io n  s p a t i a l  r e s o lu t io n  was ob­
ta in e d  weekly using bar phantoms.
The gamma cameras were in te r face d  to a dedicated minicomputer (General  
E l e c t r i c  "Star"  or Link "Maps").  The images could be viewed on e i t h e r  a 
black  and wh ite  or colour t e l e v i s i o n  d is p la y .  D i g i t a l  images were sub­
je c te d  to  cont ras t  enhancement, but n e i th e r  to smoothing nor background 
s u b t r a c t i o n .  Hard copy images were produced e i t h e r  on colour Polaro id  
f i l m  or black and whi te  f i l m  from the t e l e v i s i o n  screen or on X- ray f i l m  
using a m u l t im a t r ix  imager.
Time a c t i v i t y  curves and s t a t i s t i c a l  a n a lys is  of  the curves were ob­
ta in e d  using standard programmes In the STAR computer. The STAR com­
puter  was l inked  w ith  a p r i n t e r  and the curve po in ts  were p r i n t e d .  The 
stu d ies  were stored  on magnetic tapes in unprocessed form.
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1 1 ( 3 ) ( c )  P a t l e n t s
A l l  our p a t i e n t s  came through the Kuwait Cancer Control Centre or Glas­
gow Royal In f i r m a r y  w it h  proven h is to p a th o lo g ic a l  d iagnosis.
The d iagnosis are summarized in Table 1. More d e t a i l e d  d e sc r ip t io n s  of  
the p a t i e n t  popula t ion  w i l l  be provided in the re le v a n t  sect ions  o f  the 
t h e s i s .
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Tab Ie  ( 1 )  
Summary o f  P a t i e n t s
B r e a s t  C a r c in o m a  p r i m a r y  & m £ t a s t a t l c
Lung C a n c e r
C a r c i n o i d  tumour  
S a r c o I d  
Lung a b c e s s  
T . B  ^
F i b r o s i n g  a y e o I  111 s 
N e u r o b l  astom a e x c i s e d  
Sca r
Lymphoma M e d i a s t i n a l  
AbdomIna I  
R e c t a  I
Bone P r i m a r y  & S o f t  t i s s u e
L i v e r  P r i m a r y  hepatoma
C I r  r h o s I s  
H y d a t i d  c y s t  
M e t a s t a s e s
B r a i n  Pr WStyry b r a i n  tu m ours
B r a i n  M e t a s t a s e s  
CVA
P o s t  r a d i a t i o n  t h e r a p a y  
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CHAPTER I I I
THE TIME COURSE OF THALLIUM-201 UPTAKE IN MALIGNANT TUMOURS
111(1)  In t ro d u c t Io n
Previous s tu d ies  o f  th a l l lum -2 01  Imaging of  tumours have not es ta b l is h ed  
the opt imal  t ime a f t e r  i n j e c t i o n  of  the t r a c e r  fo r  o b ta in in g  the images. 
In the present  study,  t h e r e f o r e ,  the f i r s t  step was to ca r ry  out an 
a n a ly s is  o f  the t ime course of  uptake o f  the rad io n u c l id e  in var ious  
tumours.
The aim o f  t h i s  p a r t  o f  the study was to  determine the t ime of  maximal 
tumour uptake o f  the t r a c e r ,  and to study changes In the tumour to back­
ground a c t i v i t y  r a t i o s  in order to e s t a b l i s h  the opt imal  t ime fo r  tumour 
imaging w i th  T I - 2 0 1 .
I I I ( 2 )  P a t i e n t  Popula t ion
Ninety -seven p a t i e n t s  with  h i s t o l o g i c a l l y  proven malignant  tumours have 
been examined. F i f t y - s i x  p a t i e n t s  (47 male, 9 female)  had lung car­
cinoma. The ir  mean age group (+ SD) was 59 .5  (+ 11 .3  y e a rs ) .  Twenty-  
s ix  p a t i e n t s  (1 male,  25 female) had breast  carcinoma. The ir  mean age
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( + SD) was 4 4 .9  (+ 7 . 6 )  years .  The remaining 15 p a t i e n t s  (12 male,  3 
female)  had mal ignant  lymphoma. The mean age of  t h i s  group was 39 .3  
( + 1 5 .6 )  years .
The s tu d ies  performed p r i o r  to r a d i a t i o n  therapy or chemotherapy in 35 
p a t i e n t s  w it h  lung carcinoma, 16 p a t i e n t s  with  breast  carcinoma, and 
nine  p a t i e n t s  w ith  mal ignant  lymphoma. The rest  o f  the p a t i e n t s  had a l ­
ready s t a r t e d  the f i r s t  course o f  rad io th erapy  e i t h e r  alone or in com­
b i n a t i o n  w i th  chemotherapy. Three p a t i e n t s  of  the lung cancer group
were d i a b e t i c s  under medicat ion.  A l l  o ther  p a t i e n t s  were on no therapy
apart  from an a lg e s ic .  P a t ie n ts  on B-b lockers  or d igoxin  were excluded  
because o f  the known e f f e c t s  o f  these drugs on T I -201  k i n e t i c s .  
However, a l l  medicat ion  o f  the p a t i e n t s  was not a l t e r e d .  A l l  stud ies
were performed at  res t  a f t e r  four hours o f  f a s t .
I I I ( 3 )  Data Acqulsi t ion
A cannula was inserted  into an an te cu b i ta l  ve in  and the p a t ie n t  placed  
supine under the gamma camera wi th  the f i e l d  o f  view centred over the 
primary tumour s i t e .  Two m i l l i c u r i e s  (75 MBq) T I -201  were in jec ted  as a 
bolus v ia  the cannula and f lushed with  10 mis normal s a l i n e .  Data was 
acquired as two "dynamic" s tud ies  covering the f i r s t  hour a f t e r  in je c ­
t i o n  and a delayed s t a t i c  image as fo l lows:
( 1 )  For the f i r s t  f i v e  minutes,  data was acquired cont inuously  as f i v e  
second frames,  using a 64 by 64 m a t r ix .
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( 2 )  For the next  55 minutes,  data was acquired cont inuously as 30 
second frames using a 128 by 128 m a t r i x .  Data a c q u i s i t i o n  was 
then d iscont inued u n t i l  four hours a f t e r  i n j e c t i o n .
(3 )  At four hours post i n j e c t i o n ,  a ten minute long s t a t i c  image was 
acquired in a 128 by 128 m a t r ix .
AI I data was stored  on a computer in an unprocessed form.
I 11( 4 )  Data a n a ly s is
The 60 frames o f  the i n i t i a l  dynamic study were summated to c rea te  one 
image. Then e q u a l ly  s ized  regions o f  in t e r e s t  (ROIs)  were chosen over  
an area o f  the tumour s i t e ,  background close to  the tumour and the 
myocardium. Time a c t i v i t y  curves were generated over these areas.  The 
curves were d isp layed on the screen and recorded on Po la ro id  p ic t u r e s .  
The same procedure was fol lowed with  the second dynamic study. The 
frames were summated and the p rev io u s ly  crea ted ROIs over tumour, back­
ground and hear t  were assigned ( F ig .  1 ) .  A c t i v i t y  t ime curves were gen­
era te d  and d isplayed  on the screen and recorded on Po la ro id  p ic t u r e s .  
The processed data were stored on the d is k .  The computer was l inked  
w ith  a p r i n t e r  and curve po in ts were p r in t e d .
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For each p a t i e n t  the t ime a c t i v i t y  curves were analyzed fo r  the time of  
maximal tumour uptake of  T I - 2 0 1 .  The t ime o f  maximal tumour uptake in 
the tumour was def ined  as the e a r l i e s t  t ime a f t e r  i n j e c t i o n  at  which 
peak uptake occurred.
Using the computer, the tumour time a c t i v i t y  curve was d iv id ed  by the 
background curve to y i e l d  the tumour to background r a t i o s .  The time of  
maximal tumour /  background r a t i o s  was est imated  in each p a t i e n t .
For each p a t i e n t  the tumour to background a c t i v i t y  r a t i o s  were ca lcu ­
la ted  a t  5 ,  10,  20,  30,  40,  50,  and 60 minutes a f t e r  i n je c t i o n  to  enable  
assessment o f  changes in tumour to background r a t i o s .
The changes in th a l l iu m -201  concentra t ion  between e a r l y  and four hours 
delayed images (wash out r a t e )  were q u a n t i t a t i v e l y  assessed. An "ear ly"  
s t a t i c  image was produced by summating the dynamic data obta ined from 5 
to 15 minutes fo l lo w in g  in j e c t i o n .  Equal regions o f  in te re s t  over the 
tumour and surrounding background were generated,  and t o t a l  counts in 
the tumour and background were recorded. The same region of  in te re s ts  
were t r a n s f e r r e d  over the tumour s i t e  and surrounding background on the 
delayed four hours image ( F i g .  2 - 3 ) .  The change o f  a c t i v i t y  in the 
tumour between the e a r l y  and delayed images was c a lc u l a t e d ,  as were the 
tumour to  background r a t i o s .
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I I I ( 5 )  Results
Abnormal T I -2 01  uptake In the pr imary tumour occurred In 85 of  the 97 
p a t i e n t s  s tud ied  (48 lung cancer,  24 breast  cancer and 13 lymphoma 
p a t i e n t s ,  Table 2 ) .  F igures 4 through 6 show examples of  T I -201  uptake  
in a bronch ia l  carcinoma, a breas t  carcinoma and a med iast ina l  lymphoma.
111C5)(a)  Time course o f  tumour uptakes
Fol lowing intravenous a d m i n is t r a t io n ,  th a l l iu m -201  accumulated in 
tumours r a p i d l y .  Thal l ium-201 concentra t ion  in tumours increased 
g r a d u a l l y  u n t i l  i t  reached the t ime of  maximum uptake and then did not 
change s i g n i f i c a n t l y  during the f i r s t  one hour.
Examples o f  curves from the I n i t i a l  and subsequent dynamic s tud ies  are  
shown for  bronch ia l  carcinoma, breast  carcinoma and mediast ina l  lymphoma 
( F ig s .  7 -  1 2 ) .
I I l ( 5 ) ( b )  Time o f  maximal tumour uptake
The In d iv id u a l  values fo r  t ime o f  maximal tumour uptake in each o f  the  
tumour types stud ied  are shown in Figure 13. The mean time of  tumour 
uptake (+ SD) was 11 .9  + 3 .34  minutes fo r  lung carcinoma,  11.21 + 1.88  
minutes fo r  breast  carcinoma and 11 .76  + 3 .25  minutes fo r  lymphoma
(Table  3 ) .
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I I I ( 5 ) (c )  Time o f  maximal tumour /  background uptake
The mean (+ SD) t ime o f  maximal tumour /  background a c t i v i t y  was as­
sessed and found fo r  lung cancer to be 18 .3  + 0 .5 9  minutes,  breast  can­
cer 13 .0  + 1^16 minutes,  and lymphoma mean 16 .7  + 1.04  minutes (Table
4 ) .  Tables 5 to 7 show the ind iv idua l  r e s u l t s  of  tumour to background
r a t i o s  at  5 ,  10, 20,  30, 40 and 60 minutes.  Figure 14 shows the in­
d iv id u a l  values of  maximal tumour /  background r a t i o .  Table 8 shows the 
summary of  mean + SD of  tumour /  background r a t i o s  at 5 ,  10,  20,  30,  40
and 60 minutes fo r  each group of  p a t i e n t s .  The same r e s u l t s  are shown
in Figures 15 through 17. The mean tumour to background r a t i o s  do not 
change s i g n i f i c a n t l y  over the f i r s t  hour once the peak value is obtained  
at  around ten minutes.
111( 5 ) (d )  Tumour uptake and tumour /  background uptake at four hours versus 
the i n i t i a l  ten minutes Image produced from the data obta ined  from 
f i v e  to 15 minutes post I n j e c t i o n .
Four hours a f t e r  a d m in is t ra t io n  of  t r a c e r ,  the background and tumour ac­
t i v i t i e s  had decreased, but there  is s t i l l  c le a r  v i s u a l i z a t i o n  of  the 
tumours.
The percentage o f  loss of  tumour a c t i v i t y  (wash out va lu e)  has been es­
t im ated  in 46 p a t i e n t s  w i th  d i f f e r e n t  tumour types,  and expressed as a 
percentage o f  the a c t i v i t y  present  in the tumour In the i n i t i a l  ( e a r l y )
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s t a t i c  Image. The In d iv id u a l  values are shown In Table 9.  For the 
whole group,  the average (+ SD) wash out was 25 .4  (+ 3 3 .5 )  percent
(T ab le  1 0 ) .
The tumour to  background r a t i o s  were also  compared In the e a r l y  and
delayed 10 minutes and found to be (mean + SD) 1 .8  + 0 .3 0  fo r  the i n i ­
t i a l  image and 1 .6 7  + 0 .35  fo r  the delayed image.
These va lues are not s i g n i f i c a n t l y  d i f f e r e n t  (P > 0 . 0 5 ) .
I 11( 6 )  Discussion
The aim o f  the present  study was to e s t a b l is h  the best t ime fo r  Imaging 
tumours fo l lo w in g  i n j e c t io n  o f  T I - 2 0 1 .  Our r e s u l t s  show that  uptake oc­
curs r a p i d l y  in tumours wi th  a peak value obtained ten to 15 minutes 
post i n j e c t i o n  in most cases. There were no s i g n i f i c a n t  d i f fe r e n c e s  in 
d i f f e r e n t  tumour types.
Tumour to  background r a t i o s  also r a p i d ly  a t t a in e d  peak values and
remained r e l a t i v e l y  constant over the hour fo l lo w in g  i n j e c t i o n .  No s i g ­
n i f i c a n t  change in tumour /  background r a t i o  was found in the four hour 
post i n j e c t i o n  images compared to one hour post i n j e c t i o n  data.
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Previous s tu d ies  of  T I -201  tumours Imaging have u t i l i z e d  v a r i a b l e  delays  
a f t e r  i n j e c t i o n .  Kaplan e t  a l ,  1987 ( 24?) s t a r t e d  imaging b ra in  tumours 
f i v e  minutes a f t e r  i n j e c t i o n  of  T I - 2 0 1 .  Senga e t  a l ,  1985 <248) ,  study­
ing t h y r o id  tumours imaged at  ten to 20 minutes post i n j e c t i o n  and 
repor ted  th a t  these e a r l y  images produced a c l e a r e r  sc in t ig ram  than 
delayed s t u d ie s .  On the other  hand, Ochl e t  a l ,  1982 ( 244>, emphasized 
the importance o f  delayed imaging and concluded that  three to f i v e  hours 
post i n j e c t i o n  was the most ap pro p r ia te  time for  imaging.
From our own data we conclude that  tumour imaging wi th  T I -201  is best 
performed 20 to 60 minutes post i n j e c t i o n .  M u l t i p l e  views can be ob­
ta in e d  in t h i s  per iod with  no s i g n i f i c a n t  loss of  lesion uptake.  We did  
not f i n d  any evidence tha t  delayed (4 hour) imaging was advantageous be­
cause tumour /  background is not s i g n i f i c a n t l y  changed and the count in 
tumour decreased.  No tumour not seen in the e a r l y  image was v is u a l i z e d  
at  four hours.  The shor t  w a i t in g  per iod  a f t e r  i n je c t io n  with  TI -201  
c l e a r l y  o f f e r s  a major p o t e n t i a l  advantage over a l t e r n a t i v e  tumour imag­
ing agents,  such as G al l iu m -67  or r a d i o - l a b e l e d  monoclonal an t ibodies  
which r e q u i r e  much longer delays from i n je c t i o n  to image.
T a b l e  ( 2 )
u p fo k t
Abnormal  T I - 2 0 1 ^ 1 n t h e  p r i m a r y  tumour  o c c u r e d  
In 85 o f  t h e  97 p a t i e n t s  s t u d i e d .
G roup o f  p a t i e n t s  P o s i t i v e  w i t h  T I - 2 0 1
Lung c a r c i n o m a  4 8 / 5 6
V
B r e a s t  c a r c i n o m a  2 4 / 2 6
M a l i g n a n t  lymphoma 1 3 / 1 5
T o t a  I 8 5 / 9 7
T a b l e  ( 3 )
T i me  t o  max i ma l  T I - 2 0 1  u p t a k e
Lung c a r c i n o m a  
B r e a s t  c a r c i n o m a  
Lymphoma 
M y o c a r d I  urn
( m l n s ;  mean +  SD) £
1 1 .  9 + 3 . 3 4  
1 1 . 2 1  + 1 . 8 8  
1 1 . 7 6  + 3 . 2 5  
1 1 . 6 1  + 3 . 2 8
^  ' / u m p i a T  U n e o n r t t f c u f  oxtrjUzf.
T a b l e  ( 4 )
T im e  o f  m a x im a l  t u m o u r / b a c k g r o u n d  r a t i o  ( m l n s ;  mean +_ SD)
Lung c a r c i n o m a  1 8 . 3  hh 0 . 5 9
B r e a s t  c a r c i n o m a  1 3 . 0  +_ 1 . 1 6
Lymphoma 1 6 . 7  1 . 0 4
V
%  IwmoiaT UACon»t«>t ouekv*bj
Table (5 )
Lung carcinoma p a t i e n t s  In d iv id u a l  values fo r  tumour and back ground a c t i v i t i e s
(co u n ts /3 0  sec)  and tumour to background r a t i o s  at  v a r io s  I n t e r v a l s  a f t e r  I n je c t io n
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 283 296 313 332 317 315 320
F.G BG 211 284 212 209 206 229 209
Rat Iio 1 .34 1 .61 1 .48 1 .58 1 .54 1 .37 1 .53
T 1290 1500 1410 1430 1510 1460 1430
R.A BG 816 754 712 720 767 726 740
Rat Ilo 1 .58 1 .99 1 .98 1 .98 1 .96 2 .00 1 .93
T 545 470 437 396 409 384 357
B.A BG 293 251 245 251 239 246 227
Rat io 1 .8 6 1 .87 T.78 1 .57 1 .71 1 .56 1 .57
T 571 578 584 544 574 560 545
L.S BG 309 329 281 282 290 259 295
Rat Io 1.85 1 .76 2 .0 8 1 .93 1 .98 2 .16 1 .85
T 548 531 492 483 465 458 457
A . Y BG 339 329 302 296 286 263 282
Rat lo 1.61 1 .61 1 .63 1 .63 1 .62 1 .74 1 .62 •
T 711 700 680 640 602 610 570
M.F BG 411 419 362 358 296 323 319
Rat Io 1.61 1 .67 1 .88 1 .78 2 .0 3 1 .88 1 .79
T 226 226 231 185 205 193 204
S.A BG 162 146 170 161 147 141 140
Rat io 1.39 1 .55 1 .35 1 .15 1 .39 1 .36 1 .46
T 317 263 237 238 235 216 216
H. J BG 197 153 141 141 149 133 131
Rat lo 1 .61 1 .72 1 .68 1 .69 1 .58 1 .63 1 .65
T 160 168 163 144 144 106
M.M BG 147 117 135 128 123 76
Rat lo 1.09 1 .44 1 .21 1 .12 1 .17 1 .39
T 177 175 168 147 146 138 153
S.A BG 113 107 82 .8 96 .6 111 8 6 .8 92 .9
Rat lo 1.57 1 .64 1 .93 1 .52 1 .31 1 .59 1 .64
T 430 454 428 459
R.A BG 283 270 271 257
























5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 117 101 94.1 9 4 .4 7 9 .4 8 7 . 6 8 7 .8
BG 61 .1 59.1 6 0 . 8 53 .9 55 .2 51 .4 5 2 .0
Rat Io 1 .91 1 .69 1 .55 1 .75 1 .44 1 .70 1 .69
T 164 214 211 213 205 160 163
BG 8 7 .4 87.1 9 9 .6 9 7 .6 96 .4 8 6 .2 88
Rat lo 1 .88 1 .46 2.11 2 .1 8 2 .13 1 .86 1 .85
T 238 229 226 213 224 202 196
BG 106 9 5 .4 103 105 107 99 99
Rat io 2 .25 2 .4 0 2 .1 9 2 .0 2 2 .0 4 2 .09 2 .0 8
T 247 245 249 244 246 239 241
BG 154 130 118 117 116 114 116
Rat lo 1 .60 1 .89 2.11 2 .09 2.12 2 .1 0 2 .0 8
T 384 379 380 372 369 366 352
BG 222 214 221 213 215 220 217
Rat lo 1 .73 1 .77 1 .72 1 .74 1 .71 1 .66 1 .62
T 170 168 168 166 154 162 144
BG 9 4 .4 91 .8 93 .8 93 .3 87 105 8 8 .3
Rat lo 1 .8 1 .83 1 .79 1 .78 1 .77 1 .53 1 .63
T 81 .6 100 88 .8 83 .6 73.1 8 6 .8 9 0 .9
BG 53 .2 46 .4 4 8 .2 46 .2 53 .9 48 .9 5 2 .2
Rat io 1 .53 2 .15 1 .84 1 .80 1 .36 1 .78 1 .74
T 564 464 375 462 453 489 436
BG 9 4 .4 91 .8 93 .8 93 .3 87 105 8 8 .3
Rat io 1 .98 2 .03 2.01 1 .99 1 .96 2 .04 1 .99
T 915 1010 809 1018 987 884 878
BG 609 599 646 645 554 499 469
Rat lo 1 .52 1 .69 1 .25 1 .57 1 .78 1 .77 1 .87
T 345 309 325 316 299 293 286
BG 233 207 207 212 197 189 188
Rat lo 1 .48 1 .49 1 .57 1 .49 1 .51 1 .59 1 .54
T 119 109 105 98 101 97 89
BG 68 62 59 58 .3 6 0 .8 59 61
Rat lo 1 .75 1 .76 1 .71 1 .63 1 .66 1 .64 1 .61
T 739 698 692 660 653 624 598
BG 391 347 346 332 351 334 336
Rat lo 1 .89 2.01 2 .0 1 .99 1 .86 1 .87 1 .78
Table  5: Lung carcinoma p a t i e n t s
Name 5 mln 10 mln 20 mln
T 968 967 896
L.M BG 457 430 433
Rat lo 2 .12 2 .2 5 2 .0 7
T 306 302 298
H.M BG 268 238 177
Rat lo 1 .14 1 .27 1 .68
T 997 911 920
F.A BG 702 533 609
Rat io 1 .42 1 .71 1 .51
T 114 109 113
S.M BG 4 6 .6 44 .5 69 .7
Rat lo 2 .4 4 2 .65 1 .34
T 350 353 352
A . S BG 245 239 205
Rat lo 1 .43 1 .48 1 .72
T 277 284 387
F.A BG 244 241 269
Rat io 1 .13 1 .17 1 .43
T 160 153 155
A.A BG 9 2 .8 84 .4 94 .9
Rat io 1 .64 1 .81 1 .63
T 186 196 223
A. E BG 9 3 .3 9 5 .9 9 2 .3
Rat lo 1 .99 2 .05 2.41
T 187 165 174
A.T BG 111 84 .5 8 9 .8
Rat lo 1 .68 1 .94 1 .76
T 177 176 185
H.M BG 9 4 .2 9 2 .8 98 .6
Rat lo 1 .87 1 .89 1 .87
T 786 720 660
H. A BG 444 395 344
Rat lo 1 .77 1 .82 1 .91
T 336 349 328
M.S BG 302 277 250
Rat lo 1.11 1 .25 1 .31
30 mln 40 mln 50 mln 60 m
761 822 795 760
416 413 398 422
1 .83 1 .99 2 .00 1 .80
275 288 256 270
199 188 182 221
1 .38 1 .53 1 .41 1 .22
902 1003 893 898
553 599 383
1 .63 1 .72 1 .49 1 .54
114 101 106 105
7 2 .7 4 8 .9 43 .3 51 .5
1 .57 2 .23 1 .90 2 .0 5
351 345 338 352
220 218 226 224
1 .6 1 .79 1 .5 1 .57
381 379 380 375
270 243 240 280
1 .41 1 .54 1 .58 1 .33
147 108 120 113
86 .8 7 3 .4 8 8 .4 84 .0
1 .69 1 .47 1 .42 1 .35
208 200 232 220
92 .7 101 119 116
2 .24 1 .98 1 .94 1 .89
170 160 172 149
88 .2 9 0 .2 91 .9 101
1 .92 1 .77 1 .87 1 .47
174 176 172 166
95 .4 97 .2 9 6 .3 8 9 .8
1 .82 1 .81 1 .78 1 .84
640 604 611 605
365 336 330 336
1 .75 1 .79 1 .85 1 .80
307 301 268 266
244 230 213 221
1 .25 1 .30 1 .25 1 .20
Tab Ie 5: Lung carcinoma p a t i e n t s
Name 5 mln 1 0 m i n  20 mln
T 1070 1020 1040
N.H BG 493 453 453
Rat lo 2 .0 4 2.25 2 .3
T 286 280 272
A.S BG 161 134 131
Rat io 1 .7 2 .09 2 .08
T 246 243 280
W.S BG 195 157 146
Rat lo 1 .26 1 .55 1 .91
T 1030 965 967
K.K BG 538 451 456
Rat lo 2.01 2.18 2 .28
T 267 270 226
I .S BG 187 140 147
Rat io 1 .43 1 .93 1 .81
T 138 136 130
S.S BG 7 2 .3 71 .6 69
Rat lo 1 .91 1 .90 1 .88
T 432 440 418
L . A BG 767 254 263
Rat lo 1 .62 1 .73 1 .59
T 498 480 472
M.L. BG 398 329 335
Rat lo 1 .25 1 .46 1 .41
T 93.1 118 9 7 .9
R.M BG 5 8 .2 67 56 .3
Rat lo 1 .60 1 .76 1 .74
T 8 0 .9 101 95 .6
F.G BG 4 2 .6 42 .3 47
Rat io 1 .90 2.39 2 .03
T 153 125 115
A.T BG 9 4 .8 75 68 .3
Rat lo 1 .61 1 .66 1 .68
T 267 265 250
L.H BG 205 198 201
Rat lo 1 .30 1 .34 1 .24
30 mln 40 mln 50 mln 60 l
972 1040 1020 991
464 469 461 476
2.09 2.21 2.21 2 .0 8
255 248 231 237
135 131 126 138
1 .90 1 .90 1 .83 1 .78
241 250 253 241
159 179 159 172
1 .51 1 .39 1 .59 1 .40
839 822 775 757
481 448 412 442
1 .94 2 .05 2 .19 2 .1 7
261 244 258 230
144 159 147 151
1 .81 1 .53 1 .76 1 .52
119 132 132 129
82 .6 7 7 .6 7 4 . 2 7 3 .3
1 .44 1 .70 1 .78 1 .76
402 397 382 366
244 234 251 256
1 .65 1 .70 1 .52 1 .43
433 438 435 442
316 304 315 289
1 .37 1 .44 1 .38 1 .51
94 .2 8 5 .6 8 3 .2 8 9 .4
63 .6 5 0 .4 5 8 .6 58 .4
1 .48 1 .70 1 .42 1 .53
8 8 .4 7 2 .8 7 8 .6 6 7 .7
42 40 .3 36 .8 3 9 .3
2.10 1 .81 2 .16 1 .72
105 114 105 94
66 .0 69 .9 64 .2 5 9 .4
1 .59 1 .63 1 .64 1 .58
241 237 240 221
197 187 190 192
1 .22 1 .27 1 .26 1.15
Table (6 )
Breast  Carcinoma P a t ie n t s  
I n d iv id u a l  va lues fo r  tumour and background a c t i v i t i e s  (co u n ts /30  secs)  and
tumour to background r a t i o s  at  var ious  I n t e r v a l s  a f t e r  I n j e c t i o n  o f  T I - 201
CTiAMour rut* CfimcbcM.
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 159 148 145 153 151 177 155
F.Sh BG 144 9 2 .9 118 103 117 113 101 .1
Rat io 1.10 1 .59 1 .23 1 .48 1.29 1 .57 1 .53
T 513 510 487 475 418 469 422
H.J BG 211 261 250 200 231 198 220
Rat io 2 .43 1 .95 1 .95 2 .38 1 .81 2 .37 1 .92
T 501 472 428 432 455 462 405
H.M BG 239 227 256 213 234 222 237
Rat io 2 .1 0 2 .0 8 1 .67 2 .0 3 1 .94 2 .0 8 1 .71
T 188 165 175 180 188 148 181
M.M BG 8 4 .6 8 2 .7 83 .3 9 2 .7 8 2 .9 81 .8 7 7 .4
Rat io 2 .22 2 .0 2.10 1 .94 2 .27 1 .81 2 .34
T 197 244 250 250 249 231 224
M.S BG 6 6 .7 65 .9 69 .4 6 7 .3 7 9 .9 92.1 69 .8
Rat lo 2 .9 5 3 .7 3 .6 0 3 . 7 3.11 2.51 3.21
T 153 137 133 139 145 160 152
M.L BG 81 .3 69 .9 172 71 .3 95.1 7 8 . 4 7 2 .3
Rat io 1 .88 1 .96 1 .83 1 .95 1 .52 2 .0 3 2.10
T 117 96 .3 7 8 .4 94 .4 7 7 .4 8 7 .6 8 7 .8
R.S BG 61 .1 63.1 46 .3 53 .6 5 5 .4 51 .8 52 .0
Rat lo 1 .91 1 .53 1 .69 1 .76 1 .40 1 .69 1 .69
T 164 196 211 213 205 160 163
K.M BG 9 7 .4 87.1 87 .9 9 7 .6 9 6 .4 8 2 .7 8 4 .6
Rat io 207 2.25 215 2 .1 8 2 .1 3 1 .93 1 .92
T 71 .3 61 .1 53 .9 9 2 .3 7 3 .6 9 6 .8
S.M BG 58 .5 54 .6 42 .8 5 5 .7 4 7 .2 44 .3
Rat lo 1 .22 1 .12 1 .26 1.65 1 .54 2 .1 8
Table 6 : Breast  Carcinoma P a t ie n t s
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 108 115 114 109 96 86 89
S.H BG 91 8 7 .2 88 84 .2 7 6 . 3 7 0 . 4 71 .1
Rat lo 1 .19 1 .32 1 .29 1 .30 1 .26 1 .22 1 .25
T 91 .5 96.1 94.1 8 4 .3 8 8 .2 8 7 . 2 85 .5
M.G BG 96 95.1 96 84 .2 89.1 85 .5 85
Rat io 0 .95 1 .01 0 .98 1 .00 0 .99 1 .02 1 .01
T 423 392 365 353 361 383 369
F.S BG 270 363 225 232 235 206 223
Rat lo 1 .57 1 .52 1 .82 1 .52 1 .54 1 .86 1 .65
T 404 404* 3663 363 383 346
R.K BG 250 207 224 220 240 219
Rat lo 1 .63 1 .95 1 .63 1 .65 1 .60 1 .58
T 238 287 283 252 236 272 272
F.A BG 162 153 170 181 184 158 178
Rat io 1 .47 1 .87 1 .66 1 .39 1 .28 1 .72 1 .52
T 2350 2310 2300 2210 2222 2150- 2160
F.Ah BG 2080 1770 1890 1770 1720 1730 1650
Rat io 1 .13 1 .31 1 .21 1 .24 1 .29 1 .23 1 .30
T 630 522 519 503 471 444 452
M.S BG 315 318 360 329 341 322 308
Rat lo 2 . 0 1 .64 1 .44 1 .53 1 .38 1 .38 1 .48
T 649 676 671 625 584 610 615
A.A BG 312 338 348 324 321 301 289
Rat io 2 .0 8 2 .0 1 .93 1 .93 1 .82 2 .03 2 .1 3
T 361 375 339 381 367 342 295
Z.S BG 319 232 217 227 214 201 231
Rat io 1 .73 1 .61 1 .56 1 .67 1 .71 1 .70 1 .27
T 264 256 262 239 260 263 247
F.M BG 141 130 142 139 151 143 157
Rat io 1 .87 1 .97 1 .85 1 .72 1 .72 1 .84 1 .57
T 1620 1530 1590 1330 1190 1110 1050
M.B BG 782 694 678 620 561 567
577
Rat io 2 .0 7 2 .20 2.34 2.15 2 .1 2 1 .95 1 .82
Table 6: Breast  Carcinoma P a t ie n t s
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 282 278 303 283 278 303 316
F.B BG 136 124 137 142 116 128 117
Rat lo 2 .0 7 2 .24 2.21 1 .99 2 .39 2 .3 7 2.70
T 595 635 589 589 603 639 567
K.N BG 568 441 424 473 450 465 464
Rat lo 1 .05 1 .44 1 .39 1 .26 1 .34 1 .37 1 .22
T 732 757 682 661 669
M.R BG 562 521 486 471 465
R a t io 1 .30 1 .45 1 .40 1 .40 1 .43
T 6 5 .9
N
70 63 .8 6 2 .9 4 5 .9 5 8 . 6 55 .5
S.H BG 47 43 44 .8 41 .5 37 .9 41 .6 35 .6
Rat lo 1 .40 1 .63 1 .42 1.51 1 .21 1 .41 1 .56
Table 7
Mal ignant  Lymphoma P a t ie n t s
In d iv id u a l  va lues of  tumour/background a c t i v i t i e s  (counts /3 0  secs)  and tumour 
to background r a t i o s  at var ious I n t e r v a l s  a f t e r  I n j e c t i o n  o f  T I - 2 0 1 .
C T m v h w  a th v c tf
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 1070 1180 1100 1230 1170 1190 1210
T.M BG 602 566 517 538 507 489 478
Rat lo 1 .78 2 .08 2 .1 3 2 .29 2 .30 2 .43 2.53
T 818
X
853 863 881 900 830 841
K.Y BG 500 503 511 530 535 532 539
Rat lo 1 .64 1 .70 1 .69 1 .66 1 .68 1 .56 1 .65
T 2320 2360 2410 2560 2540 2580 2660
B. A BG 1180 1280 1270 1410 1350 1370 1370
Rat lo 1 .97 1 .84 1 .90 1 .82 1 .88 1 .88 1 .94
T 692 694 767 720 743 693 670
M. J BG 207 167 223 212 207 217 215
Rat lo 3 .3 4 4.15 3 .44 3 .4 0 3 .59 2 .19 3.11
T 286 417 410 416 399 302 375
M.A BG 279 248 230 257 255 225 280
Rat lo 1 .38 1 .68 1 .78 1 .63 1 .56 1 .34 1 .34
T . 213 229 248 205 169 172 185
F.F BG 141 160 178 147 124 123 151
Rat lo 1 .51 1 .43 1 .39 1 .39 1 .36 1 .40 1 .23
T 225 199 207 167 165 139
D.M BG 147 132 139 121 117 91 .5
Rat lo 1 .53 1 .51 1 .49 1 .38 1 .41 1 .52
T 170 172 168 149 146 161 141
V.K BG 101 102 101 94 .3 93 101 92
Rat io 1 .68 1 .69 1 .66 1 .58 1 .57 1 .59 1 .53
T 115 111 114 116 103 107 108
M.A BG 7 6 .7 7 4 .2 7 9 .7 80.1 7 8 .3 7 3 .2 71 .5
R a t io 1 .50 1 .49 1 .43 1 .45 1 .32 1 .46 1 .51
Table 7: Mal ignan t  Lymphoma P a t ie n t s
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
T 165 157 152 147 118 136 117
S.A BG 101 8 6 .7 93 88 78 91 .2 81 .8
Rat lo 1.63 1 .81 1 .64 1 .68 1 .52 1 .49 1 .43
T 603 635 592 576 531 513 511
B.G BG 538 438 435 440 385 383 396
Rat lo 1 .17 1 .45 1 .36 1 .31 1 .38 1 .34 1 .29
T 284 253 270 224 198 183 193
S.K BG 192 182 186 174 156 140 146
Rat lo 1 .48 1 .39 1 .45 1 .29 1 .27 1 .31 1 .32
T 115 113n 83 101 93 97 85
M.S BG 101 92 74 83 78 80 73
Rat lo 1 .14 1 .23 1.12 1 .2 2 1 .19 1 .21 1.16
Table  8
Tumour to  background r a t i o s  (mean + SD) of  T1-201 In the hour f o l lo w in g  In je c ­
t i o n .
O u i r t d a r  A-el ivofcj  f i r
Name 5 mln 10 mln 20 mln 30 mln 40 mln 50 mln 60 mln
Lung
Care I noma
1.65 1.81 1 .77 1 .70 1 .71 1.71 1.67
+0 .3 0 +0.19* +0.20 +0.27 +0 .08 +0.26 +0 .24
Breast 1 .7 4 1 .81 1 .74 1 .77 1 .68 1 .78 1 .68
Care I noma
+0 .47 +0.51 +0.50 +0.41 +0.36 +0.37 +0.59
Lymphoma 1 .67 1 .8 0 1 .73 1.70 1 .6 9 1 .67 1 .67
+0 .55 +0.52 +0 .57 +0 .58 +0 .64 +0.54 +0.59
Table 9
The washout r a t e  between e a r l y  and 4 hours delayed Images In var io us  tumours.
C l O u c t w d u A  a M .  C u r tA & i t o t k ' f f i A M A x j t )  .
Name E a r ly  T/BG R a t io  Delayed T/BG R a t io  % Washout
M.M 5720 /  3788 1 .51
S.A 6654 /  3520 1 .72
W.M 4192 /  2065 2.03
L.S 18261 /  9085 2.01
A.Y 8500 /  4030 2.11
M.F 12180/  6870 1 .78
W.S 8773 /  4514 1 .94
F.B 8355 /  4104 fO -N
M.S 10532/  4994 2.11
S.H 9768 /  4579 2 .1 3
A.A 19695/11540 1 .71
Z.H 5645 /  2610 2.16
K.N 5140 /  3292 1 .56
A.M 10950/  6260 1 .75
F.A 6197/  4201 1 .48
S.A 8905 /  6850 1 .30
H.M 10726/  4915 2 .18
S.A 26790/16000 1 .67
M.H 17000/  9000 1 .89
F.A 4330 /  3520 1 .23
M.S 15176/  8980 1 .69
M. J 13305/  6000 2 .22
A.A 5498 /  3899 1 .41
M.K 462 /  382 1 .21
M.L 3243 /  2100 1 .54
M.S 4518 /  2235 2.02
R.A 9432 /  5639 1 .67
H. A 14931/  9450 1 .58
M.S 15438/ 7903 1 .95
K.N 13615/  5360 2 .54
A .0 24700/15470 1 .60
W.A 5850 /  3530 1 .66
S.A 11630/  6020 1 .93
M.G 8350 /  5400 1 .55
D.N 11012/  4882 2.25
A.Y 9852 /  4975 1 .98
N.H 10250/  6313 1 .62
S. J 13830/  9763 1 .62
A.S 24060/10020 2 .40
A.T 3485 /  2041 1 .71
5060 /  3530 1 .43 20.81
5909 /  3410 1 .90 - 1 0 . 4 6
3847/  2224 1 .73 23 .70
17949/  7770 2.31 - 1 0 . 9 3
4800 /  3200 1 .50 64.21
7670 /  4460 1 .72 39.55
6730 /  4306 1 .56 43 .08
6506/33319 1 .96 25 .03
3053/  2159 1 .41 83 .85
9150 /  5423 1 .69 28 .17
9810 /  6941 1 .41 64.81
5003 /  2448 2 .04 15.81
3361/  2965 1 .13 7 8 .57
5666/  3522 1 .61 54 .28
3954/  2816 1 .40 42 .98
5146 /  4253 1 .21 .56.54
1790/  900 1 .98 8 4 .6 8
17000/11000 1 .54 44 .39
16000/12000 1 .33 50 .00
4136 /  2870 1 .44 - 5 6 . 3 0
10400/ 6342 1 .52 42 .58
13127/ 7100 1 .84 17.49
4308/  3122 1 .38 25.82
551 /  477 1 .15 7 .50
5443/  4165 1 .30 -11 .8 1
4588/  1674 2 .74 - 2 7 . 6 4
7788 /  3793 2.05 -  5 .30
10555/ 7486 1 .41 44 .06
10383/  6300 1 .65 45.81
12235/ 4894 2 .5 0 11 .07
24100/10955 2 .1 9 -42 .41
4032 /  1785 2.25 3.15
8560 /  4380 1 .95 25.49
7900 /  4700 1 .68 -  8 .4 7
9281 /  4730 1 .96 25.75
7403 /  4569 1 .62 41 .89
8380 /  5624 1 .49 29 .99
11725/ 8450 1 .39 46.02
18960/10744 1 .76 41 .86
4632 /  2405 1 .92 - 5 4 . 2 2
Table (9 )
Name E a r ly  T/BG Rat lo Delayed T/BG R at io % Washout
E.E 4962 /  3101 1 .60 4778 /  3057 1 .56 7 .5 2
A.A 6785 /  4526 1 .50 3524/  2670 1 .32 62 .1 9
S.A 79 45 /  4786 1 .66 4830 /  3157 1 .53 47 .04
A.T 6961 /  3889 1 .79 6052 /  3478 1 .74 16.21
S.J 15830/  9763 1 .62 11725/  8450 1 .39 46 .17
A.Ar 3841 /  2222 1 .73 4824 /  2975 1 .62 -1 4 .2 1
\
Tab le  10
Mean (+ SD) T I -201  washout from . tumour 
between 1 and 4 hrs post i n j e c t i o n  was 
25.4% (+ 3 3 . 5 ) .
J A B IA  AHHEB/TL
Figure (1): Regions of interest over the tumour, 
background and myocardium.
EARLY IilAGE
Figures (2 & 3): Regions of interest, over the tumour, 
background in early (figure 2) and delayed image 
(figure 3). The counts in each ROI were obtained and 
washout rate was calculated.
tusior
Figure (4): Abnormal TI-201 concentration in the 





Figure (5): Abnormal TI-201 chloride concentration in 
the right breast in a patient with breast carcinoma.
Figure (7): Flow I. The initial uptake immediately, after
I.V. injection of TI-201 by the heart, liver, tumour and 
background in a patient with lung carcinoma.
Figure (8): Flow II. Time activity curve until 55 
minutes of the heart, tumour, and background in a 
patient with lung carcinoma.
77.3 132.3 227.3
Figure (9): Flow I. The intiial uptake of TI-201 by the 
heart, tumour and background in a patient with 
breast carcinoma.
Figure (10): Flow II, time activity curve until 55 
minutes of the heart, tumour and background in a 
patient with breast , carcinoma.
Figure (6): Abnormal TI-201 concentration in the 
mediastinum in a patient with malignant lymphoma.
Figure (11): Flow I, the initial uptake of TI-201 by 
heart, tumour and background (lung) in a patient with 
malignant lymphoma.
192 
i e i  
91
e ______________________
9.9 88.9 199.9 229.8 3 M I
Figure (12): Flow II, time activity curve until 1 hour of 
the heart, tumour and lung (as a background) in a 
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Figure (13): The individual values of maximal tumour 
uptake in lung cancer n=(50), lymphoma (n-13) 
breast cancer n=(24), heart n=(88).
The mean (± SD)
13. (+ 1.16) minutes
The mean (± SD) 
16.7 (±1.04) minutes
The mean (± SD) 

















Figure (14) : The individual values of maximal 
tumour to background ratio in breast cancer (n=24), 
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MECHANISM OF T I-2 0 1  UPTAKE IN TUMOURS
IV ( 1 )  I n t r o d u c t Io n
T h a l l iu m  Is a m e t a l l i c  element In group I 11—A of  the p e r io d ic  t a b le .  
The use o f  T I -201  as a myocardial  imaging agent is dependent upon i t s  
s i m i l a r i t i e s  to  Ionic  potassium in b io lo g ic  systems. As a potassium 
analogue,  t h a l l i u m  a c t i v a t e s  the sodium-potassium (Na-K) ATP-ase depend­
ent  pump and the c e l l u l a r  uptake of  T1 is i n h ib i t e d  by ouabain and
sodium f l o r i d e  which block the Na-K pump ( 2 8 ) s Update of  T l + and K+ is
not i d e n t i c a l :  Tha l l ium appears to bind to two s i t e s  on the enzyme sys­
tem compared to one fo r  potassium C29) .  This may e xp la in  the more 
prolonged c learance of  th a l l iu m  from the myocardium compared to potas­
sium ( 5 1 ) .  Tha l l ium also  has h ighly  p o l a r i z a b l e  outer  e le c t r o n  s h e l ls  
and r e a d i l y  complexes with  water ,  and the membrane is almost equ a l ly
permeable to T1 + as i t  is to K + . I t  has been suggested that  I n t r a c e l ­
l u l a r  accumulat ion of  t h a l l iu m  Is dr iven  by the transmembrane 
e l e c t r o p o t e n t i a l  grad ie n t  ( 26) .
T h a l l iu m  and potassium belong to d i f f e r e n t  groups in the p e r io d ic  ta b le .  
The b i o l o g i c a l  s i m i l a r i t i e s  between th a l l iu m  and potassium in terms of  
organ d i s t r i b u t i o n  have been exp lained by the fac t  that  the hydrated
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io n ic  rad ius  o f  t h a l l i u m  l i e s  between potassium and rubidium in s i z e .  
This  ra d iu s  has been suggested as the e s s e n t ia l  proper ty  that  determines  
passive  p e n e t ra t io n  through a l i q u id  layer and membrane ( 26 ) ( 2 4 9 ) .
Mechanism o f  T I -201  uptake in tumours has not been e s ta b l is h e d .  In the  
present  study t h i s  mechanism was evaluated  by a) comparison o f  the time 
course o f  T I -201  uptake in tumours and myocardium; b) comparison of  
r a t i o s  o f  uptake o f  T I -201  and T l ( " m^-microspheres in tumour and normal 
t i s s u e s  in a p a t i e n t ;  and c)  by in v i t r o  s tu d ies  o f  T I -201  uptake by a 
tumour ceI I I i n e .
IV (2 )  Comparison o f  tumour and myocardial  uptake
I V ( 2 ) ( a )  P a t i e n t s  and Methods
As descr ibed In Chapter I I I ,  97 p a t ie n t s  with  proven malignancy were ex­
amined fo r  the opt imal t ime fo r  tumour imaging by T I - 2 0 1 .  Of these,  88 
p a t i e n t s  (53 with  lung carcinoma, 24 wi th  breast  carcinoma and 13 with  
medias t in a l  lymphoma), had a comparat ive study was made of  t ime course 
of  tumour and myocardial  uptake.
Also described in Chapter I I I ,  the data was acquired as two dynamic 
stu d ies  at  f i v e  seconds in t e r v a ls  fo r  f i v e  minutes then at  30 seconds 
in t e r v a l s  fo r  55 minutes.  A ten minutes s t a t i c  image was obtained at  
four hours post In j e c t i o n .  And a f t e r  c r e a t in g  e q u a l ly  s ized  regions of  
in t e r e s t  over the tumour, background close to the tumour and myocardium,
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a c t i v i t y  t ime curves were generated from the two dynamic s tu d ies .  These 
were analyzed fo r  t ime course o f  uptake o f  T I -201  in the tumour and 
myocard ium.
The wash out  r a t e  between e a r l y  and four hours delayed images was quan­
t i t a t i v e l y  assessed. An e a r l y  s t a t i c  image was produced by summating the 
dynamic data obta ined  from f i v e  to 15 minutes f o l lo w in g  i n j e c t i o n .  Equal 
reg ions o f  In t e r e s t  over the tumour, myocardium, and surrounding back­
ground were recorded.  The same region o f  in t e r e s t s  were t r a n s f e r r e d  over 
the tumour s i t e ,  myocardium and surrounding background on the delayed  
four hours image. The change of  a c t i v i t y  in the tumour and myocardium 
between the e a r l y  and delayed images was c a l c u l a t e d .
I V ( 2 ) ( b )  Results
Fo l lo wing  intravenous i n j e c t i o n ,  T I -201  uptake in the tumour and myocar­
dium occurs r a p i d l y .  Figures 7 - 1 2  show t y p ic a l  a c t i v i t y  t ime curves of  
the tumour and myocardium obtained from lung carcinoma, breast  car­
cinoma, and med iast ina l  lymphoma.
In the whole s e r ie s  of  p a t ie n t s  the time from I n je c t i o n  to peak tumour 
a c t i v i t y  ranged from e ig h t  to 20 minutes.  The mean time to peak tumour 
a c t i v i t y  ( ISD) was 11 .9  (+ 3 .34 )  minutes fo r  lung carcinoma, 11.21 (+
1 . 8 8 )  minutes fo r  breast  carcinoma and 11.76 (+ 3 .2 5 )  minutes fo r  lym­
phoma. These r e s u l t s  were compared with the maximum t ime of  myocardial
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uptake and found to be s i m i l a r .  The t ime from i n j e c t io n  to peak 
myocardial  a c t i v i t y  ranged from e ig h t  to  20 minutes. The mean t ime to 
peak myocardial  a c t i v i t y  ( + SD) was 11.61 Tg i 26 )<
The t ime course o f  tumour uptake p a r a l l e l e d  myocardial  uptake with  a l ­
most id e n t i c a l  t imes of  peak uptake being obtained in tumour and myocar­
dium.
Comparison o f  e a r l y  " s t a t i c "  and four hours post in je c t io n  images were 
p o ss ib le  in 46 p a t i e n t s  (20 lung carcinoma, 17 breast  carcinoma and 9 
lymphoma). The mean (+ SD) wash out of  T I -201 from the tumour over t h is  
period  was 25 .4  (+ 3 3 .5 )  percent  of  the a c t i v i t y  present in the e a r ly  
s t a t i c  image. The mean wash out of  T I -201  from the myocardium over four  
hours 29 .7  (+ 1 6 .7 )  precent .
I V (3 )  Blood f low d i s t r i b u t i o n  o f  Tc 99m-mlcrospheres versus T I -201  in tumours 
I V ( 3 ) ( a )  In t ro d uc t Io n
As described p rev io u s ly  (Chapter I )  the uptake of  T I -201  in the myocar­
dium r e f l e c t s  myocardial  blood f low  and Na-K pump a c t i v i t y .  In view of  
the s i m i l a r i t y  of  the time course of  uptake of  TI -201  in the tumours and 
myocardium, the opp o r tu n i ty  was taken o f  making a comparat ive study of
the d i s t r i b u t i o n  o f  T I -201 and Tc 99m -  microspheres ( r e f l e c t i n g  blood
f lo w )  In tumour and normal t issues  In a p a t i e n t .
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I V ( 3 ) (b )  Methods
The sub je c t  was a 63 year o ld  p a t i e n t  w it h  known h epat ic  metastases from 
a carcinoma o f  colon who was undergoing a laparotomy for  placement of  a 
h ep a t ic  a r t e r y  c a th e te r  fo r  the purpose of  reg ional  chemotherapy.
Fol lowing in s e r t io n  of  the c a t h e t e r ,  20 MBq th a l lo u s  c h lo r id e  ( T I - 2 0 1 )  
and 40 MBq 99m-techn^t  ium microspheres were in jec ted  into the c a t h e t e r .  
The microspheres were obta ined from Sorin Biomedlca ( I t a l y )  and had a
p a r t i c l e  s i z e  range o f  23 to 45^<. Ten minutes a f t e r  i n j e c t io n  o f  the
t r a c e r s  b io ps ies  were obta ined from hepat ic  metastases and from normal 
l i v e r .  The lesion obtained was submitted to h is t o l o g i c a l  examinat ion and 
to  w e l l  count ing fo r  T I -201  and Tc 99m.
Three b io ps ies  were taken,  one gram of  normal l i v e r  t i s s u e ,  and two
grams o f  tumour t i s s u e .  These samples were analyzed using a three chan­
nel Packard autogamma counter .
Channel 1 was set on Tc 99m spectrum 120-160 kev. Channel 2 was set  on 
T I- 201  spectrum 65-85  kev.
The samples were counted on day one and a f t e r  f i v e  days (12 2 .6  hours) .  
The Tc-99m was decayed by more than 20 h a l f - l i v e s .  The sc a t te re d  r a d i a ­
t i o n  o f  both rad ionuc l ides  were c a lc u la t e d  and t ru e  count from each
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ra d io n u c l id e  was o bta in ed .  The samples were weighted and counts per gram 
t i s s u e  fo r  each r ad io n u c l id e  were obta ined .  The tumour/normal uptake  
r a t i o  was c a lc u la t e d  fo r  both T I -201  and and Tc-99m.
I V ( 3 ) ( c )  Results
Table 11 summarizes the weight of  the samples and t ru e  count uptake of  
both rad io nu c l ide s  by the tumour, and normal l i v e r  t issues  and counts 
per gram t issu e  fo r  both Tc-99m and T I -201 c h lo r id e .
The t o t a l  tumour uptake of  Tc-99m was found 4050 counts per gram.
The t o t a l  tumour uptake of  T I -201  was found 1653 counts per gram.
The normal l i v e r  t issu e  uptake of  Tc-99m was 66431 counts per gram and 
fo r  T I - 201  was 297931 counts per gram.
Table 12 shows the r a t i o  of  uptake in tumour to normal l i v e r  t issu e  (per  
gram t i s s u e )  fo r  the Tc-99m was 0 .0 6 1 ,  and fo r  TI -201  was 0 .0 0 6 .
H is to lo g y  confirmed that  no tumour was present  in the area of  macro­
scop lea l l y  normal l i v e r .
The tumour area was shown to contain a mixture o f  v ia b le  and n ec r o t ic  
t issue.
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I V ( 3 ) C d ) Comments
The d i s t r i b u t I o n  o f  tha l l iu m -201  w i t h in  the tumours t iss u e  is not
p r o p o r t io n a l  to the d i s t r i b u t i o n  o f  Tc-99m microspheres which r e f l e c t s
the reg ional  blood f low  of  the l i v e r  deposits .  These data suggest that  
T I -201  c h lo r id e  did not r e f l e c t  the regional  blood f low of  the tumour. 
And I concluded that  T I -201  d i s t r i b u t i o n  in tumours is not pure ly  a 
f low dependent process.
IV (4 )  In v i t r o  s tu d ies :  Thal l ium-201 uptake in non-small c e l l  lung cancer
I V ( 4 ) ( a )  Aim o f  the Study:
To assess whether Thal l ium-201 uptake by tumour c e l l s  is dependent on
the Sodium potassium ATPase pump, in a squamous carcinoma c e l l  l in e  SK-
MES.
SK-MES c e l l s  grow as a monolayer in t is sue  c u l t u r e  f l a s k s ,  grow in F10 
DMEM and are t r y p s in  I zed and passaged weekly.
IV C 4 ) (b )  Methods
Measurements of  T I -201 a c t i v i t y  have been made under contro l  condi t ions  
and a f t e r  digoxin in te rv en t io n  in tumour c e l l s .  Five experiments were 
done, in each 5 cm2 of  c e l l s  incubated with  T I -201 wi thout  digoxin  
( co n t ro l  group) and 5 cm2 of  c e l l s  with  d ig ox in .
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The tumour Cel l  l in e  is SK-MES (a squamous c e l l  carcinoma).  The mean 
c e l l  count was 5 X 10 ® c e l l s  in 25 cm2 f l a s k s .  The c u l t u r e  medium was 
F10-EM, supplemented with  fo e t a l  bovine serum. A n t i b i o t i c s  were not 
added.
To 5 cm2 sample added e i t h e r  o.1mg digox in  i n j e c t a t e  BP In 0.4ml or 
0.4ml s a l i n e  to  the contro l  group.
Twenty minutes l a t e r ,  3-4  MBq of  TI -201 c h lo r id e  added and incubated for  
45 minutes at 37°C.
The c e l l s  were cen t r i fu g e d  down. The supernatant decanted and re ta in e d .  
C e l l s  were resuspended in f i v e  ml s a l i n e ,  r e c e n t r i fu g e d ,  supernatant  
separated and r e t a in e d .  The c e l l s  were resuspended In 5 ml s a l in e  and 
again c e n t r i fu g e d  and the supernatant r e ta in e d .  C e l ls  were resuspended 
in 5ml s a l i n e .  The c e l l s  were t r y p s in iz e d  and harvested and the radioac­
t i v e  content  o f  the c e l l s  was measured.
Counting was c a r r i e d  out in a gamma counter ,  for  60 seconds per tube.  
Blank tubes were used for  background at  beginning and end of  count ing  
the samples.
In each experiment two samples were t re a te d  with  digoxin  and two samples 
without  d ig o x in .  Each of  0.5ml samples of  c e l l s  suspension,  and o.5ml  
samples o f  mixed supernatdpit were counted s e p a ra te ly .
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Total  a c t i v i t y  in c e l l u l a r  and supernatant  f r a c t i o n s  c a lc u la t e d  and c e l ­
l u l a r  a c t i v i t y  expressed as a percentage of  t o t a l  c e l l u l a r  and super­
natan t  a c t i v i t y .
I V ( 4 ) ( c )  ResuIts
The r a d io a c t i v e  content  of  the c e l l s  was higher when incubated with  
Thal l ium  alone (Tab le  1 3 ) .  The r a d io a c t iv e  content of  the supernatant  
was higher when the c e l l s  were Incubated with  Thal l ium and Digoxin.  This  
suggests tha t  Digoxin blocks the uptake of  th a l l iu m  by squamous lung 
carcinoma c e l l s  SK-MES.
I VC 5)  Discussion
The t ime course of  tumour uptake p a r a l l e l e d  myocardial  uptake,  wi th  a l ­
most id e n t ic a l  t imes of  peak uptake being obtained in tumours and 
myocardium. The range of  t imes to peak a c t i v i t y  th a t  I found in tumour 
and myocardium ( 8-20  minutes)  is very s i m i la r  to that  reported by 
Bradley-Moore et  a l . ,  1975 for  TI -201  myocardial  uptake in an
an imaI mode I .
The s i m i l a r i t y  in tumours and myocardial  TI -201  uptake may in d ic a te  a 
s i m i l a r  mechanism of  t r a c e r  uptake. Myocardial  T I -201 uptake is 
g e n e r a l l y  accepted to r e f l e c t  both blood f low and Na+ -  K+ ATPase de­
pendent pump a c t i v i t y  (2 5 0 ) .
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There are c o n f l i c t i n g  reports  in the l i t e r a t u r e  concerning the exact  
r o l e  o f  blood f low in the e x t r a c t i o n  of  T I -201 by the myocardium. Abbate 
et  a l . ,  1977 ( 5 5 )  ^ repor ted  that  the i n i t i a l  e x t r a c t i o n  of  t h a l l iu m  by 
myocardium fo l lo w in g  bolus in j e c t io n  in man does not appear to be in­
f luenced by myocardial  blood f low.  On the other  hand severa l  stud ies  
have shown that  the d i s t r i b u t i o n  of  th a l l iu m  is a f low dependent 
process^32 ) <251> ^  .
Other authors have reported that  T I -201 uptake in the tumours occurred  
r a p i d l y ,  w ith  a p a t te r n  of  t is sue  d i s t r i b u t i o n  s i m i la r  to tha t  seen with  
potassium ( 247) (252)  This led them to p os tu la te  that  the mechanism of  
t h a l l i u m -201 uptake by the tumour c e l l s  is c e r t a i n l y  r e la t e d  to a func­
t i o n  o f  blood f low and the (Na-K)-ATP-ase c e l l  membrane pump that  is the 
same mechanism as T I -201 myocardial uptake.
Tumours o f t e n  have abnormal v a s c u la r i t y  and T I -201 may accumulate 
r a p i d l y  in the e x t r a  c e l l u l a r  space e i t h e r  due to the increased per­
m e a b i l i t y  o f  new vessels with  large i n t r a c a p i l l a r y  pores ( 189  ^ or simply  
to increased v a s c u l a r i t y .
I was ab le  to  study In a s in g le  p a t ie n t  the ro le  of  blood f low in the 
i n i t i a l  d i s t r i b u t i o n  of  TI -201 in tumour c e l l s .  The data from t h i s  
s i n g l e  p a t i e n t  suggest that  the d i s t r i b u t i o n  of  T I -201  in tumour t issue
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Is not p u re ly  p ro p o r t io n a l  to the microspheres d i s t r i b u t i o n .  I concluded 
th a t  I n i t i a l  e x t r a c t i o n  of  TI -201  by tumour c e l l s  is not completely a 
f low  dependent process.
According to the work of  M u l l in s  and Moore, 1960 ( 26) ,  conf irmed by 
Gehring and Hammond, 1964 ( 27  ^ and 1967 with  b i o d i s t r i b u t i o n  s tud ies  in 
animal models, the mechanism involved in a c t i v e  tr anspor t  o f  potassium 
cannot d i f f e r e n t i a t e  between potassium and t h a l l i u m .  The c e l l u l a r  uptake  
of  T1 + was in h i b i t e d  by card iac  g lycoside ouabain and sodium f l o r i d e ,  
which are we l l  e s ta b l ish ed  s e l e c t i v e  Na+ K + ATP-ase pump i n h ib i t o r s  
(28 )  Digoxin also  has been postu la ted  that  blocks the sodium-potassium
ATP ase In the c e l l  membrane and decrease the e x t r a c t io n  of  T I -201 (50)
The data obta ined  in my in v i t r o  study showed a large decrease in ex­
t r a c t i o n  o f  t h a l l i u m -201 by the tumour c e l l  l in e  fo l low ing  incubat ion  
w ith  d ig o x in .  The Na ( + ) K ( + ) ATP-ase pump a c t i v i t y  i n h ib i t e d  fo l lo w ­
ing d igox in  a d m in is t r a t io n  r e s u l t in g  in low e x t r a c t io n  e f f i c i e n c y  by the 
tumour c e l l s .  This ind icates  that  the mechanism of  i n t r a c e l l u l a r  tumour 
uptake is a c t i v e  transpor t  through the c e l l  membrane with  in f lu x  of  T I -  
201 and i t  is mediated by Na+, K+ ATP-ase system.
The i n i t i a l  e x t r a c t i o n  a f t e r  intravenous i n j e c t io n  of  tha l l iu m -201  does 
not remain f i x e d  In the tumour. Most tumours showed considerab le  loss of  
TI -201  a c t i v i t y  by four hours post in j e c t i o n .  The r a t e  o f  T I -201 loss we 
found is s i m i l a r  to tha t  reported by Ziada e t  a l ,  1986, fo r  myocardial  
vo lu n teers  stud ied at res t  (28% + 7)  ( 25 3 ) .
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Areas o f  necros is  do not accumulate t h a l l i u m - 2 0 1 ,  and t h i s  was proved 
c l i n i c a l l y  by imaging the tumours, and q u a n t i t a t i v e l y  using SPECT in 
some p a t i e n t s  (F ig u re  1 9 ) .  The presence o f  n e c r o t ic  t is s u e  in the l i v e r  
metastases is a poss ib le  exp la na t ion  of  the poor c o r r e l a t i o n  between 
TI -201  and Tc 99m microspheres uptake presented above. I t  may be due to  
n o n - fu n c t io n in g  ATP-ase c e l l  membrane pump a c t i v i t y ,  so tha t  there is 
not a c t i v e  t ran s po r t  Into the n e c ro t ic  tumour c e l l s .  I t  appears thus 
th a t  T I -201  r e f l e c t s  the v i a b i l i t y  and metabol ic  a c t i v i t y  of  the tumour 
ceI Is .
In conclus ion,  r e s u l t s  of  the s tud ies  in d ic a te  that  T I -201 uptake in 
tumours is not pure ly  a f low dependent process. The mechanism of  
i n t r a c e l l u l a r  uptake o f  T I -201  demonstrates the v i a b i l i t y  and metabol ic  
a c t i v i t y  o f  the p a tho lo g ic a l  c e l l s .  I t  appears to be s i m i l a r  to the 




The weight  o f  the samples and counts/gm o f  normal and tumour t issu e s  fo r  both 
Tc-99m and T I —201 c h l o r i d e .
Weight Counts Counts
gm Tc-99m Count/gm T 1-201 Counts/gm
1.722  n 6 ,975  4 ,050  2 ,846  1,653
0 .682  45 ,306  66,431 203 ,189 297,931
Tota l  tumour 
Norma I I Iver
Table 12
Tumour/Normal uptake r a t i o  (per  gram) fo r  T 1-201 and TC-99m
TC-99m -  0.061  
T 1-201 -  0 .006
Table 13
The percentage o f  t o t a l  a c t i v i t y  In c e l l u l a r  f r a c t i o n  a f t e r  d lg ox in  t r e a te d  
and w i th o u t  In tumour c e l l s .
Without  d lgoxin  With d lgoxin
Experiment 1 11.3% 0.6%




Figure (18) : Increased TI-201 uptake in primary left 
lung carcinoma.
Figure (19) : Single photo emission computerized 
tomography (SPECT) transaxial cuts showed the 
tumour uptake with central photopenia.
CHAPTER V
THALLIUM-201 CHLORIDE SCINTIGRAPHY IN THE 
DIAGNOSING AND STAGING OF MALIGNANT DISEASE
V( 1 ) I n t r o d u c t Io n
E s t a b l is h in g  the extent  o f  tumour spread is a major fa c t o r  in choosing 
the most ap p ro p r ia te  therapy fo r  p a t i e n t s  with  mal ignancy. Staging is 
c r i t i c a l  in t reatment p lann ing,  because inadequate staging can r e s u l t  in 
less than optimum treatment or excessive local t reatment (2 0 4 ) .
Biochemical in v e s t ig a t io n s ,  immunological markers, imaging t e s ts  and 
s u r g ic a l  procedures a l l  p lay a ro le  in t h i s  assessment. The information  
d er iv ed  from such procedures inf luences the choice of  therapy in many 
malignancies  and in some tumours has been e s s en t ia l  in improving sur­
v i v a l  ( 2 5 5 ) e However many of  these procedures have inherent  l i m i t a ­
t io n s  Including m o rb id i ty ,  expense and f a i l u r e  to detect  a l l  tumour 
s i t e s .
Non InvasIve  nuclear  medicine procedures are e a s i l y  performed, have no 
s i g n i f i c a n t  m o r b id i ty ,  and can be repeated s a f e l y .
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With the curren t  in t e r e s t  in tha l l iu m -2 01  c h lo r id e  as a tumour imaging 
agent ,  we have c a r r i e d  out a c l i n i c a l  ev a lu a t io n  of  t h i s  ra d io n uc l id e  in 
the d iagnos is  and stag ing  var ious common mal ignancies.
In t h i s  chapter  I w i I  I present the c l i n i c a l  r e s u l t s  o f  T I -201 imaging in 
t h i s  co n ten t .  The chapter  is d iv ided  into var ious  s ec t io n s ,  each dea l ing  
w ith  a p a r t i c u l a r  type of  mal ignancy.
V (2 )  Tha l l ium-201  c h lo r id e  In the stag ing o f  lung cancer
V ( 2 ) ( a )  Aim o f  the study
The aim o f  study was to eva lua te  the a b i l i t y  o f  tha l l ium -201  ch lo r id e  to 
detec t  pr imary lung cancer and to demonstrate medias t inal  spread of  the 
disease .
Demonstrat ing whether or not there is mediast inal  involvement in lung 
cancer is c ru c ia l  as p a t ie n t s  with  disease spread to the mediastinum are 
g e n e r a l l y  held to have no chance of  being cured by surg ica l  resect io n  
C256) .  Med ia s t in a l  spread can be es tab l ished  by p reo p era t ive  medias­
t inoscopy but the technique is invasive causing a s i g n i f i c a n t  morb id i ty  
and Is not completely accurate .  A non- invas ive method of  e s t a b l is h in g  
m edia s t ina l  involvement would spare p a t ie n t s  t h i s  a d d i t io n a l  trauma and 
be ex tremely cost e f f e c t i v e  (256)  ( 2 5 7 ) . To be e f f e c t i v e ,  however, the
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technique would need to be both s e n s i t i v e ,  tha t  is abnormal in a high 
pro p o r t io n  o f  p a t i e n t s  with  m ediast inal  involvement, and s p e c i f i c ,  i . e .  
y i e l d  a low r a t e  of  f a l s e  p o s i t i v e  r e s u l t s .
P re l im in a r y  rep o r ts  have appeared in l i t e r a t u r e  dea l ing  with  T I —201 up­
take in the pr imary lung cancer ( 25Q) (243)  (259)  These i n i t i a l  s tudies
y ie ld e d  encouraging r e s u l t s  but did not attempt to eva lua te  spread to 
m edias t in a l  or h i l a r  nodes. In a recent  review o f  the use of  
rad io n u c l id e  techniques in lung cancer,  Waxman 1986, concluded that  a 
large s e r i e s  with  independent documentation of  medias t ina l  s ta tus  was 
req u ir ed  before  the r o le  of  t h i s  rad io n u c l id e  as a stag ing modal i ty  in 
lung cancer could be e s ta b l is h ed  (208)  jh e  f in d ing s  in such a ser ies  
are now presented .
V ( 2 ) ( b )  P a t ie n t  popula t ion
Two groups o f  p a t i e n t s  with h i s t o l o g i c a l l y  proven lung cancer were ex­
amined. Group A, co ns is t in g  of  72 p a t ie n t s  (62 male,  10 female,  age 
range 5 8 .2 9  + 13.34 years)  w ith a diagnosis of  i r r e s e c ta b le  lung cancer,  
had been r e f e r r e d  to the rad io therapy department fo r  rad io th erapy  or 
p a l l i a t i v e  t rea tm ent .  Group B, cons is t in g  of  75 p a t i e n t s  (53 male,  22 
female ,  age range 59 .6  + 11.25 years)  w ith p o t e n t i a l l y  resec tab le  lung
cancer ,  had been r e f e r r e d  to the c a rd io th o ra c ic  surg ic a l  u n i t .  This
group of  p a t i e n t s  underwent f u r t h e r  stag ing procedures to e s t a b l is h  
whether surgery was f e a s i b l e .
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In a d d i t i o n ,  ten p a t i e n t s  (7  male,  3 female,  mean age + SD = 51 .5  + 5.04  
y e a r s ) ,  w i th  proven benign lung disease were examined. Three had a c t iv e  
s a r c o id o s is ,  one f ib r o s in g  a l v e o l i t i s ,  two chronic o b s t r u c t iv e  airway  
disease (COAD), th ree  tu b ercu lo s is  (1 a c t i v e ,  and 2 were in ac t ive  tuber­
c u lo s is )  and one lung abscess.
V ( 2 ) ( c )  Methods
A l l  p a t i e n t s  underwent ro u t in e  staging by c l i n i c a l  examinat ion,  chest  
x - r a y ,  CT scanning, ro u t in e  biochemical and haematological  screens,  
bronchoscopy, and re le v a n t  isotope organ scans i f  in d icated .
CT scanning o f  the thorax was performed using an EMI 5005 2nd generat ion  
scanner w ith  20s scanning t imes and with  s l i c e  thickness of  13 mm at  
s l i c e  d is tances of  15mm to the t rachea l  b i f u r c a t i o n  and 15mm or 20mm 
more c a u d a l ly .  The m atr ix  was a 320 x 320 with  in d iv id ua l  p ixe l  s i z e  of  
one mm.
Thal l ium-201  Images o f  thorax were performed 30 minutes a f t e r  
intravenous a d m in is t ra t io n  of  75 MBq of  T I -201 c h l o r i d e ,  f lushed with  10 
ml. normal s a l i n e .  The p a t ie n t s  fasted  for  four hours before  the in je c ­
t i o n .  The medicat ion of  the p a t ie n t s  were not a l t e r e d .  A l l  the stud ies  
were c a r r i e d  out at r e s t .  The p a t ie n t s  were pos it io ned under a large  
f i e l d  o f  view gamma camera which was peaked on T I -201 with  a 20% window 
centered over the 69-80 keV x - ra y s .  S t a t i c  images were then acquired in 
a n t e r i o r ,  p o s t e r io r  and both l a t e r a l  views o f  the thorax ,  500,000 counts
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being obta ined  in each view.  In 23 p a t i e n t s ,  an a n t e r i o r  view only was 
obta ined  w i th  15 minutes a c q u i s i t i o n  producing over 1500 K counts in the 
whole f i e l d  o f  vlew.
Tha l l iu m-201  images were displayed on coloured P o la ro id  images or on 
x - r a y  f i l m  and were in te rp re te d  independently of  any other  data includ­
ing the ex ten t  of  mediast inal  disease apar t  from chest radiographs which 
were a v a i l a b l e  in a l l  cases.
Tha l l ium -201  scanning was performed during the week before o p era t io n .  CT 
scanning o f  the thorax also was performed during the same week.
A l l  p a t i e n t s  in the surg ica l  group (B) had mediast inoscopy and/or s u r g i ­
cal  e x p l o r a t i o n  of  the mediastinum at  thoracotomy, thus enabl ing h is ­
t o l o g i c a l  v e r i f i c a t i o n  of  the mediast inal  s ta tu s .  P a t ie n ts  with  negat ive  
chest x - r a y  and CT examinat ions underwent thoracotomy without  p r io r  
mediast inoscopy.  P a t ie n ts  in whom radio logy was suspicious fo r  medias­
t i n a l  involvement had preopera t ive  mediast inoscopy and proceeded to 
thoracotomy i f  the mediast inoscopy f a i l e d  to reveal  h is t o lo g i c a l  
evidence o f  tumour spread.
V ( 2 ) ( d )  Results
Abnormal tha l l iu m -201  uptake was seen in the primary tumour of  126 out 
of  147 (85.7%) p a t i e n t s  examined ( t a b l e  1 4 ) .  The pr imary tumour showed 
abnormal T I -201  uptake In 90 o f  99 (91%) squamous c e l l  tumours, 21 o f  25
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(84%) adenocarcinoma, 7 of  11 (64%) small c e l l  and 4 of  6 an a p la s t ic  
tumours. Abnormal tha l l ium -201  uptake also  was seen in four out of  s ix  
other  tumours of  the lung (1 neuroblastoma, 1 neurof ibrosarcoma,  and 4 
carcinoma o f  the lung in which c e l l  type could not conf i rmed) .
The f a l s e  negat ive r e s u l t s  of  T I -201 c h lo r id e  (14.5%) scans in p a t ie n t s  
w ith  pr imary lung cancer may r e l a t e  to the s i z e  of  the tumours in six  
p a t i e n t s .  Four tumours were 1.5  cm in diam eter ,  2 cm, and 2 .5  cm in 
diameter  fo r  the other  two tumours. No smal ler  tumour than 2 .5  cm in 
diameter  was seen. The s i z e  of  other  tumours with  negat ive  T I -201 uptake  
ranged between 5 -9  cm in diameter .  These tumours had not rece ived p r io r  
an t i - tumour t rea tm ent .  Two were in the p o s te r io r  mediastinum, three were 
complicated with  massive p le u ra l  e f f u s io n s ,  and three  in the lower base 
of  the r i g h t  lung with  co l lapse  of  the r i g h t  lower lobe. The remaining  
seven tumours were d i s t r i b u t e d  in both lung f i e l d s  and there was no ap­
parent  cause o f  f a l s e  negat ive r e s u l t s .
F igure  20 showed abnormal TI -201  uptake in the primary tumour of  the 
lungs.
Of the ten p a t i e n t s  with  benign lung disease who were s tu d ie d ,  seven 
showed no evidence o f  abnormal T I -201  uptake (Tab le  1 5 ) .  Abnormal up­
take o f  T I -201  was seen in one p a t ie n t  w i th  sarco id os is  and In two with  
a c t i v e  pulmonary t u b e rc u lo s is .  Figures 21 — 23 showed abnormal TI -201  
uptake in a c t i v e  tu b ercu lo s is  and In s arco id o s is .
107
From these r e s u l t s ,  TI -201 had a s e n s i t i v i t y  o f  85.5% for  the d e tec t io n  
of  pr imary lung cancer and a s p e c i f i c i t y  of  70%.
Tha l l ium-201  images were c o r r e la t e d  with the CT scanning f in d in g s  in the 
mediastinum in the 72 p a t i e n t s  in the rad io therapy  group (Tab le  16 ) .  
None o f  the 25 p a t i e n t s  with  negat ive mediast inal  CT s tu d ies  showed ab­
normal m ediast in a l  T I -201 uptake.  Of the 47 p a t ie n t s  wi th  CT evidence of  
m ed ia s t in a l  involvement, nine (19%) showed medias t inal  uptake o f  TI -201  
c h l o r i d e .  F igure 24 demonstrates abnormal TI -201  uptake in the medias­
t inum. In the 75 p a t ie n t s  in the su rg ica l  group, 24 (32%) had h i s t o l o g i ­
cal evidence of  tumour spread to the mediastinum. The remaining (51)  had 
neg at iv e  med iast ina l  h is to lo gy  on the o p e ra t iv e  specimens. Of the 24 
w ith  m ediast ina l  involvement, only three  (12.5%) showed abnormal TI -201  
uptake in the mediastinum whi le  21 had a normal mediast ina l  appearance 
on T I -201  Imaging. CT imaging showed the presence of  mediast inal  in­
volvement in 16 of  these 24 p a t i e n t s .  Of the 51 p a t ie n t s  with  negat ive  
m ediast in a l  h is t o lo g y ,  none had abnormal mediast inal  T I -201  uptake but 
14 had abnormal CT f in d in g s  (Table 17 ) .  From these f ind in gs  TI -201 imag­
ing had a s e n s i t i v i t y  of  12.5% for  de tec t in g  mediast ina l  spread and a 
s p e c i f i c i t y  o f  100%. For the CT the s e n s i t i v i t y  was 67 and the 
s p e c i f i c i t y  70.5%. In 23 p a t ie n t s  who underwent thoracotomy an a n t e r io r  
view on ly  was obtained with  15 minutes a c q u is i t io n  conta in ing more than 
1 , 5 0 0 ,0 0 0  counts in the whole f i e l d  of  view in most of  the p a t i e n t s .  The 
r e s u l t s  were also d isappo in t in g  In that  only one p a t ie n t  wi th  h i s t o l o g i ­
cal evidence o f  mediast ina l  Involvement had abnormal T I -201 uptake in 
the mediast inum. Of these 23 p a t i e n t s ,  seven (30%) had h is t o l o g i c a l
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evidence of  tumour spread to the mediastinum. From these f in d in gs  TI -201  
imaging had a s e n s i t i v i t y  o f  14% for  d e tec t in g  med iast inal  spread and a 
spec I f I c  i t y  o f  100 .
V ( 2 ) ( e )  Comparison o f  Thal l ium-201 ch lo r id e  and Gal l lum -67  c i t r a t e  imaging 
In lung cancer
F o r t y - f i v e  o f  the p a t i e n t s  in the rad io therapy  group (A) underwent both 
T I -2 01  and Ga-67 c i t r a t e  imaging. Five p a t ie n t s  were female and 40 
p a t i e n t s  were male.  The mean age group + (SD) -  50 .13  (+ 7 . 5 )  years.
Fol lowing complet ion o f  the tha l l ium-201  imaging as described above 200 
MBq g a l l iu m - 6 7  c i t r a t e  was in je c ted  into the p a t i e n t .
Images were performed 48 hours post i n je c t io n  using a large f i e l d  of  
view gamma camera in te r face d  to a m i n i -  computer. The gamma camera was 
f i t t e d  w i th  a high energy c o l l i m a t o r .  The 93,  184 and 296 keV photopeaks 
of  g a l l iu m - 6 7  were u t i l i s e d .  In a l l  cases a n t e r i o r ,  p o s te r io r  and both 
l a t e r a l  p r o je c t io n s  of  the thorax were obtained with  500 K counts each 
view.  Images were displayed on x - ray  f i lm s  or colour P o la ro id  p ic t u re s .  
Images were in te rp r e te d  v i s u a l l y  independent o f  knowledge of  the r e s u l t s  
of  the rad io lo gy  and T I -201 imaging. In the group of  45 p a t i e n t s ,  39 
(87%) showed p o s i t i v e  uptake of  TI -201 into the primary tumour, w h i le  36 
(80%) had p o s i t i v e  Ga-67 uptake into the tumour (Tab le  18 ) .  The d i f ­
ferences are not s t a t i s t i c a l l y  s i g n i f i c a n t .
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The r e s u l t s  fo r  in d iv id ua l  tumour types are l i s t e d  in Table 18.
There is a marked discordance in the degree of  abnormal Ga-67 uptake
when compared to T I -201  images. Only In e ig h t  p a t ie n t s  both T I -201 and
Ga-67 images showed s i m i l a r  abnormal t rac er  uptake into the tumour. In
four p a t i e n t s  both TI -201  and Ga-67 showed no abnormal t ra c e r  uptake
in to  the tumour. Three p a t i e n t s  had abnormal TI -201 uptake and negat ive
AO
w ith  Ga-67,  w h i le  two p a t i e n t s  were p o s i t i v e  with  Ga-67 and there is 
abnormal T I -201  uptake.  Table 19 showed s c i n t i g r a p h ic  f in d in g s  of  T1-20  
and Ga-67 imaging in tumours.
Of the 45 p a t i e n t s ,  CT scanning demonstrated 28 p a t ie n t s  with  evidence  
of  m ed ia s t in a l  involvement. Five (18%) showed p o s i t i v e  uptake of  TI -201  
in to  the mediast inum, w h i le  16 (58%) had med iast inal  Ga-67 uptake (Table  
2 0 ) .  The s p e c i f i c i t y  was high (100%) for  both rad io nucl ides  in com­
par ison to the CT f in d in g s .  No h i s t o lo g ic a l  c o r r e l a t i o n  was done in t h is  
group o f  p a t l e n t s .
V ( 2 ) ( f ) Discussion
There is a high c o r r e l a t i o n  between surv iv a l  In p a t i e n t s  with  lung can­
cer and the ex ten t  o f  m e ta s ta t ic  spread from the pr imary les ion .  Detec­
t i o n  o f  m e t a s t a t ic  spread is necessary to determine a r a t i o n a l  approach 
fo r  s e le c t i n g  p a t ie n t s  fo r  thoracotomy. In assessing s u i t a b i l i t y  for  
su rg ic a l  t rea tm en t ,  accurate staging and e va lu a t io n  o f  mediast inal
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tumour spread is of  v i t a l  importance (260)  | t has been Sh0wn that  
p a t i e n t s  w i th  m ediast inal  metastases t re a t e d  s u r g i c a l l y  have a poor 
prognosis 2®1 .
Non Invas ive  methods o f  mediast ina l  stag ing would be va luab le  in reducing  
the need fo r  mediast inoscopy and in present ing inappropria te  
thoracotomies.
Since the r e s o lu t io n  in ro u t in e  chest radiographs for  de tec t io n  of  
primary  lung cancer is 1 .5  cm, radiography remains the p re fe r red  
screening  method fo r  pr imary lung carcinoma (262)  However, i t  cannot 
be r e l i e d  upon In a i l  p a t i e n t s  to p rese le c t  those who should undergo 
mediast inoscopy (263)  (264)
Fosburg e t  a l ,  (1 9 7 9 ) (2 6 3 )  f OUncj the s e n s i t i v i t y  of  chest radiography in 
d e t e c t in g  med iast ina l  metastasis was 75% and mediast inal  tomography 81%. 
Lunia e t  a l ,  1 9 8 l ( 2®4  ^ found the o v e r a l l  accuracy of  the chest radiog­
raphy fo r  assessment of  regional  nodes to be 56%.
The value o f  the g a l l iu m -6 7  scan for  the de tec t io n  of  h i l a r  and medias­
t i n a l  tumour spread is a co n t ro vers ia l  quest ion .  A la z rak i  et  a l ,  
1980^257^, studied  the value of  Ga-67 imaging in de te c t ing  mediast ina l  
disease in a group of  p a t ie n t s  with  p o t e n t i a l l y  resec tab le  lesions.  They 
reported  a 100% s e n s i t i v i t y  and 71% s p e c i f i c i t y  fo r  d e te c t ion  of  medias­
t i n a l  nodal involvement wi th  ga l l iu m  s tu d ies .  Me Meester et  a l ,  
( 1 9 7 9 ) ( 2 6 5 )  demonstrated a 56% s e n s i t i v i t y  and 94% s p e c i f i c i t y  in the
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d e t e c t i o n  o f  m ediast ina l  tumour spread to the mediastinum with ga l l ium  
s c i n t i g r a p h y .  Richardson et  a l ,  ( 1 9 8 0 ) (266)  reported s im i la r  f in d in g s .  
Low s e n s i t i v i t y  of  55% and poor o v e r a l l  accuracy was repor ted  by Neumann 
e t  a l , 1980( 2 6 7 ) .
Waxman e t  a l ,  ( 1 9 8 6 ) ( 288) evaluated  51 p a t ie n t s  who underwent 
thoracotomy for  pr imary lung cancer.  They demonstrated the e f f e c t  of
tumour lo c a t io n  and the c r i t e r i o n  fo r  a p o s i t i v e  study on s e n s i t i v i t y  
and s p e c i f i c i t y  o f  the g a l l iu m  study.  I t  was ev ident  that  when the
mediastinum Is evaluated  s e l e c t i v e l y ,  the s e n s i t i v i t y  for  de tec t io n  is 
low (56%), w h i le  the s p e c i f i c i t y  is high (100%). I f  the hilum and
mediast inum are considered to ge th er ,  the s e n s i t i v i t y  o f  ga l l iu m  study is 
high (91%),  but the s p e c i f i c i t y  f a l l s  cons iderab ly (58%).
Based on t h e i r  f in d in g s  of  high s e n s i t i v i t y  of  a p o s i t i v e  ga l l ium scan 
fo r  m ed iast in a l  spread of  the d isease ,  A la z rak i  et  a l ,  (1978 )^256^, 
recommended p a t i e n t s  wi th  negat ive ga l l ium  scans be considered can­
d id a tes  fo r  thoracotomy without  the necessi ty  for  mediast inoscopy.  
However, because of  low s p e c i f i c i t y ,  p a t ie n ts  wi th  a p o s i t i v e  or equivo­
cal r e s u l t s  were r e f e r r e d  for  mediastinoscopy. Conversely , McMeester 
et  a l ,  ( 1 9 7 9 ) (2 6 5 ) ,  demonstrated a low s e n s i t i v i t y  and high s p e c i f i c i t y  
fo r  m ed iast in a l  nodal de tec t ion  and they recommended mediastinoscopy  
only  when p a t i e n t s  had a negat ive g a l l ium  study.  Neumann et a l ,  
1980( 2 6 7 ) , and Waxman et  a l ,  1986(208)  concluded that  g a i l iu m -6 7  sc in -
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t ig r a p h y  is an in s e n s i t i v e  and n o n -s p e c i f i c  in d ica tor  fo r  de tec t ion  of  
nodal m e t a s t a t i c  involvement of  the mediastinum, and they suggested 
mediast inoscopy i f  the h i l a r  regions were p o s i t i v e  with  Ga-67 study.
CT scanning has been found to s u b s t a n t i a l l y  improve the reso lu t io n  of  
po s s ib le  m ed iast ina l  les ions.  Hirleman et  a l ,  1980^ 68 ) reported a sen­
s i t i v i t y  o f  95% and s p e c i f i c i t y  o f  80% in p r e d ic t in g  medias t inal  metas-  
t ases .  CT scanning has the advantage of  providing precise  anatomical  
d e l i n e a t i o n  o f  m ediast inal  s t r u c t u r e s ,  although i t  cannot d i f f e r e n t i a t e  
between lymph nodes enlarged due to tumour i n f i l t r a t i o n  or simple reac­
t i v e  inf lammation r e s u l t i n g  in f a ls e  p o s i t i v e  scans ( 2" ) .
Richardson e t  a l ,  (1 980 )^266  ^ studied  96 p a t ie n t s  with  suspected 
bronchogenic carcinoma by p ro sp ect ive Iy  performing mediast inal  s taging,  
in c lu d ing  CT, Ga-67 s c in t ig ra p h y ,  and surg ica l  sampling of  mediast ina l  
t i s s u e s .  Gal l ium was found to be h igh ly  s p e c i f i c  for  mediast inal  d is ­
ease:  31 o f  32 p a t i e n t s  wi th  negat ive  ga l l ium scans of  the mediastinum 
had no evidence of  mediast inal  metastasis at surgery.  S p e c i f i c i t y  for  CT 
was 81%. Of 18 p a t i e n t s  who had proven m eta s ta t ic  disease in the medias­
t inum, only  ten ( 55%) had a p o s i t i v e  ga l l ium scan, whereas 11 (61%) had 
a p o s i t i v e  CT scan. Evaluat ion of  the h i l a r  regions using CT was d i f ­
f i c u l t  because of  the super imposit ion of  the great  vesse ls .  They con­
cluded that  CT scanning had l i t t l e  value in the stag ing of  bronchogenic 
carcinoma,  but the g a l l iu m  scan was u s e f u l .  S im i la r  f ind in gs  were 
reported  by Ju l ia n  e t  a l ,  ( 1 9 8 2 ) ( 27^ .
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In a p ro sp ect ive  study o f  p reo p era t ive  stag ing o f  p a t ie n t s  wi th  lung 
carcinoma,  M i l r o y  e t  al ( 1986) (269) compared Ga-67,  CT scanning and 
mediast inoscopy.  They reported that  g a l l iu m -6 7  imaging had a s im i la r  
s e n s i t i v i t y  w it h  the CT scanning, (72%) versus (79%) for  the medias­
t inoscopy in d e te c t in g  mediast inal  involvement. The Gal l iu m-67  scan had 
a s p e c i f i c i t y  o f  85%, CT scanning 82% versus 100% to the mediast inos­
copy.
We eva lu a ted  T I -201  ch lo r id e  in the de tec t io n  of  both primary lung can­
cer and m ediast in a l  spread of  the disease in 147 p a t i e n t s  wi th  h is ­
t o l o g i c a l l y  proven lung cancer.  Of these,  45 p a t ie n t s  underwent both 
t h a l l iu m -2 0 1  and g a l l iu m -6 7  imaging. In a d d i t i o n ,  ten p a t ie n t s  with  
benign lung disease were s tud ied .
In the present  s e r ie s  the s e n s i t i v i t y  of  tha l l ium -201  in detect in g  
pr imary lung cancer was dfa ( £ 4/T4^j)' and the s p e c i f i c i t y  of  70%. Tonami 
and Hisada,  (1 977 )^ 243^, reported t h e i r  experience of  p o s i t i v e  TI -201  
uptake in the pr imary tumour of  lung cancer p a t i e n t s .  Hisada et a l ,  
1978( 2 5 9 ) , a lso  reported tha t  in 57 p a t ie n t s  wi th  known pr imary lung 
cancer ,  49 ( 86%) were p o s i t i v e  with  T I - 2 0 1 .  The h i l a r  and/or  mediast ina l  
involvement and the s i z e  of  the primary tumours was not considered in 
t h i s  r e p o r t .
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S a lv a to r e  e t  a l ,  1976(258)  repor ted that  In 43 p a t ie n t s  with  metas tasis ,  
20 o f  23 p a t i e n t s  demonstrated p o s i t i v e  T I -201 uptake of  the hi lum.  
Twenty had p er ip h era l  masses on x - r a y ,  18 o f  the 20 showed p o s i t i v e  T I -  
201 uptake .
Waxman 1986^288) ,  showed an example of  a p a t ie n t  w ith  mal ignant thymoma 
in which a combined T I -201  and Ga-67 study was performed. He reported  
t h a t  the ex ten t  o f  the tumour v i s u a l i z a t i o n ,  e s p e c i a l l y  in the medias­
t inum, was b e t t e r  seen wi th  T I -201 scan. He also  showed another example 
o f  lung cancer wi th  metas tasis to the mediastinum demonstrated at  
mediast inoscopy.  The TI -201  scan was accurate in determining the extent  
o f  med ia s t in a l  spread of  the disease,  but he s ta ted  that  there was lack 
o f  in format ion r e l a t i v e  to the s e n s i t i v i t y  and s p e c i f i c i t y  of  TI -201 in 
d e t e c t in g  h i l a r  and/or  mediast inal  involvement, and suggested cont inuing  
these s tu d ies  e s p e c i a l l y  w ith  surg ica l  documentation. Our re s u l t s  in 75 
p a t i e n t s  in the surg ica l  group showed that  TI -201 c h lo r id e  had a low 
s e n s i t i v i t y  o f  15% for  the de tec t io n  o f  mediast inal  spread and a 
s p e c i f i c i t y  o f  100%. For the CT the s e n s i t i v i t y  was 46% and the 
s p e c i f i c i t y  70%.
The s e n s i t i v i t y  of  T I -201 scans in d e te c t in g  pr imary tumours and i t s  ex­
ten sion  Is h ig h ly  dependent on the v a s c u l a r i t y ,  the s i z e  and locat ion  of  
the les io n .
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The anatomic s i t e  o f  the lesion a f f e c t s  the s e n s i t i v i t y  o f  T I - 2 0 1 ,  and 
T I -2 0 1  may lack s e n s i t i v i t y  in imaging o f  deeply s i t e d  tumours due to a 
short  h a l f  va lue layer  in t iss u e  fo r  I t s  gamma and x - r a y s .  (D 1 /2  in 
t i s s u e  fo r  i t s  gamma rays at  167 keV is 4 .95  cm, and fo r  135 keV and 
x - r a y s  at  69 -83  keV is 4 .1 5  cm.) <22 ) .
Tha l l ium-201  imaging has poor i n t r i n s i c  r es o lu t io n  and thus may l i m i t  
the s i z e  o f  lesions v i s i b l e .  Okerlund et  a l ,  1984^271^, reported that  
92% of  p a ra th y ro id  adenomas > 1 .0  cm were located wi th  T I -201 as opposed 
to  only 50% o f  those < 0 .7  cm. S ing le  and m u l t ip l e  tumours and hyper­
p l a s i a  could be i d e n t i f i e d .  Winzelberg,  Hydov itz ,  (198 5 )^272^, studied  
31 cases of  p a ra th yro id  adenoma with  dual isotope su b t rac t io n  technique  
and found the 73% of  tumours weighing 499mg or less and 78% of  tumours 
weighing 500 -  1499 mg were c o r r e c t l y  i d e n t i f i e d ,  and 100% of  adenomas 
weighing more than 1500 mg were detected.
In our c l i n i c a l  study,  per iphera l  pr imary lung cancers smal ler  than 2 cm 
in diameter  were not detected with T I - 2 0 1 .  In a d d i t i o n ,  diseased lymph 
nodes 2 .5  cm in diameter  in p a r a h i la r  and mediast inal  region were not 
detected  by TI -201  when compared to mediast inal  e x p lo r a t io n .
The f a l s e  negat ive  r e s u l t s  of  TI -201 c h lo r id e  scans in p a t ie n t s  with  
large tumours o f  the lung may r e l a t e  to poor v i a b i l i t y  o f  the tumours.
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Twenty minutes f o l lo w in g  Intravenous in j e c t i o n  of  tha l l lum-201  c h lo r id e ,  
the uptake by the tumour achieved peak values and remained constant  
during the f i r s t  hour.  M u l t i p l e  views can be obtained with  no s i g ­
n i f i c a n t  change in ta rg e t  to back r a t i o s  throughout the time of  imaging.  
Maximum in formation is obtained with  a s in g le  a n t e r io r  p r o je c t io n  of  the 
chest  r e q u i r i n g  15 minutes of  a c q u is i t io n  t ime.  This method was per­
formed on 23 p a t i e n t s  obta in in g  more than 2000 k count per view.  The aim 
of  t h i s  study was to obta in  more counts from the tumours and to detect  
smal le r  les ion in the mediastinum. But i t  has been shown that  t h is  
method does not o f f e r  any advantage over the 500 k counts p er -v iew.  Only 
in one out of  seven p a t ie n t s  was mediast inal  involvement detected in 
t h i s  study w ith  a s e n s i t i v i t y  of  14%. La te ra l  p ro je c t io n s  may be help­
f u l ,  e s p e c i a l l y  when the tumour is located in the lower base of  the l e f t  
lung, due to  abnormal ly high t race r  by the myocardium.
In the comparison study o f  TI -201  and Ga-67, both rad io nucl ides  showed 
n e a r ly  s i m i l a r  s e n s i t i v i t y  in d etect in g  pr imary lung cancer,  but Ga-67 
showed higher s e n s i t i v i t y  (57%) in determining mediast inal  spread of  the 
disease .
The d e te c t io n  r a t e  o f  the tumours by tha l l ium-201  may not be a f f e c t e d  by 
the tumour c e l l  type.  Tumour uptake Is d i f f e r e n t  from one p a t ie n t  to 
another even w i t h in  the same h Is top a th o lo g lca l  type.  This was 
demonstrated by the wide v a r i a t i o n  In the tumour/background r a t i o .
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Togawa, e t  a l ,  ( 1 9 8 5 ) (2 7 3 ) ,  claimed that  he could c l a s s i f y  the lung can­
cer h i s t o l o g i c a l l y  by measuring the "crude uptake r a t i o "  (CUR) of  
t h a l l iu m - 2 0 1  to  g a l l lu m -6 7  c i t r a t e  uptake.  P a t ie n ts  received 2 mCi of  
T I -20 1  c h l o r i d e ,  fol lowed by 2 mCi of  Ga-67 one week l a t e r .  Regions of  
I n t e r e s t s  o f  s i m i l a r  s i z e  were symmetr ical ly  created over the tumour and 
normal lung f i e l d  on the same p a t i e n t ,  and the mean counts of  each 
region o f  i n t e r e s t  were recorded. CUR for  TI -201 and Ga-67 was obtained  
by c a l c u l a t i n g  (Tumour-Background) /Background. They found that  
adenocarcinoma had a CUR of  2 + 1 .55 ,  epidermoidal  carcinoma and oat  
c e l l  carcinoma showed a CUR of  0 .47  + 0 .30  and 0 .3 7  + 0 .05  r e s p e c t iv e ly ,  
w h i le  adenosquamous carcinoma represented a CUR of  0.91 + 0.15  i n t e r ­
mediate between adenocarcinoma and epidermoidal  carcinoma. These f i n d ­
ings were not r e l i a b l e  because s ix  p a t ie n t s  with  adenocarcinoma had 
g r e a t e r  g a l l iu m - 6 7  c i t r a t e  uptake than tha l l iu m -201  c h l o r id e ,  and one 
p a t i e n t  w i th  oat c e l l  carcinoma had grea te r  tha l l ium-201  uptake than 
gaI I ium-67 c I t r a t e .
In the present  s e r ie s  we compared tha l l iu m-201  uptake and ga l l iu m -67  
c i t r a t e  uptake in 45 p a t ie n ts  with lung cancer.  I t  was found that  pa t ­
te rn s  o f  T I -201  and Ga-67 accumulation in lung cancer d i f f e r e d  among 
p a t i e n t s  having the same h is t o l o g ic a l  type.  In the same h is t o lo g i c a l  
typ e ,  negat ive  tha l l ium-201  uptake and p o s i t i v e  wi th  g a l l iu m -6 7  were 
found on the one hand and p o s i t i v e  tha l l ium -201  uptake and negat ive  
g a l l lu m - 6 7  c i t r a t e  uptake on the o th e r .  The r e s u l t s  obta ined  do not sup­
port  these of  Togawa et  a l ^ 273  ^ and suggest tha t  T I -201 /G a 67 d i f f e r e n ­
t i a l  uptake Is not he lp fu l  In p r e d ic t in g  c e l l  type.
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V (3 )  Thai Mum-201 c h l o r i d e  Imaging In breast  cancer
V ( 3 ) ( a )  In t ro d u c t Io n
Various  Imaging techniques are used to demonstrate pr imary breast  car ­
cinoma and a ls o  to detec t  the ex tent  o f  the disseminat ion  of  the d is ­
ease .
In c l i n i c a l  p r a c t i c e ,  mammography is the best complementary method of  
examinat ion o f  the primary s i t e  o f  breast  carcinoma ( 274) .
The demonstrat ion of  disseminat ion of  breast  carcinoma is important in 
the assessment and management of  the disease.  The de tec t ion  of  metas-  
ta ses ,  whether s k e l e t a l  or in so f t  t i ss u es ,  a l t e r s  the pr imary surg ica l  
t rea tment and adds secondary the rap eu t ic  procedures when discovered on 
f o l lo w  up examinat ion .
R a d i o l o g i c a l ,  u l t r a s o n i c  and s c i n t i g r a p h ic  techniques are used in the 
d e t e c t io n  o f  d is t a n t  metastases but f a l l  in demonstrat ing nodal spread 
o f  the disease C274) A tes t  that  could reduce the need for  surg ica l  
sampling o f  the a x i l l a  and o f f e r  prognost ic  information would be of  v i ­
t a l  Importance ( 275 ) .
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Ege ( 1 9 7 8 ) ,  developed a method of  r a d i o c o l l o i d  in te rna l  mammary lymphos­
c i n t i g r a p h y ,  and reported that  i t  is a u s e f u l ,  non- invasive  method of  
e v a lu a t i o n  o f  the paras terna l  nodes in the management of  breast  car­
cinoma ( 2 7 6 )  ^ a lthough the technique cannot rep lace  lymph node sampling 
fo r  p a t i e n t  s tag in g  ( 275) .
E f f o r t s  to  o b ta in  useful  demonstrat ion o f  involved a x i l l a r y  lymph nodes 
by means o f  lymphoscint igraphy have been d is ap p o in t in g ,  mainly due to  
the r e l a t i v e l y  large numbers of  a x i l l a r y  nodes and t h e i r  wide drainage  
areas which req u i r e  m u l t i p l e  in je c t i o n s .  In a d d i t io n ,  the t e s t  is non­
s p e c i f i c  w i th  high f a l s e  p o s i t i v e  r a t e  ( 277) .
I examined T I - 201  c h lo r id e  in de tec t in g  pr imary breast  cancer and tumour 
spread.
V ( 3 ) ( b )  P a t i e n t  popula t ion
Twenty s ix  p a t i e n t s  with  h i s t o l o g i c a l l y  proven breast  cancer were ex­
amined, one male p a t ie n t  and 25 p a t ie n t s  were female.  The mean age of  
the group (+ SD) was 49 .92 (+ 7 . 6 )  years.  Of the 26 p a t i e n t s ,  20 were 
present in g  with  primary breast  cancer and s ix  had local recurrence f o l ­
lowing pr imary trea tment .
P a t i e n t s  were studied  a f t e r  a four hour f a s t ,  at  res t  and medicat ions of  
the p a t i e n t s  were not a l t e r e d .
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V ( 3 ) ( c )  Methods
The p a t i e n t  was ly ing supine,  under a large f i e l d  o f  view gamma camera
f i t t e d  w i th  a low energy,  high s e n s i t i v i t y  c o l l im a to r  and in te r faced  to
a mlni -computer  camera was posi t ioned over the tumour s i t e .  S eve n ty - f ive  
MBq T I -2 01  c h lo r id e  were in jec ted  intravenously and f lushed with  10 ml 
normal s a l i n e .  Images were then acquired as fo l lows:  (A) 5 second
frames fo r  5 minutes,  64 X 64 matr ix  s i z e ;  (B) 30 seconds frames for  55
minutes 128 X 128 m a t r ix .  A l l  images were stored on disc for  subsequent 
a n a l y s i s .  An e a r l y  s t a t i c  image was created from the dynamic data ob­
ta in e d  from 5 to 15 minutes p o s t - i n j e c t i o n .
The s t a t i c  images were displayed on coloured Pola ro id  p ic tu re s  and in­
t e r p r e t e d  v i s u a l l y .  Results of  TI -201 sc in t ig rap h y  were compared to  
c l i n i c a l  and surg ic a l  f in d in g s .
V ( 3 ) ( d )  Results
Tha l l ium-201  ch lo r id e  uptake occurred in a l l  20 p a t ie n t s  wi th  primary  
adenocarcinoma of  the breast  (F igure 3 3 ) .
Of the s ix  p a t i e n t s  with  recu rren t  disease,  four showed abnormal TI -201  
uptake at  the tumour s i t e .  The remaining two p a t ie n t s  had normal TI -201  
images In s p i t e  of  h is t o lo g ic a l  proof  of  tumour recurrence .
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In f i v e  p a t i e n t s  who had tumours wi th  a n ec r o t ic  ce n te r ,  a rim of  in­
creased T I -201  uptake with  cen t ra l  o f  photopenia was seen (F ig ure  34 ) .
Tha l l iu m-201  c h lo r id e  imaging was in s e n s i t i v e  in d e tec t in g  nodal spread 
of  the d isease .  Of 14 p a t i e n t s  with  c l i n i c a l  evidence of  nodal metas-  
tas es ,  on ly  three  (21%) p a t ie n t s  were detected on TI -201 scans. One
p a t i e n t  had a large mass in the r i g h t  s u p rac lav ic u la r  reg ion,  the second
p a t i e n t  had a large mass in the l e f t  a x i l l a r y  reg ion,  and the last  one
had 2 1 /2  X 2 1 /2  cm in the r i g h t  a x i l l a .  Each of  the three p a t ie n ts
a lso  had m u l t i p l e  other  small lymph nodes metastases not detected by 
T I -2 01  scans.
Four p a t i e n t s  underwent surgery w i t h in  a week of  the TI -201 study. There 
was p a th o lo g ic a l  evidence of  metastasis in the a x i l l a r y  lymph nodes in 
a l l  p a t i e n t s ,  none o f  which were demonstrated by TI -201  scans.
Thal l ium-201  scan was accurate In loca t ing b ra in  lesions in two p a t ie n ts  
who had c l i n i c a l  evidence of  b ra in  metas tas is .  Lung metastasis  were
, QQ_ , M bP
detected  In two p a t i e n t s .  In one p a t ie n t  a Tc ^yymJ MOP bone scan showed 
m u l t i p l e  areas of  increased t rac er  uptake In the s k u l l ,  lumbar spine and 
r fbs.
T I - 201  scan detected  the sku l l  and lumbar spine les ion ,  but f a i l e d  to 
demonstrate the r i b  lesions.  This was due to high uptake in the h e a r t ,  
l i v e r  and lungs and poor re s o lu t io n  wi th  T I -201  c h l o r id e .
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V ( 3 ) ( e )  Discussion
T h al l iu m -201  scans were found to be h ig h ly  s e n s i t i v e  in d e tec t in g  the 
pr imary  s i t e  o f  breas t  carcinoma. Twenty out of  20 mal ignant  primary  
breas t  les ions  took up T I —201 f o c a l l y  at  the primary s i t e  whi le  abnormal 
uptake was seen in four out o f  s ix  p a t ie n t s  with  recu rren t  disease.
In p a t i e n t s  s tud ied  before  surgery,  the s e n s i t i v i t y  in p r e d ic t in g  nodal 
involvement was very poor. The s e n s i t i v i t y  of  T I —201 scans was also very 
poor in comparison to the re s u l t s  of  p a lp a t io n  in p a t ie n ts  who had 
c l i n i c a l  evidence of  nodal spread of  the disease.  The s e n s i t i v i t y  of  
T I -201 images in e va lu a t io n  of  local spread of  the disease and nodal 
d e t e c t i o n  was d is ap p o in t in g .  I t  f a i l e d  to detect  any lesions less than 
2 1 /2  cm In diameter but did show lesions larger  than t h i s .  Thus, TI -201  
scan is not h e lp fu l  in reducing the number of  p a t ie n t s  who needs lymph 
nodes sampling.
T I -2 0 1  scans were not s e n s i t i v e  in demonstrat ing small d is ta n t  metas­
t a s i s ,  e s p e c i a l l y  in the r i b s ,  lungs and mediast ina l  regions.
The high hear t  and l i v e r  a c t i v i t y  a lso  causes problem in Imaging of
breast  cancer,  e s p e c i a l l y  when the lesion is located in the l e f t  lower
zone and the r i g h t  lower zone of  the chest wal l  (F igure  39 ) .
Our data suggest that  TI -201 scan has not proven useful  in the local
s tag in g  o f  breast  cancer.
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V(4 )  Tha i l lum-201  imaging in malignant  lymphoma
V ( 4 ) ( a )  In t ro d u c t Io n
For Mal ignant  lymphomas, the choice of  t reatment and the chance of  sur­
v iv a l  are c r i t i c a l l y  dependent on adequate pre - t rea tm ent  stag ing of  the 
disease  ( 27®).
In the assessment o f  the ex tent  of  the disease at the time of  i n i t i a l  
p r e s e n t a t io n ,  ro u t in e  c l i n i c a l  and radiographic  examinat ion are i n s u f f i ­
c i e n t  C279 )e Lymphoangiography has become an e s sen t ia l  part  of  the ex­
aminat ion .  This technique is e s p e c ia l l y  useful in de tec t in g  occult  d is ­
ease in those p a t i e n t s  who have c l i n i c a l l y  l im i te d  involvement and few 
symptoms. The contrast  m ater ia l  in jec ted  in the lower ex t re m i ty  enters  
the th o ra c ic  duct below the second lumbar segment and thus may f a i l  to 
demonstrate the involvement of  nodes above t h i s  l e v e l .  Since the opaque 
m a te r ia l  may remain In the nodes for  weeks or months, repeat ing the 
study showing the e f f e c t  of  the treatment is d i f f i c u l t  (279)^
Enlarged lymph nodes in the r e t r o p e r i t o n e a l  space or mediastinum can be 
I d e n t i f i e d  a c c u r a te ly  by CT Imaging, but the presence o f  enlarged nodes 
does not mean m e ta s ta t ic  Involvement
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Ga-67 c i t r a t e  can l o c a l i z e  In malignant  lymphoma, but Is ,  however, non­
s p e c i f i c  and Is a lso  taken up In a v a r i e t y  of  non-maI ignant cond it io ns .  
The presence o f  bowel a c t i v i t y  may obscure uptake in mal ignant  disease  
In lymph nodes below the diaphragm ( 278) .
For some lymphomas, the accuracy of  Ga-67 c i t r a t e  approaching 80-85 per ­
cent  has been cla imed,  although i t s  value in non-Hodgkin's lymphoma is 
doubt fu l  ( 2 7 8 ) # i t  appears th a t  g a l l iu m -6 7  image supplements, but cannot 
s u b s t i t u t e  f o r ,  lymphoangiography.
In the present  study,  I eva luated  TI -201  ch lo r id e  images in the staging  
o f  mal ignant  lymphoma.
V ( 4 ) ( b )  P a t i e n t  Populat ion
F i f t e e n  p a t i e n t s  with  h i s t o l o g i c a l l y  proven mal ignant  lymphoma were ex­
amined. T h i r t e e n  p a t i e n t s  had mediast inal  tumours (7 p a t ie n t s  with  
Hodgkin's disease and 6 p a t ie n t s  with non-Hodgkin's lymphoma), one 
p a t i e n t  had r e c t a l  lymphoma (p lasmocyt ic  lymphoma), and one p a t ie n t  had 
abdominal and p e lv i c  lymphoma. Twelve p a t ie n t s  were male and three were 
female.  The mean age o f  the group(+ SD) was 39 .3  (+ 15 .6 )  years.  
P a t ie n t s  were studied  a f t e r  a four hour f a s t ,  at  res t  and ly ing supine.
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V ( 4 ) ( c )  Methods
A la rge  f i e l d  o f  v iew gamma camera f i t t e d  w i th  a low energy,  high sen­
s i t i v i t y  c o l l i m a t o r  and in t e r f a c e d  to  a mini computer was p o s i t io n e d  
over the tumour s i t e .  S e v e n t y - f i v e  MBq T I -2 0 1  c h l o r i d e  was in je c t e d  
In t ra v e n o u s ly  and f lushed  w i th  10 ml normal s a l i n e .  Images were then ac­
q u i re d  as mentioned in Chapter  I I I .  (A)  5 second frames f o r  5 minutes,  
64 X 64 m a t r ix  s i z e .  (B) 30 seconds frames fo r  55 min utes ,  128 X 128 
matr i x .
A l l  images were s to red  on d is k .
An e a r l y  s t a t i c  image was c re a ted  from the dynamic data  ob ta in ed  from 5 
to  15 minutes post  i n j e c t i o n .
Images were d isp la yed  on P o la r o id  images and i n t e r p r e t a t e d  v i s u a l l y .  
V ( 4 ) ( d )  R esu l ts
In p a t i e n t s  w i t h  m e d ias t in a l  tumours, 11 cases (84.6%) were p o s i t i v e  
w i t h  T I - 2 0 1  scans.  The two neg a t ive  cases included one w i th  Hodgkin's  
disease  5 cm in diameter  (nodu lar  s c le ro s in g  mixed c e l l u l a r  ty pe )  and 
one w i th  non-Hodgkin 's  lymphoma 5 cm In diameter  and w i th  su p e r io r  vena
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caval  o b s t r u c t i o n  ( d i f f u s e  mixed lymphocyt ic type )  (T ab le  2 2 ) .  The s i z e  
o f  the tumour seen on T I -2 01  scans were in between 4 and 9 cm in 
d i a m e t e r .
T I - 2 0 1  c h l o r i d e  a ls o  was accura te  in lo c a t in g  m e t a s t a t i c  spread o f  the  
disease  In s ix  out o f  n ine  cases. Two p a t i e n t s  w i th  c e r v i c a l  lymph 
nodes,  t h r e e  w i t h  s u p r a c la v i c u la r  lymph nodes and one w i th  proven metas­
t a t i c  les io n  in the r i b  showed abnormal T I -2 0 1  uptake ( F ig u re  4 3 ) .  The 
s i z e  o f  the lesions d e tec ted  by T I -2 0 1  scans ranged between 2 . 5  -  5 cm 
in d ia m e te r .  The remaining th ree  p a t i e n t s  had involvement o f  c e r v i c a l  or  
a x i l l a r y  lymph nodes which were less than 1 .5  cm in d ia m ete r .  A l l  were 
negat  iv e .
The d ia g n o s t i c  e v a l u a t io n  o f  a l l  above mentioned p a t i e n t s ,  CT scanning,  
lymphoangiography and laparotomy showed no evidence o f  subdlaphragmatic  
Involvement o f  the d isease .
The p a t i e n t  w i th  abdominal lymphoma had e x te n s iv e  abdominal lymph node 
involvement w i th  c l i n i c a l l y  p a lp ab le  masses in the lower abdomen and a 
p a lp a b le  mass in the r i g h t  g ro in  re g io n .  T I -2 0 1  scan showed markedly in­
creased t r a c e r  uptake in the abdomen ( F ig u r e  4 3 ) .  However, in v iew o f  
the normal uptake o f  T I -2 0 1  seen in the la rge  bowel and k id neys ,  the ex­
ac t  e x t e n t  o f  the in t ra -abdomin a l  disease could not be assessed.
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There were a ls o  m u l t i p l e  large and small areas o f  Increased t r a c e r  up­
take  In both inguinal  reg ion re p res en t in g  the involved chains o f  lymph 
nodes and h i s t o l o g i c a l  examinat ion revea le d  non-Hodgkin's lymphoma 
( F Ig u r e  4 4 ) .
The p a t i e n t  w i th  r e c t a l  lymphoma had a large mass in the r e c t a l  region  
p o s t e r i o r l y  which showed marked increased t r a c e r  uptake ( F ig u r e  4 5 ) .
V ( 4 ) ( e )  Discussion
In a recent  a imp-he case r e p o r t ,  L inde and Basso (1 9 8 7 ) ^ 2®2  ^ discussed  
the In c id e n t a l  f i n d i n g  o f  a Hodgkin's lymphoma in a p a t i e n t  undergoing  
T 1-201/Tc-99cm Imaging o f  the p a ra th y ro id s  because o f  hypercalcaemia.  
The present  study has al lowed a more extended ap p ra is a l  o f  T I -2 01  imag­
ing in a s e r i e s  o f  p a t i e n t s  w i th  lymphomas.
The a p p l i c a t i o n  o f  Tha l l ium -201  c h l o r i d e  scans as a s ta g in g  tool  in lym­
phoma has been d is a p p o in t in g  because not a l l  tumour s i t e s  were v i s u a l ­
ized w i th  t h i s  technique .  The data  obta ined  from the study showed th a t  
the s i z e  o f  the les ion  is c r i t i c a l .  The chances o f  lo c a t in g  a tumour 
less than 2 . 5  cm in diameter  is n e g l i g i b l e  even i f  i t  is in the  
s u p r a c l a v i c u l a r  or neck re g io ns .  This is due to  normal (background)  
t r a c e r  accumulat ion in the muscular s t r u c t u r e s  and t h y r o id  g land.  In ad­
d i t i o n ,  the photon a t t e n u a t io n  w i t h i n  the o v e r l y i n g  t i s s u e s  serves to  
f u r t h e r  degrade the Image.
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In p a t i e n t s  w i th  sub-d iaphragmat ic  ex tens ion  o f  the d ise ase ,  the loca­
t i o n  o f  the tumour is a lso  a problem. I f  the les io n  is in the abdomen, 
i t  can l i e  In j u x t a p o s i t i o n  to  the l i v e r ,  sp leen ,  k idney or  sp in e ,  a l l  
o f  which norm al ly  co n ta in  high c o n c e n t ra t io n  o f  T I -2 0 1  c h l o r i d e .  At the  
same t ime i t  w i l l  be surrounded by high g a s t r o i n t e s t i n a l  a c t i v i t y  which 
causes confusion in i n t e r p r e t a t i o n .
The s e n s i t i v i t y  o f  T I -20 1  c h l o r i d e  in lo c a t in g  m ed ias t in a l  lymphoma does 
not appear to  depend upon the c e l l  type .  S i m i l a r  s e n s i t i v i t y  has been 
found in d e t e c t in g  pr imary  tumours o f  Hodgkin's disease (85.7% versus  
87.5% fo r  non- Hodgkin's lymphoma). The s e n s i t i v i t y  o f  T I -2 0 1  c h l o r i d e  
In d e t e c t i n g  smal l nodal spread o f  the disease is d is a p p o i n t i n g .
The improved r e s u l t s  o f  t reatment  fo r  a l l  stages o f  mal ignant  lymphomas 
have fo l lo w ed  the more accurate  assessment o f  disease ex te n t  a t  presen­
t a t i o n ,  to g e th er  w i th  advances in ra d io th erap y  equipment and technique ,  
and the i n t r o d u c t io n  o f  e f f e c t i v e  combinat ion chemotherapy f o r  systemic  
disease  (280 )
V (5 )  T h a l l ium -201  c h l o r i d e  Imaging in b ra in  tumours
V ( 5 ) ( a )  In t r o d u c t Io n
Accurate l o c a l i z a t i o n  o f  a b r a i n  les ion  b e fo re  surgery  g r e a t l y  
f a c i l i t i e s  the o p e r a t i v e  procedure by p e r m i t t i n g  sm a l le r  c ran io tomies  
and reducing the incidence o f  n e g a t ive  b io p s i e s .  The s e n s i t i v i t y  o f  con­
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v e n t io n a l  r a d io n u c l id e  b r a in  imaging fo r  d e t e c t i o n  pr imary b r a in  tumour
or m e t a s t a t i c  disease is r e l a t i v e l y  h igh.  In the las t  ten yea rs ,
however,  CT scanning has become the p r e f e r r e d  imaging m o d a l i ty  fo r
screen ing  and d e t e c t in g  p a t i e n t s  w i th  suspected i n t r a c r a n i a l  lesions  
( 2 8 1 ) .
Most comparat ive  s tu d ie s  have shown b e t t e r  s e n s i t i v i t y  w i th  c o n t r a s t -  
enhanced CT imaging than w i th  convent iona l  r a d i o n u c l id e  imaging in the  
d e t e c t i o n  o f  i n t r a c r a n i a l  tumour (282)  (283)
Kaplan e t  a l ,  1987^247^, observed t h a t  the damage incurred by the  
c e n t r a l  nervous system as a r e s u l t  o f  i n i t i a l  tumour d e s t r u c t io n  which 
is compounded by s u r g ic a l  in t e r v e n t i o n  and/or  r a d i a t i o n  therapy  is per ­
manent. On standard  CT i t  is sometimes d i f f i c u l t  to  d i f f e r e n t i a t e  such 
damage from re s id u a l  or rec u r re n t  tumour. They found t h a t  ra d io n u c l id e  
stu d y ,  p a r t i c u l a r l y  T I -20 1  imaging, gave the most p re c is e  es t im a te  of  
I n t r a c e r e b r a l  tumour.
In t h i s  s tu dy ,  I e va lu a te d  T I -2 0 1  c h l o r i d e  in d e t e c t i n g  i n t r a c r a n i a l  le­
s ions .
V ( 5 ) ( b )  P a t i e n t  po p u la t io n
IS
We e v a lu a te d  t h a l l iu m - 2 0 1  uptake in ^ p a t i e n t s  w i t h  known b r a i n  les ions  
—  nine  p a t i e n t s  w i th  pr imary b r a in  tumours, two p a t i e n t s  w i th  
cereb ro vascu la r  acc id ent  secondary to  a r t e r i o s c l e r o s i s ,  and seven
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p a t i e n t s  w i t h  b r a in  metastases.  Eleven p a t i e n t s  were male and seven
female .  The mean age fo r  group (+ SD) was 46.27C+ 1 3 .9 5 )  y e a rs .  The
m edicat io ns  o f  the p a t i e n t s  were not a l t e r e d .
V ( 5 ) ( c )  Methods
S e v e n t y - f I v e  MBq th a l l iu m - 2 0 1  c h l o r i d e  were In j e c t e d  in t ra v e n o u s ly .  
S t a t i c  images were o b ta ined  ten minutes p o s t -  i n j e c t i o n .  The p a t i e n t  was 
p o s i t io n e d  under a large  f i e l d  o f  v iew gamma camera in t e r f a c e d  to  a 
m ln i -c o m p u te r . A n t e r i o r ,  p o s t e r io r  and both l a t e r a l  views o f  the b ra in  
(300  K counts)  were obta in ed  fo r  each view.  The 80 keV x - r a y  photopeak 
was u t i l i z e d  w i th  a 20% window. Images were d isp layed  on coloured  
t e l e v i s i o n  screen and coloured P o la r o id  p i c t u r e s  were o b ta in e d .  In th ree  
p a t i e n t s ,  f lo w  s tu d ie s  o f  the b ra in  were obta in ed  a t  5 seconds per frame 
f o r  2 minutes.  In one p a t i e n t  w it h  a pr imary  b r a in  tumour, dynamic ac­
q u i s i t i o n  was performed one minute per frame for  one hour and t ime ac­
t i v i t y  curves from the tumour and background were ob ta in ed .
T I -2 0 1  Images were compared to  more standard  imaging m o d a l i t i e s  includ­
ing CT scann ing ,99m Tc-DTPA imaging and 99m Tc-HMPAO imaging.
V ( 5 ) ( d )  Results
bkrte.
The f lo w  s t u d ie s  o bta in ed  in niptrt p a t i e n t s  were not  h e l p f u l  due to  poor 
count s t a t i s t i c s .
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In the p a t i e n t s  from whom data was acquired  throughout the f i r s t  hour,  
T I -2 0 1  uptake occurred  r a p i d l y ,  peak tumour uptake being achieved by 5 
minutes post  I n j e c t i o n  and then remaining constant  throughout the imag­
ing p e r io d .  Tumour to  background r a t i o s  were high ( 2 . 3 / 1 )  and th e re  were 
no s i g n i f i c a n t  changes fo r  the d u r a t io n  o f  the t ime o f  imaging, shown 
from the t ime a c t i v i t y  curve obta in ed  from an astrocytoma o f  the b r a in  
( F ig u r e  4 7 ) .  The accumulat ion o f  T I -201  in the neopIasMut ic fo c i  p er ­
s i s t e d  and the lesions were w el l  de f in ed  and easy to  d i s t i n g u i s h  from 
normal anatomic s t r u c t u r e s  such as the base o f  the s k u l l  and large  
venous sinuses .
The s e n s i t i v i t y  o f  T I -2 0 1  fo r  pr imary  and m e t a s t a t i c  b r a in  les io ns  was 
100% (T a b le  2 3 ) .  A l l  les ions d etected  w i t h  the gold standard method CT 
scanning were v i s u a l i z e d  w i th  T I -2 0 1  scans.  Tumours w i th  c e n t r a l  
n ec ro s is  showed a r im o f  increased uptake and c e n t r a l  photopenia  
( F ig u r e  5 0 ) .
The Images ob ta in ed  by T I -2 0 1  were s i m i l a r  in s ix  cases ,  and b e t t e r  in 
two cases to  those obta in ed  in Tc 99m -DTPA (F ig u re s  5 3 - 5 4 ) .
In two p a t i e n t s  s tu d ied  f o l l o w in g  s u r g ic a l  and r a d i a t i o n  th e ra p y ,  the  
T I - 2 0 1  a b n o r m a l i t i e s  were sm a l le r  than those on CT and Tc 99m -  HMPAO
(which r e f l e c t  both re s id u a l  tumour and surrounding oedema) ( F ig u r e  5 8 ) .
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In p a t i e n t s  w i t h  CVA (2 cas e s ) ,  the re  was no abnormal t r a c e  accumulat ion  
In the In s u l te d  reg ion  r e s u l t i n g  In normal s c i n t i s c a n s  appearance  
(F ig u re s  5 9 - 6 1 ) .
V ( 5 ) ( e )  D iscussion
The s e n s i t i v i t y  o f  T I -2 0 1  in d e t e c t in g  b r a i n  tumours was very  high  
(100%) ,  and because o f  the low blood background le v e ls  in the  b r a i n  and 
high tumours up take ,  c e re b ra l  lesions were we l l  v i s u a l i z e d  w i t h  T I - 2 0 1 .
Th a l l iu m -201  c h l o r i d e  accumulat ion w i t h i n  the n e o p l a s t i c  t i s s u e s  per ­
s i s t e d  fo r  the f i r s t  one hour p o s t - i n j e c t i o n  w i th  no s i g n i f i c a n t  
changes, and m u l t i p l e  views o f  the b r a in  could be o b ta in e d .  The proce­
dure is non invas ive  and the scanning t ime accep tab ly  short  a t  5 to  8 
minutes per v iew.  Using T I -2 01  c h l o r i d e  in the imaging o f  b r a i n  les io n s ,  
we could d i f f e r e n t i a t e  between ce reb ra l  vascu la r  acc id ent  (CVA), which 
showed no abnormal T I -2 01  uptake ,  from p a t i e n t s  who had b r a in  tumours 
which showed intense T I -201  uptake .
In two cases w i th  b r a in  m e ta s ta s is ,  Tc -  DTPA showed on ly  s l i g h t l y  
Increased t r a c e r  uptake f i r s t  in the f r o n t a l  reg ion  and second pos­
t e r i o r l y .  The th a l l iu m - 2 0 1  a bnorm al i t y  appeared as a focal  and we l l  
d e f in e d  area  o f  Increased t h a l l i u m  uptake in these re g io n s .
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CT Imaging Is the g e n e r a l l y  accepted method fo r  m on i to r in g  in t r a c e r e b r a l  
tumours and is f r e q u e n t l y  used to  assess the response o f  b r a i n  tumours 
t h e r a p i e s .  However, i t  is o f t e n  unable to  d i f f e r e n t i a t e  between 
f i b r o t i c ,  n o n - f l b r o t l c  and n e o p l a s t i c  t i s s u e .  Kaplan e t  a I 1987^274) ,  
noted t h a t  in four o f  seven p a t i e n t s  w i th  b r a in  tumour, t h i s  d ia g n o s t ic  
m o d a l i ty  was unable to  p r e c i s e l y  d e f in e  n e o p la s t i c  s t a t u s  when compared 
t o  h i s t o l o g i c a l  f i n d i n g s .  The CT scan could not d i f f e r e n t i a t e  c e n t r a l  
ne cro s is  from v i a b l e  tumour, and d id  not a c c u r a t e l y  d e f in e  the degree o f  
i n t r a c e r e b r a l  oedema. In a d d i t i o n ,  the CT scanning d id  not always c o r r e ­
l a t e  w e l l  w i th  the p a t i e n t ' s  subsequent c l i n i c a l  course.  T I -201  scans in 
b r a in  tumours gave the most p re c is e  es t im a te  o f  In t r a c e r e b r a l  tumour 
burden.
In the two p a t i e n t s  s tu d ied  f o l lo w i n g  s u rg ic a l  and r a d i a t i o n  therapy in 
the present  s e r i e s ,  T I -201  scan showed a sm al le r  and more foca l  area of  
increased t r a c e r  uptake than CT and Tc ®9m -  HMPAO SPECT s t u d ie s .  These 
f i n d in g s  c o r r e l a t e  w i th  a comparat ive study made by Kaplan e t  a l ,  
1987^247) ,  o f  r a d io n u c l id e  and CT scan r e s u l t s  w i th  patho logy .  Closest  
agreement was noted between the th a l l iu m - 2 0 1  images and p e r s i s t e n t  
tumour. According to  Kaplan e t  a l ,  CT scans in c o n s i s t e n t l y  de f in ed  the  
p r e c is e  amount and lo c a t io n  o f  a c t i v e  n e o p la s t i c  t i s s u e  p re s e n t .  t £ - 201 
scans showed the p r e c is e  v i a b l e  re s id u a l  t i s s u e  b e t t e r  than CT and o ther  
r a d i o n u c l i d e  s tu d ie s  ( 247>.
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A l l  o u t - p a t i e n t s  w i th  b r a in  tumours were on s t e r o i d  therapy in s p i t e  of  
abnormal T I -2 0 1  uptake seen in a l l  tumours. This  compares to  the f i n d ­
ings In Ga-67 s c i n t i g r a p h y  fo r  d e t e c t i n g  b r a in  tumour. Waxman e t  a l ,  
1978^284  ^ demonstrated the e f f e c t  o f  s t e r o i d s  a d m i n i s t r a t i o n  on the g a l ­
lium and technet ium glucoheptonate  b r a in  scan by comparing the r e l a t i v e  
s e n s i t i v i t y  o f  both ra d io pharm aceut Ica ls  in p a t i e n t s  both on and o f f  
s t e r o i d s .  Using Ga-67 c i t r a t e  they demonstrated a s i g n i f i c a n t  s t e r o i d  
e f f e c t  on the s e n s i t i v i t y  o f  95% to 64% fo l lo w i n g  s t e r o i d s .  They a ls o  
found the s t e r o i d s  d id  not a l t e r  the s e n s i t i v i t y  o f  Tc 99m -  glucohep-  
t o n a te  s tudy .  In t h e i r  s e r i e s  four p a t i e n t s  who underwent g a l l iu m  and Tc 
99m _ g lucoheptonate b r a i n  scans be fore  s t e r o i d  therapy and again  a f t e r  
being on s t e r o i d  therapy  fo r  one week, the g a l l i u m  b r a i n  scan,  in a l l  
cases ,  showed e i t h e r  a disappearance or r ed u c t io n  in g a l l iu m  uptake by
the tumour. The Tc 99m -  glucoheptonate b r a i n  scan was not a f f e c t e d
( 2 8 4 ) .
In co n c lu s io n ,  T I -2 0 1  b r a in  scan is h ig h ly  s e n s i t i v e  in d e t e c t in g  b r a in  
tumours, can be performed immediately f o l l o w in g  i n j e c t i o n ,  does not ap­
pear to  be a f f e c t e d  by concomitant  s t e r o i d  a d m i n i s t r a t i o n  and r e f l e c t s  
v i a b l e  tumour burden.
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V ( 6 )  T h a l l iu m -201  Imaging In bone and s o f t  t i s s u e  tumours
V ( 6 ) ( a )  I n t r o d u c t Io n
Fo l low in g  the in t ro d u c t io n  o f  the technet ium -  99m -  labe led  phosphate  
compounds f o r  s k e l e t a l  s c i n t i g r a p h y ,  Isotope bone scanning has been 
w id e ly  a p p l ie d  to  p a t i e n t s  w i th  pr imary bone tumours ( 2 8 5 ) f ancj b0ne 
metastases ( 28®)
The technet ium phosphate complexes fo r  s k e l e t a l  imaging have been found 
to  l o c a l i z e  in a v a r i e t y  o f  s k e l e t a l  l e s io n s ,  inc lu d in g  benign and 
m al ignan t  tumours, which made the bone scan less s p e c i f i c  than the con­
v e n t io n a l  ra d io lo g y  ( 2 8 6 ) e
Ga-67 c i t r a t e  ( 18° ) ,  Bleomycin labeled  w i th  va r io u s  r a d io n u c l id e  ( 287) ,  
and r a d io n u c l id e s  labeled  a n t ib o d ie s  have been used a lso  f o r  d e t e c t in g  
and l o c a l i z i n g  these tumours.
There are a large  number o f  neoplasmat ic and inf lammatory les io ns  o f  the  
s o f t  t i s s u e s  are  known to  accumulate these t r a c e s .
Simon and K i r c h n e r ,  198C>(288) t r i e d  to  improve the s p e c i f i c i t y  o f  s c in ­
t i g r a p h y  in d i f f e r e n t i a t i n g  mal ignant  from benign lesions by comparing 
the images w i th  T c - " m phosphonate and Ga-67 c i t r a t e  in 57 p a t i e n t s .  
They found t h a t  th e re  were co n s id erab le  d i f f e r e n c e s  in the degree o f  in­
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t e n s i t y  between mal ignant  and benign tumours. With the exce p t io n  of  
chondrosarcomas, almost a l l  mal ignant  tumours showed uptake o f  Ga-67 
which was more intense than MDP. I f  a tumour showed no Ga-67 uptake i t  
was always benign.  I t  was a lso  noted t h a t  cont inuous bone accumulat ion  
o f  g a l l i u m  was not present  in e i t h e r  mal ignant  or benign bone tumours.
In the c u r re n t  study I have e va lu a ted  T I -2 0 1  c h l o r i d e  In d e t e c t i n g  bone 
and s o f t  t i s s u e  tumours.
V ( 6 ) ( b )  P a t i e n t  p o pu la t ion
Four p a t i e n t s  w i th  pr imary bone tumours (1 Ewings sarcoma, and 3 os­
teogen ic  sarcoma),  two p a t i e n t s  w i th  pr imary s o f t  t i s s u e  tumours (1 
l iposarcoma and 1 osteogen ic  sarcoma),  one p a t i e n t  w i th  bone metastases,  
and one p a t i e n t  w i th  chro n ic  o s t e o m y e l i t i s  examined w i t h  T I - 201  
ch lo r  ide.
F iv e  were male p a t i e n t s  and th re e  were female.  The mean age (+ SD) was 
28 .2 5  (+ 1 5 .4 )  years .
V ( 6 ) ( c )  Methods
The p a t i e n t s  were p o s i t io n e d  under a large f i e l d  o f  v iew gamma camera 
I n t e r f a c e d  w i th  a mini -computer  10 minutes a f t e r  I . V .  i n j e c t i o n  o f  75 
MBq o f  T I -2 0 1  c h l o r i d e .  The f i e l d  o f  v iew was centered  over the tumour 
s i t e .  A 10 minute s t a t i c  image was performed.  In two p a t i e n t s  t ime a c -
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t l v i t y  curves were generated  over the tumour and background c lo se  to  the  
tumour. T I -201  Images were compared to  Tc 99m -  MDP Images, standard  
r a d io lo g y  and CT f i n d i n g s .
V ( 6 ) ( d )  R esu lt s
From the t ime a c t i v i t y  curves o bta in ed  from two p a t i e n t s  w i th  o s te o s a r ­
coma, tumour to  background r a t i o  was found to  be very  high ( 6 . 3 / 1  and 
7 . 2 / 1 )  ( F ig u r e  6 2 ) .
A l l  seven p a t i e n t s  w i th  mal ignant  disease  showed abnormal T I -2 0 1  uptake  
in the le s ion  (F ig u re s  6 3 - 6 4 ) .
T h a l l iu m -201  c h l o r i d e  images in four p a t i e n t s  w i th  pr imary bone tumours 
were s i m i l a r  to  those obta in ed  w i th  Tc 99m -  MDP bone scan. T I -2 01
c h l o r i d e  was a ls o  accura te  in determ in ing  the exact  e x te n t  o f  the d i s ­
ease in comparison to the CT scan f i n d i n g s .  T I -201  scan was a ls o  ab le  to  
d e l i n e a t e  areas  o f  necros is  by a d i s t i n c t  r im o f  a c t i v i t y  surrounding an 
area  o f  c e n t r a l  photopenia.
In the two p a t i e n t s  w i th  s o f t  t i s s u e  sarcoma, the Tc 99 MDP bone scans
(A .
were normal and th e re  was no e x t r a  ossec^s t r a c e r  uptake .  T I -2 0 1  Images 
were ac cu ra te  in demonstrat ing these tumours.
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In the p a t i e n t  w i th  bone m e ta s ta s is ,  Tc MDP bone scan showed in­
creased t r a c e r  uptake in the dorsal s p in e ,  r i b s ,  and d i f f u s e  increase  
t r a c e r  uptake in the s k u l l .  T I -2 0 1  scan showed fo ca l  area  o f  increased  
uptake In the s k u l l  and dorsal  s p in e ,  but f a i l e d  to  d e te c t  the smal l  le ­
sions In the r i b s .  In the p a t i e n t  w i th  chron ic  o s t e o m y e l i t i s ,  t h e r e  was 
d i f f u s e  Increased Tc 99m MDP uptake ,  but T I -2 0 1  study showed a fo ca l  
area o f  increased uptake In the re c u r re n t  s i t e  o f  I n f e c t i o n .
V ( 6 ) ( e )  Discussion
Th a l l iu m -201  c h l o r i d e  scan was h ig h ly  s e n s i t i v e  (100%) in d e t e c t in g  
primary  bone and s o f t  t i s s u e  sarcomas and provided  accura te  d i f f e r e n t i a ­
t i o n  o f  the tumour l i m i t s  as determined by CT scan.  C o n f l i c t i n g  re p o r t s  
e x i s t  in l i t e r a t u r e  about the c o r r e l a t i o n  between pathology and Tc 
MDP bone scans.  King e t  a l ,  1980^2® ® \  in a study o f  r a d i a t i o n  induced 
osteosarcoma in r a b b i t s ,  suggested th a t  the tumour ex tens io n  along the  
s h a f t  o f  the bone was b e t t e r  d e tected  by scanning than by rad iography.  
M c k i l lo p  e t  a l ,  1981 ( 29° ) ,  found a good agreement between bone scan,  
x - r a y s  and p a th o lo g ic a l  f in d in g s  in 46 o f  48 p a t i e n t  s t u d ie d .  S i m i l a r l y ,  
Papanicolaou e t  a l . ,  1982^291  ^ found an e x c e l l e n t  c o r r e l a t i o n  between 
pathology and bone s c i n t i g r a p h y ,  a length discrepancy  o f  g r e a t e r  than  
3cm being observed on two occasions o n ly .
Goldman e t  a l ,  1975^292>, found in 12 o f  13 cases the area  o f  abnormal 
r a d i o i s o t o p i c  uptake corresponded to  the e x te n t  o f  r a d i o l o g i c a l  changes,  
but d id  not exceed them, in those cases opera ted  on,  the tumour i n v o l v e -
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ment in the gross specimens c o r r e l a t e d  w el l  w i th  the areas o f  abnor­
m a l i t y  seen by both d ia g n o s t ic  imaging m o d a l i t i e s .  Only In one p a t i e n t  
the scan o b ta in ed  demonstrated s l i g h t  increase  in is o t o p ic  uptake  
throughout the s h a f t  o f  the femur proximal  to  the tumour. P a th o lo g ic a l  
examinat ion  d id  not revea l  In t ra m e d u a l la ry  tumour spread C292) By
c o n t r a s t ,  o v e r e s t im a t io n  o f  the s i z e  o f  the tumour by bone scanning oc­
curred  in 11 o f  18 osteogenic  sarcomas s tu d ie s  by Chew and Hudson, 1987 
( 2 9 3 ) t
Most s o f t  t i s s u e  sarcomas w i l l  not demonstrate uptake o f  the bone scan­
ning agent  C290) | n t wo cases s tu d ie d  th e re  was no abnormal e x t r a s -
HrfX fu iu o u r
k e l e t a l  uptake in the s i t e  o f  by Tc-99m MDP
scan.  The s o f t  t i s s u e  tumours were a c c u r a t e l y  demonstrated by T I -2 0 1  
scans.  The 99m Tc-MDP bone scan,  however, has va lue  on t h i s  c o n d i t io n  
because Increased uptake in bone ad jacent  to  a s o f t  t i s s u e  sarcoma i n d i ­
ca tes  bone involvement.  Involvement may a lso  be present  when t h e r e  is 
increased uptake in the s o f t  t i s s u e  i t s e l f  and is cont inuous w i th  the 
bone. Adequate s u r g ic a l  t rea tment  o f  these tumours needs complete resec­
t i o n  o f  a l l  contaminated s t r u c t u r e s  C293) .
T I -2 0 1  scan was found to be a use fu l  in d ic a t o r  o f  an acute ex ace rb a t io n  
In one p a t i e n t  w i th  chron ic  o s t e o m y e l i t i s .  The abnorm al i ty  was 
demonstrated by a foca l  area  o f  Increased T I -2 0 1  uptake l o c a l l y .  The 
Tc-99m MDP bone scan showed a la rge area o f  increased t r a c e r  uptake much 
more e x te n s iv e  than the T I -2 0 1  uptake.  U su a l ly  chron ic  o s t e o m y e l i t i s  
causes bone scan a b n o r m a l i t i e s ,  so th a t  the technique cannot be used to
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diagnose e x ace rb a t io n  C2^4 ) .  L o c a l l y  Increased uptake o f  e i t h e r  g a l l iu m  
-  67 c i t r a t e  or indium leukocytes may be use fu l  i n d ic a t o r s  o f  an acute  
e x a c e rb a t Io n .
In co n c lu s io n ,  T I -2 0 1  scans is h ig h ly  s e n s i t i v e  f o r  d e t e c t in g  pr imary  
bone tumours,  but not much use c l i n i c a l l y .  T I -2 0 1  scan may be o f  more 
va lu e  in lo c a t in g  s o f t  t i s s u e  sarcoma.
V ( 7 )  Tha l l iu m -201  c h l o r i d e  Imaging in tumours o f  the l i v e r
V ( 7 ) ( a )  I n t r o d u c t io n
The convent io na l  " mTc-su lphur c o l l o i d  l i v e r  scan Is the method o f
cho ice f o r  the  i n i t i a l  e v a lu a t i o n  o f  the l i v e r  f o r  mass les io n s .  I t  is
h i g h ly  s e n s i t i v e  in d e t e c t i n g  i n t r a h e p a t i c  masses but n o n - s p e c i f i c  
( 2 0 4 ) .
I t  is d i f f i c u l t  using n o n - In vas ive  methods to  determine  the na ture  o f  a 
mass les io n  p re sen t in g  as a co ld  area on " mT c - t i n  or sulphur c o l l o i d  
11ver scan.
Ult rasound s tu d ie s  are very s e n s i t i v e  in d e t e c t i n g  local  lesions o f  the  
l i v e r .  A recent  rep o r t  in d ica ted  t h a t  foca l  lesions w i th  a diameter  o f  
1 cm could be d e tec ted  ( 295 ) .  | n a re p o r t  on 39 hepatomas, 11 (28%)
were not  d e te c te d .  Two o f  the 28 cases d e tec ted  by u l t ras o u n d  were
missed by l i v e r  c o l l o i d  scan, and the l i v e r  c o l l o i d  scan de tec ted  nine
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o f  11 cases missed by US. The poor US d e t e c t i o n  r a t e  was a t t r i b u t e d  to  
les ions  under two cm, lesions  in the reg ion  o f  the p o r t a ,  and p a t i e n t  
o b e s i t y  (2 9® ) .
CT scanning had a s i g n i f i c a n t  f a l s e  n e g a t iv e  r a t e  in the d e t e c t i o n  o f  
hepatomas. Th is  has been a t t r i b u t e d  to  the small  s i z e  or isodense ap­
pearance o f  the tumours. In a d d i t i o n ,  the CT scan appearance of  
hepatoma is n o n - s p e c i f i c  (295)
Se-75 se lenometh ion ine  l i v e r  scanning has been rep o r ted  as usefu l  in 
d i s t i n g u i s h i n g  hepatoma from o ther  causes o f  foca l  les io n  in a non­
c i r r h o t i c  l i v e r .  But in the presence o f  l i v e r  c i r r h o s i s ,  t h i s  technique  
was unh e lp fu l  (297)
In an area  which is cold  on the c o l l o i d  scan, uptake o f  g a l l i u m - 6 7  which 
is equal to  or g r e a t e r  than th a t  o f  normal l i v e r  t i s s u e  has been con­
s id e re d  st rong evidence fo r  hepatoma (298 )  (299 )  Although the
g a l l i u m - 6 7  scan Is s e n s i t i v e  fo r  d e t e c t io n  o f  hepatomas (90%) ( 3 0 9 ) ,  i t  
is r e l a t i v e l y  n o n - s p e c i f i c  and has a ls o  been rep o r ted  In m e t a s t a t i c  d i s ­
ease and in abscess (301)_
B roder ic k  e t  a l ,  19 8 0 (2®®), compared the s e n s i t i v i t y  and s p e c i f i c i t y  of  
99mTC-s u lp h u r  c o l l o i d  and Ga-67 c i t r a t e  scans to  t h a t  o f  u l t rasonography  
in 19 p a t i e n t s  who had biopsy proven hepatomas. The u l t ras o un d  f in d in g s  
were n o n - s p e c i f i c  showing echographic p a t t e r n s  th a t  v a r i e d  from d i s c r e t e  
sonolucent  or sonodense areas to  d i f f u s e l y  abnormal parenchyma without
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d i s c r e t e  l e s io n s .  Two showed a normal US p a t t e r n .  A l l  cases ,  in c lu d ing  
these  two,  showed a d e fec t  on 99m Tc -su lp hur  c o l l o i d  and r e l a t i v e l y  in­
creased Ga-67 c i t r a t e  uptake in the areas o f  decreased Tc-99m sulphur  
c o l l o i d  ac t  i v i t y .
Ga-67 c i t r a t e  has been demonstrated to  be h ig h ly  usefu l  in d i s t i n g u i s h ­
ing hepatoma from "pseudotumour" o f  the l i v e r .  Pseudotumours a re  f r e ­
q u e n t ly  present  In p a t i e n t s  w i th  c i r r h o s i s  and hepatomas occur as a com­
p l i c a t i o n  o f  advanced c i r r h o s i s .  Both lesions are  seen as "cold" areas  
on sulphur c o l l o i d  l i v e r  scan.  The hepatoma accumulates Ga-67 but the  
pseudotumours do not ( 3 ° ° ) .
We have e va lu a te d  T I -2 0 1  c h l o r i d e  in d e t e c t i n g  and c l a s s i f y i n g  mass le ­
sions in the I I v e r .
V ( 7 ) ( b )  P a t i e n t  P opu la t io n
I e v a lu a te d  T I -2 0 1  c h l o r i d e  Imaging In 21 
d e f e c t s  on the Tc-99m l i v e r  c o l l o i d  scan,  
was known in each p a t i e n t .
Eight  p a t i e n t s  had pr imary  h e p a t o c e l l u l a r  carcinoma,  seven p a t i e n t s  
nodular  c i r r h o s i s  o f  the l i v e r ,  f i v e  p a t i e n t s  l i v e r  secondar ies from a 
v a r i e t y  o f  tumours and one p a t i e n t  a hy d a t id  cyst  o f  the l i v e r .  
Eighteen p a t i e n t s  were male and th ree  female.  The mean age o f  the group 
(+  SD) was 47 .0 5  (+ I 1 .44)  years .
p a t i e n t s  w i th  cold
The h i s t o l o g i c a l  d iagnosis
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V ( 7 ) ( c ) Methods
The co nvent io na l  l i v e r  scan was performed 15 minutes a f t e r  intravenous  
I n j e c t i o n  o f  200 M B ^ o f  99m T c - t l n  c o l l o i d .  S t a t i c  Images were p e r ­
formed In a n t e r i o r  p o s t e r io r  and both l a t e r a l  p r o j e c t i o n s  by o b t a in i n g  
500 K count each view.
T I - 2 0 1  images o f  the I i v e r  were performed two to  th r e e  days l a t e r  a f t e r  
in travenous i n j e c t i o n  o f  75 MBq o f  T I -2 0 1  c h l o r i d e .  The p a t i e n t  was 
p o s i t io n e d  under a la rge f i e l d  o f  v iew gamma camera. The camera was 
peaked on T I - 2 0 1  6 8 -85  keV photopeak w i th  a 20 percent  window. imaging 
began ten minutes post i n j e c t i o n  and a n t e r i o r ,  p o s t e r i o r  and r i g h t  
l a t e r a l  p r o j e c t i o n s  o f  the l i v e r  were obta in ed  500 K counts per p r o j e c -  
t  Ion.
With the excep t ion  o f  two p a t i e n t s  (both  w i th  hepatoma), a g a l l i u m - 6 7  
c i t r a t e  study was performed immediately f o l l o w in g  the T I -20 1  s tudy.
Two hundred MBq o f  Ga-67 c i t r a t e  were in je c t e d  in t rav en o u s ly  fo l lo w i n g  
complet ion o f  T I -2 0 1  imaging. The p a t i e n t  re turned  48 hours l a t e r  f o r  
Ga-67 Imaging. They were p o s i t io n e d  under a large  f i e l d  o f  v iew gamma 
camera f i t t e d  w i t h  a medium energy c o l l i m a t o r .  The 93 ,  184 and 300 keV
photopeaks o f  Ga-67 w i th  a 20 percent  window were u t i l i z e d .  A ga in ,  500 
k counts images were c o l l e c t e d  in the same p r o j e c t i o n s .
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A l l  Images were s to red  on the computer d isk  and d isp laye d  on X - r a y  f i l m s  
and coloured  P o la r o id  p i c t u r e s .  Images were i n t e r p r e t e d  v i s u a l l y .
In areas  which were co ld  on the c o l l o i d  scan,  uptake o f  Ga-67 or T I -2 01  
equal to  or g r e a t e r  than t h a t  in normal l i v e r  was considered p o s i t i v e .  
Areas showing Ga-67 or T I -2 0 1  uptake less than t h a t  in normal l i v e r  were 
considered n e g a t i v e .
V ( 7 ) ( d )  R esu lts
The r e s u l t s  are  summarized in Tab le  25.
A l l  p a t i e n t s  w i t h  hepatoma had a foca l  d e fe c t  a t  the s i t e  o f  the  tumour 
on the l i v e r  t i n  c o l l o i d  scans. Increased T I -2 0 1  uptake in the tumour 
compared to  normal l i v e r  was found in s ix  p a t i e n t s  w i th  hepatoma, one 
p a t i e n t  had uptake equal to  t h a t  in the surrounding l i v e r  t i s s u e ,  and 
one p a t i e n t  had a r im o f  increased uptake surrounding c e n t r a l  photopenia  
(F ig u re s  7 1 - 8 1 ) .  In the s ix  p a t i e n t s  who underwent G a l l iu m -6 7  Imaging,  
f i v e  p a t i e n t s  showed Increased t r a c e r  uptake and one showed e q u iv a le n t  
t r a c e r  uptake w i th  the surrounding l i v e r  t i s s u e  (F ig u re  7 4 ) .
T I -2 0 1  uptake In p a t i e n t s  w i th  nodular  c i r r h o s i s  was s i m i l a r  to  th a t  
seen w i t h  t i n  c o l l o i d  l i v e r  scan, m u l t i p l e  foca l  de fe c ts  and patchy  
t r a c e r  d i s t r i b u t i o n  being found w i th  T i -2 0 1  in a l l  cases (F ig u re s  83 ,  
8 6 ,  8 9 ) .  Ga-67 c i t r a t e  showed homogenous t r a c e r  uptake In four cases,
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w ith  no foca l  d e f e c t s  (F ig u res  84 ,  8 7 ) .  In the remaining th re e
p a t i e n t s ,  the uptake o f  Ga-67 showed foca l  d e fe c ts  in the areas which 
were co ld  on the c o l l o i d  scan (F ig u res  88 ,  8 9 ) .
A l l  f i v e  p a t i e n t s  w i th  l i v e r  metastases showed m u l t i p l e  foca l  cold  
d e f e c t s  on T I -2 0 1  Imaging due to  decreased T I -2 0 1  uptake in metastases  
compared to  normal l i v e r  ( F ig u r e  90 -  9 2 ) .  S i m i l a r  f i n d in g s  were ob­
t a in e d  on Ga-67 imaging in four p a t i e n t s ,  but one p a t i e n t  w i t h  metas­
tases  from lung cancer showed increased Ga-67 uptake in the metastases .  
N egat iv e  g a l l i u m  and T I -2 0 1  images were found in the p a t i e n t  w i th  
h y d a t id  cyst  ( F ig u r e  9 3 ) .
V ( 7 ) ( e )  Discussion
Since T I - 2 0 1  c h l o r i d e  and Ga-67 c i t r a t e  norm al ly  con cen t ra tes  in the  
l i v e r ,  the l i v e r  is thus prominent  in a l l  t h a l l iu m - 2 0 1  and g a l l iu m  
images. The use o f  these ra d io n u c l id e s  fo r  imaging tumours in t h i s  o r ­
gan in vo lves d e t e c t in g  a hot spot in a hot background f i e l d .  T h e r e fo r e ,  
*TC99m_t | n c o l l o i d  l i v e r  scan should always precede these procedures.  
The ab no rm a l i ty  o f  T I -2 01  or Ga-67 uptake in h e p a t ic  les io ns  is de f in e d  
In r e l a t i o n  to  Tc®®m- t i n  c o l l o i d  uptake In the same re g io n .
Prev ious  r e p o r t s  have noted t h a t  I f  the area o f  a co ld  d e fec t  on a T c -  
c o l l o i d  l i v e r  scan showed Ga-67 uptake equal to  or g r e a t e r  than th a t  
o f  ad ja cent  normal l i v e r ,  the c o r r e l a t i o n  w i th  hepatoma was very s trong  
( H o f f e r ,  1 9 8 6 ) ( 3 0 0 ) .
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Ga-67 Imaging o f  the l i v e r  is usefu l  In p a t i e n t s  w i th  c i r r h o s i s  where 
h e p a t ic  pseudotumours can have the same appearance as a hepatoma on the  
TC_99m t i n  c o l l o i d  scan. However, pseudotumours or r e g e n e r a t i v e  nodules  
o f  c i r r h o s i s  r a r e l y  have s i g n i f i c a n t  g a l l iu m  uptake ( 204 ) ( 3 0 0 ) .
D I p l a z z i  e t  a l . ,  1978^302^, s tu d ied  31 c i r r h o t i c  and 25 p a t i e n t s  w i th  
hepatomas on top o f  c i r r h o s i s ,  using Ga-67 and Tc-99m sulphur c o l l o i d .  
Ga-67 c i t r a t e  was concentra ted  in co ld  d e fe c ts  on the c o l l o i d  scan in 23 
out o f  25 c a n c e r - c i r r h o t i c  p a t i e n t s  w i th  e ig h t  percent  f a l s e  n e g a t iv e  
r e s u l t .  None o f  the 31 c i r r h o t i c  p a t i e n t s  had Ga-67 accumulat ion in the  
cold  reg ions on the c o l l o i d  scans (302)
From the da ta  ob ta in ed  in seven c i r r h o t i c  p a t i e n t s  s t u d ie d ,  th e re  was 
discordance between T I -20 1  images when compared to  Ga-67 images. The 
Ga-67 uptake was homogenous in four p a t i e n t s  w i th  l i v e r  c i r r h o s i s  w it h  
no foca l  d e fe c t  ev id en t  (F ig u res  8 4 , 8 7 ) .  In th re e  p a t i e n t s  the Ga-67
uptake showed foca l  d e fe c ts  in the areas which were co ld  on Tc®®m- t i n  
c o l l o i d  scan.  T I -2 0 1  images showed m u l t i p l e  foca l  d e fe c ts  and the ap­
pearance was s i m i l a r  to  t h a t  observed w i th  t i n  c o l l o i d  l i v e r  scan.
In the  present  s tudy ,  a l l  the hepatoma p a t i e n t s  had s i m i l a r  appearances  
on T I -2 0 1  and Ga-67 Imaging w i th  both showing s i g n i f i c a n t  uptake in 
areas co ld  on the Tc-99m scan.
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In four  o f  the f i v e  p a t i e n t s  w i th  metastases s t u d i e d ,  the Ga-67 and T l -  
201 Images showed s i m i l a r  appearances w i th  f a i l u r e  o f  the r ad io p h ar ­
m ace u t ica ls  to  accumulate in the cold  spots on the c o l l o i d  scan. In the  
remaining p a t i e n t  ( w i t h  m e t a s t a t i c  b ro nchia l  carc inom a) ,  the T I -2 0 1  d id  
not show a c t i v e  uptake in the metastases but Ga-67 was p o s i t i v e .
The f in d in g s  o f  the present  study on T I -2 0 1  Imaging in hepatoma and
l i v e r  metastases a re  in keeping w i th  those o f  Tonami e t  a l ,  1977^243^,
who rep o r ted  t h a t  T I -2 0 1  accumulat ion occurred In th re e  o f  four p a t i e n t s  
w i th  hepatoma but none o f  e ig h t  w i th  l i v e r  metastases.
L i v e r  uptake o f  Ga-67 is not s p e c i f i c  fo r  hepatoma and may occur in 
l i v e r  abscess as wel l  as Ga-67 av id  metastases t 234 ) .  I d id  not have 
the o p p o r t u n i t y  to  study any p a t i e n t  w i th  l i v e r  abscess using T I - 2 0 1 ,  
though a s i n g l e  p a t i e n t  w i th  hyd a t id  cyst  had a n e g a t iv e  r e s u l t .  I t  is 
not p o s s ib l e ,  t h e r e f o r e ,  to  comment on the a b i l i t y  o f  T I - 2 0 1  imaging to  
d i f f e r e n t i a t e  l i v e r  abscess from hepatoma.
I concluded th a t  T I -201  c h l o r i d e  is e q u a l l y  u se fu l  to  g a l l i u m - 6 7  f o r  Im­
aging pr imary hepatoma. I t  surpasses g a l l i u m  imaging in d i s t i n c t i o n
pseudotumours o f  the l i v e r .  In a d d i t i o n ,  I t  has the advantage over
g a l l l u m - 6 7  o f  e a r l y  imaging.
148
Table  14
T h a l l lu m -2 0 1  Imaging In Pr imary Lung Cancer
T I - 2 0 1  Scans
n +ve p o s i t i v e  S e n s i t i v i t y  - v e  n e g a t iv e
Sq. c e l l  ca 99
o0)
/ 91 % 9
Adeno ca 25 21 84 % 4
SmaII ceI  I 11 7 64 % 4
A n a p l a s t I c 6 4 67 % 2
Others 6 4 67 % 2
TOTAL 147 126 8 5 . 7  % 21
Tab le  15
T h a l l lu m -201  Scan In Benign Lung Disease
Number P o s i t i v e  (+ve )
Sarco id  3 1
F ib r o s in g  A!vea l  i t  is 1 0
COAD ^ 2 0
T.B 3 2
Lung Abscess 1 0
TOTAL 10 3
P o s I t 1ve 
N eg at Ive
Tab le  16
M e d i a s t i n a l  Imaging In Lung Cancer (Group A)
T h a l l lu m -201  Scan C T Scan





M e d ia s t i n a l  Imaging In Lung Cancer (Group B)
T h a l l lu m -20 1  C T Scans
n -  75 n -  75
True + 3 16
True -  51 36
F a ls e  + 0 14
s
F a lse  -  21 9
Table  18
T h a l l iu m -2 01  c h l o r i d e  and G a l l iu m - 6 7  c i t r a t e  Imaging In lung cancer -  
f requency o f  t r a c e r  uptake In pr imary  tumour
Number o f  
P a t l e n t s
P o s I t I v e  
w i t h  T I - 2 0 1
S e n s i t i v i t y
%
P o s i t  Ive  
w i t h  GA-67
S e n s i t i v i t y
%
Squamous ceI  I c a . 32 30 94% 27 84%
Adeno Ca. 7 6 86% 6 86%
SmaII ceI  I c a . 4 2 50% 2 50%
A n a p la s t i c  ca. 2 1 50% 1 50%
TOTAL 45 39 87% 36 80%
Table  19
S c i n t i g r a p h i c  F in d ings  o f  Th a l l lu m -2 01  and Ga-67 Imaging In Tumours
T I - 2 0 1  (+ve )  T I - 2 0 1  ( - v e )  T I - 2 0 1  (+ve)  T I - 2 0 1  ( - v e )
Ga-67 (+ve)  Ga-67 ( - v e )  Ga-67 ( - v e )  Ga-67 (+ve)
Number o f
P a t i e n t s  29
\
Table  20
Comparat ive study o f  T I - 2 0 1  c h l o r i d e  and Ga-67 c i t r a t e  In d e t e c t i n g  medias­
t i n a l  spread o f  the disease  in lung cancer.
M e d i a s t in a l  T racer  Uptake  
T I - 2 0 1  (+ve)  T I - 2 0 1  ( - v e )  Ga-67 (+ve )  Ga-67 ( - v e )
M e d i a s t in a l  x
CT (+ve )  5 23 16 12
Med l a s t  inai
CT ( - v e )  0 17 0 17
Tab le  21
The S e n s i t i v i t y  o f  T I - 2 0 1  In D e t e c t in g  Breast  Cancer
P o s i t i v e  S e n s i t i v i t y
w i t h  T I - 2 0 1
Pr imary b r e a s t  Ca 20 20 100%
\
Recurrence b r e a s t  Ca 6 4 67%
TOTAL 26 24 92.3%
Table  22
The S e n s i t i v i t y  o f  T I - 2 0 1  In M a l ig n an t  Lymphoma
M e d ia s t i n a l  Lymphoma : 
Hodgkin's Disease
Non Hodgkin 's  Disease
Abdominal and P e l v i c  
Lymphoma
R ectal  Lymphoma
Number o f  P o s i t i v e  S e n s i t i v i t y





TOTAL 15 13 86.7%
Table  23
The S e n s i t i v i t y  o f  T I - 2 0 1  In D e t e c t in g  B ra in  Lesions
Number o f  P o s i t i v e
p a t l e n t s  w i t h  T I - 2 0 1
Pr imary B ra in  Tumours :
Astrocytoma 3 3
G l io b la s tom a N 4 4
Medul ioblastoma 1 1
B ra in  Lymphoma 1 1
CVA 2 0
B ra in  M e t a s t a s i s  :
Breas t  Cancer 3 3
Lung Cancer 3 3
Renal C e l l  Cancer 1 1
TOTAL 18 16
Table  24
The S e n s i t i v i t y  o f  T I - 2 0 1  In D e t e c t in g  Bone and S o f t  T issue  Tumours
Number o f  
p a t l e n t s
P o s i t I v e  
w i t h  T I - 2 0 1
Pr imary Bone Tumours :
Ewing Sarcoma 1 1
Osteogenic Sarcoma N 3 3
Primary S o f t  T issue  Tumours :
LIposarcoma 1 1
Osteogen Icc Sarcoma 1 1 *
Bone Secondaries :
B reast  Cancer 1 1
Benign Lesions :
OsteomyI 11Is 1 1
Note :
The les io ns  In the s k u l l  and dorsal  sp ine  were p o s i t i v e  w i t h  T I - 2 0 1 ,  but  
the small  les io ns  In the r i b s  were not c l e a r l y  v i s i b l e .
Table  25
The S e n s t l t l v l t y  o f  T I - 2 0 1  and GA-67 In D e t e c t in g  Mass Lesion In the L iv e r
P o s I t I v e  
w i th  TI
P o s I t I v e  
w i t h  GA
H e p a t o c e l l u l a r  Ca 8 / 8 6 / 6
L i v e r  C i r r h o s i s 0 / 7 4 / 7  *
L i v e r  Secondaries N 0 /5 1 /5
Hydat Id  Cyst 0/1 0/1
Note :
*  GA-67 c i t r a t e  study In p a t i e n t s  w i t h  nodular  c i r r h o s i s  showed homogenous
t r a c e r  uptake In 4 p a t i e n t s  and co ld  foca l  d e f e c t s  In 3 p a t i e n t s .
Figure (20): Increased TI-201 uptake in a primary 
lung carcinoma.
Figure (21): Diffuse increased TI-201 uptake in a Figure (22): Chest X-ray of the same patient with 
patient with active tuberculosis. diffuse active Tuberculosis.
Figure (23): TI-201 (a) and Ga-67 (b) scans show 
increaseed both radionuclides uptake in both para- 
hiler region, in patient with active sarcoidosis.
Figure (24): Abnormal TI-201 uptake in the primary 
tumour and in the upper mediastinum region in 
patient with lung carcinoma.
Figure (25): 59 years old with severe cough, dysp- 
neoa and haemoptesis. Chest X-Ray showed mas­
sive pleural effusion.
Figure (26): Bilateral venography showed obstruc­
tion in the right subclavian and inomminate veins.
Figure (27): A.Thallium-201 scan demonstrates a 
large tumour in the right supraclavicular region 
involving the right lobe of the thyroid gland and 
extending to the mediastinum
b. Gallium scan demonstrates the mediastinal exten- 
tion of the tumour with minimal increased tracer 
uptake in the supraclavicular region, histopathalogy: 
Squamous cell carcinoma.
Figure (28): Chest X-Ray after therapy showing 
resolving of the pleural effusion.
X I  fM O T O
Figure (30): a) Shows abnormal Ga-67 citrate uptake 
in a patient with primary lung cancer.
Figure (29): Anterior view of the chest. 15 minutes 
acquisition time obtaining 2300 K.count. It shows 
intense TI-201 uptake in -a bronchial carcinoma of 
lower lobe of the right lung.
b) shows abnormal TI-201 uptake in the same 
patient.
Figure (31): a) Shows abnormal TI-201 chloride 
uptake in primary lung cancer 
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Figure (32): a) Thallium-201 (a) and Ga-67 (b) 
studies in a patient with lung cancer. Gallium scan 
demonstrates the primary tumour and mediastinal 
spread, a) Thallium failed to demonstrate the 





Figure (33) : Abnormal TI-201 uptake in a primary Figure (34) : Abnormal TI-201 uptake in a primary 
adenocarcinoma of the right breast. breast carcinoma. Shows a rim of increased tracer
uptake with central photopenia.
Figure (35) : A 54 years old patient with male breast 
carcinoma. TI-201 scan showed abnormal tracer 
uptake in the right breast, lung metastasis and right 
axillary lymphnodes. The liver metastasis is seen as 
cold focal defect.
____________ A t _______
Figure (37) : T c " m DTPA brain scan shows small
focal area of increased tracer uptake in the frontal
lobe due to brain metastasis.
Figure (36) : TI-201 scan demonstrates the brain 
metastasis in the above mentioned patient.
Figure (38) : T c " m tin colloid liver scan, anterior
view, shows multiple focal areas of decreased tracer
uptake in the liver.
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Figure (39) : Abnormally increased tracer uptake in Figure (40) : 52 years old patient with breast
the left breast. Activity seen is adjacent to the heart. carcinoma with bone metastases. TI-201 scan
shows the lesion in the skull and dorsal spine.
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Figure (41) : Abnormal TI-201 uptake in the upper 
mediastinum and in both supraclavicular regions in 
patient with mediastinal Lymphoma. Hodgkin’s dis­
ease.
Figure (42) : Abnormal TI-201 uptake in the upper 
mediastinum and in patient with mediastinal Lym­
phoma. Non-Hodgkin’s disease.
Figure (43) : 45 years old male with abdominal
lymphoma who had large masses in the abdomen 
and a mass in the Right groin region. TI-201 scan of 
the abdomen showed massively increased tracer 
uptake in the abdomen and in the large bowel.
Figure (44) : Shows increased TI-201 uptake in the 
Right groin region and multiple focal areas of 
increased tracer uptake in the Right thigh. There is 
also increased tracer uptake in the left groin region 
representing involved lymphatic chains.
M O M 'D  JAMAL
Figure (45) : Shows a large area of increased uptake Figure (46) : Tc99m MDP bone scan of the posterior
of TI-201 in the posterior pelvis in a patient with rectal pelvis shows pathologically increased tracer uptake
lymphoma. in the sacral and pubic bones.
Figure (47) : Time activity curve of TI-201 uptake in 
tumour and background from a patient with astrocy­
toma. The tumour background ratio is high and does 
not change during 51 minutes of the study.
Figure (49) : Brain perfusion tomography using 
T (r9m HM-PAO shows a large area of decreased 
perfusion in the right parietal lobe in the same patient 
with astrocytoma.
Figure (51) : TI-201 brain scan shows increased 
tracer uptake in the left parieto temporal region in the 
above mentioned patient. Pathology revealed 
glioma.
Figure (48) : TI-201 brain scan shows abnormally 
increased tracer uptake in the Right parieto-occipital 
region of the brain in a patient with astrocytoma.
Figure (50): 55 years old, male, diabetic. For the last 
4 years on insulin therapy, since one month, started 
to forget even his daughter’s name. T c " m DTPA 
brain scan shows a doughnut like focus of pathologi­
cally increased tracer uptake in the left parieto­
temporal region with a central photopenia.
Figure (52) : T c " m HM-PAO brain perfusion
tomography shows a large area of decreased perfu­
sion in the left temporo-parietal region.
 -________jL
Figure (53) : Anterior and left lateral views of the 
brain using T c " m DTPA showed faint area of 
increased tracer uptake in the left frontal lobe.
Figure (54): TI-201 brain scan shows clear visualiza­
tion of the lesion in the brain. Metastasis from lung 
carcinoma.
t u m o r AFTER
SURGERY
Figure (55) : T c " m HM-PAO brain perfusion Figure (56) : TI-201 brain scan shows increased
tomography shows a large area of decreased perfu- tracer uptake in the occipital region in a patient with
sion in the frontal lobe. medulloblastoma after surgical intervention.
Figure (57) : 45 years old, patient with brain 
secondaries of unknown primary, received 40 Gy 
radiation therapy. TI-201 brain scan shows focal 
area of increased tracer uptake.
Figure (59) : A 54 years old female with breast 
cancer under control, developed right sided weak­
ness in the upper and lower limbs. CT scan showed 
a large lesion in the left hemisphere dif. diagnosis 
CVA or metastasis.
Figure (60) : T c " m HM-PAO brain perfusion
tomography shows a large area of decreased perfu­
sion in the left parietal lobe.
Figure (58) : T c " m HM-PAO brain perfusion 
tomography shows a large area of decreased perfu­
sion in the occipital lobe which reflects both residual 
tumour and surrounding oedema, a) trans-axial 
section b) coronal section.
Figure (61) : TI-201 study does not show any 
abnormally increased tracer uptake in the brain. 









F ig u re  (62 ): A c tiv ity - t im e  c u rv e  fro m  a  p a tie n t w ith  
E w in g  S a rc o m a , o b ta in e d  6 0  m in u te s  p o s t in je c tio n  
(B K G  =  B a c k g ro u n d  c lo s e  to  th e  tu m o u r).
Figure (63): T c " m MDP bone scan shows increased 
tracer uptake in the upper 1/3 of the left tibia in a patient 
with osteosarcoma.
Figure (65): T c " m MDP bone scan shows increased 
tracer uptake in the proximal end of the right femur in a 
patient with osteosarcoma.
Figure (64): TI-201 chloride scan shows intense in­
creased tracer uptake in the same patient with 
osteosarcoma.
Figure (66): TI-201 scan shows intense increased tracer 
utpake in the site of the tumour in the same patient.
||S :
Figure (67): A 55 years old, male, had left groin swelling 
of 5 months duration. Pathology liposarcoma. Anterior 
view of the pelvis with marker and 24 hours after 
injection does not reveal abnormal tracer uptake, in the 




L . GRO IN SWELLING  
6NONTHS DURATION
LIPOSARCOMA
Figure (68): TI-201 chloride scan of the pelvis shows a 






Figure (69): A 23 years old, male, with chronic Figure (70): TI-201 scan shows focal area of increased
osteomyelitis. tracer uptake in the lower part of the right tibia which
T c " m MDP bone scan shows diffuse increased tracer proved to be exacerbation of the disease,
uptake in lower part of the left tibia.
Figure (71): T c " m tin colloid liver scan shows a large Figure (72): CT scan shows mass lesion in the liver, 
cold defect in the liver.
Figure (73): TI-2Q1 scan shows increased radionuclide 
uptake in the area which is cold on the T c " m tin colloid 
scan.
Figure (74): Ga-67 scan shows almost equivalent tracer 
uptake with surrounding normal liver tissue in the site of 
the tumour.
Figure (75): A 72 years old, female, had lost weight and 
appetite.
Anterior view of the liver with T c " m tin colloid shows a 
large focal defect involving mainly the right lobe of the 
liver. Biopsy showed hepatocellular carcinoma.
Figure (76): TI-201 scan shows increased tracer uptake 
with a central photopenia in the area which is cold on 
the T c " m colloid scan.
Figure (77): T c " m tin colloid scan, anterior view, shows Figure (78): TI-201 scan shows increased tracer uptake
a large cold defect occupying almost the right and ieft in the site of the tumour, 
lobes of the liver - pathology, revealed primary hepa­
tocellular carcinoma.
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Figure (79): Subtraction TI-201 T c " m tin colloid images Figure (80): T c " m tin colloid scan shows a focal defect 
showed increased TI-201 uptake in the primary hepat- in the right lobe of the liver in a patient with hepatoma, 
tocellular carcinoma.
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Figure (81): TI-201 (a) and Ga-67 (b) images revealed 
increased uptake of both radionuclides in the site of the 
tumour.
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Figure (82): T c " m tin colloid scan, anterior view shows 
poor and patchy tracer distribution in the liver with 
colloid shift to the spleen and bone marrow in a patient 
with micronodular cirrhosis.
Figure (83): TI-201 image shows patchy tracer distribu­
tion with multiple focal defects.
Figure (84): Ga-67 image of the liver shows Figure (85): T c " m tin colloid scan shows decreased 
homogenous tracer uptake in the liver. and patchy tracer distribution in the liver.
Figure (86): TI-201 scan shows patchy tracer distribu- Figure (87): Ga-67 scan shows hontogenous tracer 
tion in the liver. uptake in the liver.
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Figure (88): (a) TI-201 and (b) Gallium-67 scans show 
focal defects in the areas which are cold on the T c " m 
colloid scan in the patient with bilharzial cirrhosis.
Figure (89): Anterior view of the liver and spleen with 
Tcr9m colloid scan shows small liver with patchy tracer 
distribution and multiple focal defects. Grossly enlarged 
spleen in a patient with bilharzial cirrhosis.
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Figure (90): T c " m tin colloid scan, Anterior view in a 
patient with situs inversus — shows large focal defects 
in the Right and Left lobes of the liver. Liver metastasis 
from Liomyosarcoma of the stomach.
A .Jt-
Figure (92): Ga-67 shows a large focal defect in the
the liver. liver.
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Figure (93): a) T c " m tin colloid scan.
b) TI-201 chloride scan.
c) Ga-67 citrate scan.
Show a large focal defect in the liver in a patient with 
hydatid cyst of the liver.
CHAPTER VI
EFFECT OF ANTI-TUMOUR THERAPIES ON THALLIUM-201 UPTAKE
V l ( 1 ) ( a )  In t r o d u c t io n
Ant I - tumour t h e r a p ie s  can achieve b e t t e r  r e s u l t s  when th e re  is adequate  
i n i t i a l  e v a l u a t i o n  o f  lo c a t io n  and e x te n t  o f  a tumour ( 3 0 3 ) .  The subse­
quent management o f  a cancer p a t i e n t  is to  assess response to  t r e a t m e n t ,  
to  d e te c t  e a r l y  re lap se  and to  a s s i s t  in making d ec is io n s  concerning  
f o l lo w - u p  t rea tm ent  O O 4 ) .
The r o l e  o f  T I -2 0 1  in p r e d i c t i n g  tumour responsiveness to  an t i - tu m o u r  
t h e r a p i e s  has not been f u l l y  e v a lu a te d .  I f  a tumour s i t e  cont inues  to  
demonstrate uptake a f t e r  therapy ,  t h i s  in d ic a te s  the presence o f  metab­
o l i c  a c t i v e  t i s s u e  and may be evidence o f  the presence o f  r e s id u a l  v i ­
ab le  tumours. A p o s i t i v e  T I -2 01  scan f o l lo w i n g  t rea tment  o f  known 
tumour s i t e s  o f  disease may be used as an index o f  p e r s is te n c e  or r e c u r ­
rence o f  t r e a t e d  d isease .
T e r u i ,  e t  a l ,  1984 ( 246 ) ,  examined the e f f e c t  o f  chemotherapy on T I -2 0 1  
uptake in four p a t i e n t s  w i th  pr imary bone tumours (2  Ewing's sarcoma and 
2 osteogen ic  sarcoma). Of th ree  out  o f  four f o l lo w - u p  p a t i e n t s ,  the
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p o s t - t h e r a p y  scans showed redu ct ion  In T I -20 1  uptake more markedly than 
Tc-99m MDP uptake during e f f e c t i v e  chemotherapy. The remaining p a t i e n t  
did  not respond to  the t rea tm ent  and the scan showed no changes in the  
T I - 2 0 1  u ptake .
Kaplan e t  a l ,  1987 <247) ,  found t h a t  T I -2 0 1  b r a i n  scans o f f e r e d  a more 
a cc u ra te  assessment o f  response to  therapy  than o ther  r a d io n u c l id e s  and 
CT scanning.
v I have e v a lu a te d  the e f f e c t  o f  ra d io th e ra p y  and chemotherapy on T I -201  
uptake  In p a t i e n t s  w i th  va r io u s  mal ignant  d isease .  A s e r i e s  o f  p a t i e n t s  
were s tu d ie d  b e fo re  and a f t e r  therapy .
V l ( 1 ) ( b )  P a t i e n t  Popu la t io n
T h i r t y  t h re e  p a t i e n t s  w i th  lung carcinoma,  27 male and s ix  female ,  the  
mean age group (+ SD) 5 7 . 3  (+ 8 . 7 )  yea rs ,  had rece iv ed  p r i o r  lung i r ­
r a d i a t i o n .  Eleven p a t i e n t s  o f  these ,  two mal ignant  lymphoma, one os­
teogen ic  sarcoma, two lung carcinoma and s ix  breas t  carcinoma, had 
rec e ive d  p r i o r  chemotherapy; the mean age group was (+ SD) 38 .22
(+ 1 0 . 3 )  ye a rs .  Out o f  16 p a t i e n t s  w i th  b r a in  tumours, n ine had pr imary
m u m ,
b r a in  tumours and seven metastases,  11 male and 5 female ,  the nedfi age 
group (+SD) was 4 5 .8  (+ 1 3 .2 )  years ,w ere  r e c e i v i n g  s t e r o i d  therapy at  
the t ime o f  imaging (see b r a in  imaging) .
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VI ( 1 ) (c )  Methods
As described  In Chapter V, s t a t i c  T I -20 1  Imaging was performed ten  
minutes a f t e r  a d m i n i s t r a t i o n  o f  75 MBq o f  T I -2 0 1  c h l o r i d e  in t r a v e n o u s ly .  
The p a t i e n t  was p o s i t io n e d  under a la rge f i e l d  o f  v iew gamma camera in­
t e r f a c e d  w i t h  a m in i -c o m p u te r . The camera was peaked on T I -2 0 1  photopeak 
6 9 -8 5  Ke V x - r a y s  w i th  a 20 percent  window, and a 500K counts were ob­
t a in e d  each view.
Sequent ia l  T I -2 0 1  images were performed p r i o r ^ t h e r a p y , w i t h i n  one week 
o f  end o f  therapy  and a f t e r  f i v e  months a f t e r  th erapy .
T I - 2 0 1  images were c o r r e l a t e d  w i th  CT scanning f i n d i n g s .  Chest x - r a y  an­
t e r i o p o s t e r i o r  and l a t e r a l s  were a v a i l a b l e  In a l l  cases. G a l l iu m -6 7  im­
aging pre and a f t e r  therapy was a v a i l a b l e  fo r  comparison in 21 cases 
w i t h  lung carcinoma. CT scanning o f  the thorax was performed using new 
g e n e ra t io n  scanner w i th  a 20 S scanning t imes and w i th  s l i c e  th ickness  
o f  13mm at  s l i c e  d is tances  o f  15 mm to  the t ra ch ea l  b i f u r c a t i o n  and 15mm 
or 20mm more c a u d a l l y .  The m atr ix  was a 320 x 320 w i th  in d iv id u a l  p ix e l  
s i z e  o f  1mm ( f i g u r e  9 6 ) .
The response o f  the tumour fo l lo w i n g  i r r a d i a t i o n  was e v a lua ted  w i th  
tumour measurements on s e r i a l  p o s t e r o a n t e r io r  and l a t e r a l  chest  
rad iographs and CT scanning obta in ed  be fore  t r e a t m e n t ,  a t  the complet ion  
o f  i r r a d i a t i o n  and at  5 months f o l l o w  up i n t e r v a l s .  Complete regress ion  
o f  the tumour was descr ibed  where there  was a t o t a l  disappearance o f  a l l
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measurable masses (p r imary  tumour and m e t a s t a t i c  lymph nodes) ,  p a r t i a l  
reg re ss io n  was recorded when th e re  was at least  a 50 percent  decrease in 
the c r o s s - s e c t io n a l  areas o f  the measured masses and th e re  was no 
progress io n  o f  disease  or new areas o f  mal ignant  tumour appeared w i t h i n  
the i r r a d i a t e d  volume. The s t a b l e  (no response)  groups included p a t i e n t s  
w itho u t  s i g n i f i c a n t  tumour re g re ss io n .  The response o f  the tumour f o l ­
lowing i r r a d i a t i o n  was assessed q u a n t i t a t i v e l y .  Tha l l iu m -201  images p r e -  
and p o s t - t h e r a p y  were d isp layed  on the computer screen.  A region o f  in­
t e r e s t  around the tumour and the background surrounding the tumour was 
cre a ted  over the p re - th e r a p y  image. The mean counts in the tumour and 
background were recorded.  The same regions o f  the p a t i e n t  were recorded  
over the p o s t - th e ra p y  image and the mean counts in the tumour and back­
ground were recorded.  From these d a ta ,  the t ru e  count in the tumour p r e -  
and p o s t - t h e r a p y  was o b ta in e d .  The percentage o f  loss o f  a c t i v i t y  or  
changes o f  a c t i v i t y  in the t r u e  count o f  pr imary  tumour was o b ta in e d ,  
and t h i s  may represent  the degree o f  local  response a f t e r  t re a tm e n t .
V I ( 1 ) (d )  R esu l ts
Sequent ia l  T I -201  scans were found to  be useful  in e v a lu a t i n g  p a t i e n t s  
w ith  mal ignant  d isease ,  e s p e c i a l l y  when the scan was p o s i t i v e  pre ­
t r e a t m e n t .  In p a t i e n t s  who had rece ived  chemotherapy, o n ly  one p a t i e n t  
achieved complete regress io n  o f  the tumour and T I -2 0 1  scan showed no 
areas o f  Increased t r a c e r  uptake ( f i g u r e  9 7 ) .  Another p a t i e n t  achieved  
p a r t i a l  reg ress io n  o f  the tumour, and T I -2 0 1  scan showed red u c t io n  o f
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t r a c e r  uptake in the s i t e  of  the tumour. Nine p a t i e n t s  showed no s i g ­
n i f i c a n t  changes o f  T I -201  uptake and th e re  was no response to  t r e a t ­
ment .
Tab le  26 shows the d i s t r i b u t i o n  and degree o f  local  response a f t e r  
chemotherapy in in d iv id u a l  p a t i e n t s .
Tab le  27 shows the seq u e nt ia l  r a d io n u c l id e  s tu d ie s  and CT scanning w it h  
the d i s t r i b u t i o n  and degree o f  local  response a f t e r  r a d i a t i o n  therapy in 
in d iv id u a l  p a t i e n t s .  Table 28 summarizes the d i s t r i b u t i o n  and degree of  
local  response a f t e r  r a d i a t i o n  th erapy .
In 33 p a t i e n t  who rece ived  about 50 Gy (5000 rads)  on the tumour s i t e ,  
30 p a t i e n t s  were p o s i t i v e  w i th  T I -201  and th ree  p a t i e n t s  were n e g a t iv e .  
No s i n g l e  p a t i e n t  achieved complete regress ion  o f  the tumour a f t e r  
r a d i a t i o n  th e rap y .  Only nine p a t i e n t s  (30 %) showed p a r t i a l  response to  
t rea tm ent  and red u ct io n  o f  T I -20 1  uptake o f  less than 50 percent  in the  
s i t e  o f  the tumour ( f i g u r e  9 4 ) .
Twenty one p a t i e n t s  (70%) showed no s i g n i f i c a n t  changes in tumour uptake  
In p r e -  and p o s t - r a d i a t  Ion therapy  scans ( f i g u r e s  9 5 - 1 0 1 ) .  None o f  the  
th re e  n eg a t ive  p a t i e n t s  showed abnormal T I -2 0 1  uptake In the s i t e  o f  the  
tumour In p r e -  and p o s t - th e ra p y  scans.
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In comparison to  CT scanning,  33 p a t i e n t s  were p o s i t i v e  p r e - r a d i a t i o n  
th e ra p y ,  13 (39%) p a t i e n t s  achieved p a r t i a l  response to  t re a t m e n t ,  and 
20 (60%) p a t i e n t s  showed no response a f t e r  r a d i a t i o n  th erap y .
Of these o n ly  21 p a t i e n t s  underwent g a l l iu m  study b e fo re  and a f t e r  
t r e a t m e n t ,  t h r e e  p a t i e n t s  were ne g a t iv e  in p r e -  and p o s t - th e ra p y  scans.  
Three p a t i e n t s  (17%) showed p a r t i a l  response ( f i g u r e  111) and 15 (83%) 
showed no response to  trea tment  ( f i g u r e  1 09 ) .
T h i r t e e n  p a t i e n t s  were fo l low ed  up f i v e  months a f t e r  t rea tment  using  
T I -2 0 1  scans.  Of these ,  o n ly  two p a t i e n t s  showed red u c t ion  o f  T I -2 0 1  up­
take  in the s i t e  o f  the tumour. In the remaining the p a t i e n t s  th e re  were 
no s i g n i f i c a n t  changes from prev ious  s t u d i e s .  Of these ,  11 p a t i e n t s  were 
a ls o  fo l lo w e d  by Ga-67 imaging which showed on ly  two p a t i e n t s  had reduc­
t i o n  o f  the t r a c e r  uptake in the s i t e  o f  the tumour.
V I ( 1 ) ( e ) Discussion
A nt i - tu mour therapy regimens may produce e f f e c t i v e  responses in p a t i e n t s  
w ith  advanced mal ignant  d isease .  U n t i l  c l e a r  s u r v i v a l  advantages are  
shown fo r  s p e c i f i c  regimens,  maintenance o f  a high q u a l i t y  o f  l i f e  must 
remain a very  high p r i o r i t y .
Pr Iestman and Baum, 1976 ( 3 ° 5 ) ,  suggested t h a t  o b t a i n in g  a response im­
proves a p a t i e n t ' s  q u a l i t y  o f  l i f e  and hence might  be o f  g re a t  impor­
tance  to  in d iv id u a l  p a t i e n t s .  The c o r r e l a t i o n  o f  tumour response w i th
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an t i - tu m o u r  t h e r a p ie s  emphasizes the need to  develop the most e f f e c t i v e  
t rea tm ent  regimens th a t  w i l l  y i e l d  complete tumour re g r e s s io n ,  thus  
r e s u l t i n g  in h igher  s u r v i v a l .
Since so many p a t i e n t s  w i th  mal ignant  disease d ied w i th  d i s t a n t  metas­
t a s i s ,  s u r v iv a l  a lone may not be a r e l i a b l e  p rognost ic  i n d ic a t o r  and lo­
cal  tumour co n t ro l  must be c a r e f u l l y  eva lu a ted  ( 3 ° 6 ) .
The response o f  tumour f o l lo w i n g  a n t i - tu m o ur  t h e r a p ie s  was eva lu a ted  
w ith  tumour measurement on s e r i a l  r a d i o l o g i c a l  s t u d ie s .  In a d d i t i o n  
r a d io n u c l i d e  s tu d ie s  have e s t a b l is h e d  r o le s  in the f o l l o w  up and manage­
ment o f  p a t i e n t s  w i th  cancer C254) .  Al though ra d io g r a p h ic  moda111ies 
have s u p e r io r  s p a t i a l  r e s o l u t i o n ,  they cannot d i f f e r e n t i a t e  bulky  
f i b r o s i s  from a c t i v e  n e o p l a s t i c  disease ( 247 ) .
G a l l iu m - 6 7  scanning was found to be usefu l  fo r  f o l lo w - u p  s t u d ie s  o f  the
course o f  lymphomatous disease a f t e r  therapy .  A p o s i t i v e  g a l l i u m - 6 7  scan
may be the o n ly  o b j e c t i v e  evidence o f  p e r s is te n c e  or recurrence  o f
t r e a t e d  disease  ( 204) .  i t  can d i s t i n g u i s h  between re c u r r e n t  tumour and
f i b r o s i s  secondary to  p o s t - i r r a d i a t  ion th e ra p y ,  s ince  the former Is
u s u a l l y  g a l l i u m - p o s i t i v e  and the l a t e r  is u s u a l l y  g a l l i u m - n e g a t i v e
( 3 0 7 ) ^
During or s h o r t l y  a f t e r  th erap y ,  g a l l i u m - 6 7  uptake may be suppressed,  
even I f  the tumour is not comple tely o b l i t e r a t e d .  I f  the tumour s i t e  
cont inues  to  demonstrate uptake a f t e r  th e rap y ,  t h i s  is a s t rong Ind ic a ­
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t i o n  o f  the presence o f  res id u a l  v i a b l e  tumour. I t  is g e n e r a l l y  accepted
t h a t  a p o s i t i v e  scan Is more r e l i a b l e  than a n eg a t ive  scan a f t e r  therapy  
( 2 0 4 ) #
There is a good c o r r e l a t i o n  between the change In g a l l i u m  uptake and the  
change in tumour s i z e  a f t e r  t re a tm e n t ,  as determined r a d i o g r a p h i c a l l y
(3 08 )  Changes in tumour uptake o f  g a l l i u m - 6 7  have been c o r r e l a t e d  w i th  
r a d i a t i o n  dose in p a t i e n t s  w i th  lung tumours. B I t r a n  e t  a l ,  1978 
re p o r te d  t h a t  a f t e r  chest  rad io th e r a p y  a g a l l i u m  scan may show no abnor­
m a l i t i e s  even though v i a b l e  tumour is s t i l l  p re sen t .
G a l l iu m -6 7  scanning may be useful  in d e t e c t i n g  e x t r a  t h o r a c ic  metastases  
from non-smal l  c e l l  lung can cer,  but f a i l s  s p e c i f i c a l l y  w i t h i n  the  
b r a i n ,  and i t  is less s e n s i t i v e  then bone scans In d e t e c t i n g  osseous 
metastases.  I t  does not supplant  CT scans o f  the b r a i n  or  bone scans 
when metastases are suspected ( 2 ° 4 ) .
In the present  s tudy ,  I found T I -2 01  c h l o r i d e  usefu l  in d e te rm in in g  lo­
cal  tumour response a f t e r  ant  I -tumour t h e r a p i e s .  Complete suppression o f  
T I -2 0 1  uptake occurred  a f t e r  chemotherapy in one p a t i e n t  w i th  Hodgkin's  
lymphoma. Decreased T I -201  uptake occurred a f t e r  r a d i a t i o n  therap y in 
p a t i e n t s  w i t h  pr imary lung cancer.  There was a good c o r r e l a t i o n  between 
the change in T I -20 1  uptake and the change in the pr imary  tumour s i z e  
a f t e r  t rea tm ent  as determined r a d i o g r a p h i c a l l y .
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' „  T I —20 scan is h ig h ly  s e n s i t i v e  in d e t e c t i n g  pr imary lung cancer  
but f a i l s  to  I d e n t i f y  m ed ia s t in a l  node involvement or small  a x i l l a r y  or  
s u p r a c l a v i c u l a r  lymph node in p a t i e n t s  w i th  mal ignant  d isease .
U n f o r t u n a t e l y ,  in none o f  these p a t i e n t s  fo l low ed  up w i th  T I -2 0 1  or Ga-  
67 scans were p a th o lo g ic a l  c o r r e l a t i o n  or autopsy data obta in ed  because 
using  T I -2 0 1  as s tag in g  m o da l i ty  n e c e s s i t a te s  at  least  an e x p l o r a t o r y  
thoracotomy,  which is im prac t ic a l  and sometimes m e d ic a l ly  c o n t ra ­
in d ic a te d  in la rge number o f  p a t i e n t s  w i th  un res ec ta b ie  lesions t r e a t e d  
by r a d i a t i o n  or chemotherapy.
The r o l e  o f  r a d i a t i o n  therapy  in the management o f  u n rese c tab ie  or medi­
c a l l y  in operable  bronchogenic carcinoma remains undef in ed .  Perez e t  a l ,  
1980 (30®) and Roswit e t  a l ,  1968 ( 31° ) ,  re por ted  a 22 percent  one year  
s u r v iv a l  r a t e  fo r  a la rge  group o f  p a t i e n t s  t r e a t e d  w i th  4000-5000 rads 
in four to  f i v e  weeks in co n t ra s t  to a 16 percent  one year s u r v iv a l  r a t e  
f o r  a s i m i l a r  cont ro l  group g iven a p lacebo.  They found the s u r v iv a l  
r a t e  a ls o  was the same whether the p a t i e n t s  were t r e a t e d  w i th  4000,  
5000,  or 6000 rads.  Other in v e s t ig a t o r s  quest ioned whether t h i s  was a 
t r u e  r e f l e c t i o n  o f  t h e r a p e u t ic  e f f e c t i v e n e s s  o f  i r r a d i a t i o n  since  the  
p a t i e n t s  In the i r r a d i a t e d  group may have had more sup p o r t ive  care  than 
those in the co n t ro l  group.
On the o th e r  hand, Bloedorn e t  a l ,  1964 ( 311 ) ,  rep o r ted  no h i s t o l o g i c  
evidence  o f  res id u a l  tumour a t  pr imary  s i t e  In 54 percent  o f  26 p a t i e n t s  
r e c e i v in g  6000 rad in s ix  weeks p r e o p e r a t I v e l y .  The m e d ia s t in a l  lymph
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nodes showed res id u a l  tumour in on ly  8 percent  o f  the cases. Heilman et  
a l ,  1964 (3 12 )  descr ibed  re s id u a l  microscopic pr imary tumour in 17 o f  24 
p a t i e n t s  t r e a t e d  w i th  5500-6000 rad fo r  carcinoma o f  the lung four  to  
s ix  weeks p r i o r  to  thoracotomy. Of 15 p a t i e n t s  w i th  p r e - o p e r a t i v e  
ra d io g r a p h ic  evidence o f  h i l a r  or m ed ia s t in a l  adenopathy,  on ly  t h r e e  had 
res id u a l  tumour in the p a th o lo g ic  specimen.
In the study h e r e i n ,  33 p a t i e n t s  rece iv ed  5000 rad in four to  f i v e  weeks 
to  the tumour s i t e .  T h i r t y  p a t i e n t s  were p o s i t i v e  w i th  T I -2 0 1  scans in 
p r e -  and p o s t - r a d i a t i o n  therapy .  None o f  these had achieved complete 
r eg res s io n  o f  the tumour a f t e r  therapy .  Only 13 out  o f  30 were p a t i e n t s  
fo l lo w e d  up f i v e  months a f t e r  th e ra py ,  n ine p a t i e n t s  died  du ring  t h i s  
p e r io d ,  f i v e  p a t i e n t s  were c r i t i c a l l y  i l l  and have developed e x -  
t r a t h o r a c l c  metas tases,  and the remaining th ree  p a t i e n t  were lost  during  
f o l l o w  up.
F i n a l l y ,  the a d m i n i s t r a t i o n  o f  a n t i n e o p l a s t i c  agents and s t e r o i d  therapy  
p r i o r  to  i n j e c t i o n  o f  Tha l l iu m-201  appeared not to  a f f e c t  the d i s t r i b u ­
t i o n  o f  T I -2 0 1  in the tumour. Any changes in the uptake o f  T I -2 0 1  in 
p o s t - t r e a t m e n t  scans thus be assessed c a r e f u l l y  i f  is to  determine  
whether these changes represent  tumour e r a d i c a t i o n ,  incomplete c o n t r o l ,  
or recurrence  o f  d isease .
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In con c lu s io n ,  the changes o f  uptake o f  T I -2 0 1  in the tumour 
appear h i g h ly  s p e c i f i c ,  i t s  use fo r  measuring the e x te n t  o f  
disease  has been d i s a p p o in t in g  due to  I n s e n s i t i v i t y  in d e te c t  
t i n a l  and nodal spread o f  the d isease .
s i t e  may 
n e o p la s t i c  
ng medlas-
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T ab le  26
D i s t r i b u t i o n  o f  Degree o f  Local Response A f t e r  Chem otherapy  Treatment
Name Pre Therapy  
Tumour/Background  
A c t i v i t i e s  (K counts)
Post Therapy  
Tumour/Background 
A c t i v i t i e s  (K counts)
Degree o f  Local  
Response ^
56
M .J . 7 6 . 4 / 2 2 . 9
V
7 3 . 3 / 2 0 . 7 1 .7
K.Y . 8 2 . 6 / 5 3 . 6 5 1 . 2 / 4 9 . 8 9 5 . 0
W.M. 2 0 9 . 2 / 1 0 3 . 5 2 2 5 . 0 / 1 0 9 . 0 -  9 . 7
F .A . 6 2 . 9 / 4 3 . 0 6 4 . 8 / 4 4 . 5 -  2 . 0
H.M. 4 7 . 2 / 2 2 . 7 5 5 . 3 / 2 5 . 6 -21  .2
S.M. 5 6 . 9 / 3 4 . 2 4 8 . 9 / 3 1 . 4 -  4 . 8
M.M. 7 9 . 5 / 4 2 . 3 6 2 . 8 / 4 8 . 2 6 0 . 8
K.N. 5 4 . 2 / 3 3 . 0 4 9 . 8 / 3 1 . 0 1 1 .3
S.A. 2 6 . 7 / 1 7 . 3 2 6 . 4 / 1 8 . 2 1 2 .8
Z . A. 5 6 . 5 / 2 8 . 2 5 2 . 0 / 3 0 . 2 2 2 .9
A.A. 2 0 . 3 / 1 2 . 3 1 9 . 2 / 1 1 . 9 8 . 7
Tab le  27
D i s t r i b u t i o n  o f  Degree o f  Local Response A f t e r  R a d ia t io n  Therapy
Pre Therapy Post Therapy
Pos111ve No Response P a r t  I a I Response
T I - 2 0 1  (n « 33)
CT Scan (n -  33)




T ab le  28
D i s t r i b u t i o n  o f  Degree o f  Local Response A f t e r  R a d ia t io n  Therapy
Name Pre Therapy  
Tumour/Background 
A c t i v i t i e s  (K counts)
Post Therapy  
Tumour/Background 
A c t i v i t i e s  (K counts)
Degree o f  Local  
Response &  
% *
H .J . 4 0 . 8 / 2 5 . 9 4 1 . 5 / 2 7 . 2 4 . 0
S.M. 2 3 . 4 / 1 5 . 2 2 7 . 1 / 2 0 . 3 1 7 .0
F.A . 6 4 . 7 / 4 5 . 4 5 8 . 2 / 3 9 . 5 1 .5
N.S. 1 9 . 0 / 1 6 . 0 1 7 . 0 / 1 5 . 6 5 3 .3
A.H. 6 7 . 7 / 5 2 . 2 1 1 7 . 0 / 1 0 4 . 0 1 6 .0
M .R . 7 3 . 8 / 4 9 . 8 6 0 . 0 / 4 2 . 0 2 5 .0
M.K. 8 8 . 2 / 4 5 . 0 8 0 . 3 / 6 1 . 2 5 5 . 7
W.A. 5 8 . 5 / 3 5 . 2 5 3 . 6 / 4 2 . 0 5 5 .8
S.K. 4 6 . 3 / 3 2 . 0 3 8 . 2 / 2 7 . 5 25.1
L .H . 1 2 . 5 /  8 . 5 1 6 . 4 / 1 1 . 9 - 1 2 . 5
A .T . 3 3 . 0 / 2 6 . 0 4 4 . 5 / 3 0 . 0 - 1 0 7 . 0
A .F . 4 3 . 0 / 2 2 . 5 3 8 . 8 / 2 8 . 5 4 9 .8
H.M. 1 9 . 0 / 1 3 . 0 8 . 0 /  6 . 0 6 6 .6
M.A. 2 7 . 0 / 2 4 . 0 1 6 . 0 / 1 4 . 0 4 5 .9
A. J . 2 9 . 0 / 2 1 . 0 3 4 . 0 / 2 6 . 0 0 . 0
A.M. 1 6 . 0 / 1 2 . 0 1 0 . 0 /  7 . 0 2 5 .0
S. J. 1 8 . 0 / 1 6 . 0 2 3 . 5 / 2 1 . 6 5 . 0
A.S. 4 2 . 6 / 3 6 . 7 3 9 . 8 / 3 4 . 0 1 .6
F.M. 4 2 . 0 / 4 0 . 0 3 6 . 0 / 3 5 . 0 5 0 .0
F.A. 5 8 . 4 / 3 7 . 0 1 0 3 . 0 / 6 4 . 0 - 8 2 . 2
M.K. 3 2 . 0 / 2 7 . 0 .35.0/31 .0 1 2 .0
A.K. 5 2 . 0 / 3 7 . 0 4 7 . 0 / 3 5 . 0 5 3 .3
M.A. 4 7 . 3 / 3 1 . 0 4 3 . 0 / 2 9 . 0 14.1
A.A. 2 5 . 8 / 2 2 . 3 1 7 . 3 / 1 5 . 0 3 4 .0
S.K. 1 0 . 4 /  8 . 5 1 7 . 9 / 1 5 . 6 -21 .0
A.S . 5 8 . 4 / 2 8 . 1 5 6 . 6 / 2 8 . 9 8 . 0
A.M. 1 9 . 5 / 1 6 . 2 2 2 . 0 / 1 8 . 9 6 . 0
S.S. 3 3 . 6 / 2 5 . 6 3 5 . 7 / 2 8 . 8 13 .8
E.H. 5 7 . 0 / 3 1 . 8 6 4 . 3 / 4 1 . 2 1 2 .0
A.K. 2 5 . 6 / 1 9 . 6 2 3 . 5 / 2 0 . 8 55 .5
% flAUtiU-f (L/tlvCti
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Figure (94) : Regions of interest around the tumour 
and background were created in patient with lung 
carcinoma in pre-therapy scan (a) and post-therapy 
scan (b). The patient received 50 Gy and showed 
partial response to treatment.
Figure (95) : Regions of interest surrounding the 
tumour and background close to the tumour pre and 
post therapy in a patient with lung carcinoma 
received 50 Gy to the tumor site and showed no 
response after treatment.
b)
Figure (96) : CT scans before therapy (a) and after 
therapy (b) do not show significant changes.
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Figure (97) : a - Pre-therapy TI-201 scan in a patient 
with mediastinal lymphoma (Hodgkin’s lymphoma), 
shows increased TI-201 uptake in the enlarged 
mediastinal lymphnodes.
b - Post-chemotherapy TI-201 scan shows good 
response to treatment, and nearly complete regres­
sion of the disease (95%).
d)
Figure (98) : Chest X-ray (a) Pretherapy (b) post 
therapy CT scan pre-therapy (c) CT scan post 
therapy (d) The large mass which occupies the 
whole upper mediastinum showed nearly complete 
regression after chemotherapy.
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Figure (99): a) Pre-therapy TI-201 scan in a patient 
with recurrent breast cancer, shows focal areas of 
increased tracer uptake in the left breast.
b) post chemotherapy TI-201 scan shows more 
intense TI-201 uptake in the site of the tumour and 
progression of the disease.
Figure (100): a) Pre-therapy TI-201 scan b) post 
chemotherapy TI-201 scan showed no significant 
changes in TI-201 uptake in the site of the tumour of 
a patient with rectal lymphoma. The patient received 
6 courses of VAC regime.
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Figure (101): a) Pretherapy TI-201 scan shows 
increased TI-201 uptake in the upper lobe of the right 
lung. The patient received 50 Gy radiation therapy, 
b) Post therapy TI-201 scan shows intense TI-201 
uptake in the site of the tumour and no response to 
treatment.
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Figure (102): a) Pre-therapy TI-201 scan 
b) Post-therapy scan. The patient received 50 Gy of 
radiation therapy and showed partial response to 
treatment.
Figure (103): Ga-67 scans a) Pre-therapy b) post­
therapy. The scans show no tracer concentration in 
the site of the tumour in both studies (negative).
Figure (104) Chest X-Ray a) pre-therapy b) after 
therapy in the same patient with bronchial carcino­
ma. Regression of the disease is noted after 50 Gy of 
radiation therapy.
a) b)
Figure (105) CT scan of the same patient a) 
pre-therapy b) post-therapy showed partial response 
to radiation therapy.
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Figure (106): a) Pre-therapy TI-201 scan shows a 
large area of increased TI-201 uptake in the upper 
zone of the left lung, b) Post-therapy TI-201 scan 
shows minimal increased TI-201 uptake in the site of 
the tumour after receiving 50 Gy radiation therapy.
Figure (107): a) Chest X-Ray pre-therapy shows a 
large shadow in the upper zone of the le ft lung.
b) Chest X-ray post therapy shows partial response 
to treatment.
c) Pre therapy C.T. scan.
d) Post-therapy C.T. scan.
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Figure (108): a) Pre-therapy TI-201 scan shows 
intense TI-201 concentration in the primary lung 
cancer of the left lung.
b) Post therapy TI-201 scan shows slightly de­
creased tracer uptake in the site of the tumour.
b)
Figure (109): Ga-67 studies a) Pre-therapy b) Post­
therapy showed slightly reduced tracer uptake in the 
site of the tumour after radiation therapy.
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Figure (110): TI-201 scan a) Pre-therapy shows 
increased TI-201 uptake in the primary tumour of the 
upper lobe of the right lung, b) Post-therapy scan 
shows minimal TI-201 uptake in the site of the 
tumour.
b)
Figure (111): Ga-67 studies a) Pre therapy b) After 
50 Gy radiation therapy showed minimal Ga-67 
uptake in the site of the tumour.
Figure (112): Radiographically a) Chest X-Ray be­
fore treatment b) Chest X-Ray after treatment, c & d) 
C.T. scanning of the same patient pre and post 
therapy reveal no significant changes in the size of 
the tumour. The patient showed clinical response to 
treatment.
CHAPTER VI I 
SUMMARY AND CONCLUSIONS
T h a l l iu m  (a tomic  number 81)  is a m e t a l l i c  element o f  group I I I  A o f  the  
p e r i o d i c  t a b l e .  I t  belongs to  d i f f e r e n t  element group from potassium,  
rub id iu m, and caesium.
The use o f  T I -2 0 1  as a myocardial  imaging agent Is dependent upon i t s  
s i m i l a r i t i e s  to  io n ic  potassium in b i o l o g i c  systems.  As potassium 
analogue,  t h a l l i u m  a c t i v a t e s  the sodium-potassium (Na-K)  ATP-ase depend­
ent  pump, and the c e l l u l a r  uptake o f  T h a l l iu m  is i n h i b i t e d  by ouabain  
and sodium f l o r i d e  which block the Na-K pump.
Charkes e t  a l ,  1 9 6 5 , ( 241) re por ted  th a t  the potassium analogue caesium 
concent ra ted  in tumour and in in t roduc in g  th a I  I iu m - 2 0 1 , Lebowitz  e t  a l ,  
1975 suggested t h a t  I t  might be usefu l  fo r  tumour l o c a l i z a t i o n  in add i­
t i o n  to  I t s  r o l e  as a myocardial  and rena l  imaging agen t .
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A number o f  r e p o r ts  appeared in l i t e r a t u r e  d e a l in g  w i th  T I -2 01  uptake in 
tumours. The background o f  these few re p o r ts  on T I -201  tumour imaging 
led to  t h i s  work which a ttempts  to  e v a lu a t e  more s y s t e m a t i c a l l y  the r o l e  
o f  T I - 2 0 1  as a tumour imaging agent in c o n d i t io n s  o th er  than Thyroid  
Carcinoma.
I s tu d ie d  the t ime course o f  T I -2 0 1  uptake in va r io u s  mal ignant  diseases  
in ord er to  assess the opt imal  t ime fo r  tumour imaging w i th  T I - 2 0 1 .  I 
determined the  t ime o f  maximal tumour uptake o f  the t r a c e r ,  and s tu d ie d  
the changes in the tumour to  background a c t i v i t y  r a t i o s  in order to  es­
t a b l i s h  the opt imal  t ime fo r  tumour imaging w i th  T I - 2 0 1 .
N in e ty -s eve n  p a t i e n t s  w i th  h i s t o l o g i c a l l y  proven mal ignant  tumours were 
examined. A f t e r  IV i n j e c t i o n  o f  75 MBq o f  T I - 2 0 1 ,  the p a t i e n t  was p os i ­
t io n ed  under a large  f i e l d  o f  view gamma camera centered  over the
primary tumour s i t e ,  two data a c q u i s i t i o n  were recorded,  the f i r s t  was
every 5 seconds fo r  5 minutes and the second fo l low ed  immediately every  
30 seconds fo r  55 minutes.  Then a 10 minute s t a t i c  image at  4 hours 
post i n j e c t i o n  was o b ta in e d .  Time a c t i v i t y  curves over the tumour sur­
rounding background area and the myocardium were generated fo r  both 
dynamic data a c q u i s i t i o n .  For each p a t i e n t  the t ime a c t i v i t y  curves  
were analysed fo r  the t ime o f  maximal tumour uptake o f  T I - 2 0 1 .  The
tumour t ime a c t i v i t y  curve was d iv id e d  by the background curve and the
t ime o f  maximal tumour to  background r a t i o s  was est im ated  in each 
pat  l e n t .
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The changes in T I -2 0 1  co n ce n t ra t io n  between e a r l y  and 4 hours delayed  
images were q u a n t i t a t i v e l y  assessed.
The r e s u l t s  o f  t h i s  study show t h a t  uptake occurs r a p i d l y  in tumour with  
a peak va lue  obta ined  10 to  15 minutes post i n j e c t i o n  in most cases.  
There were no s i g n i f i c a n t  d i f f e r e n c e s  in d i f f e r e n t  tumour types .  Tumour 
to  background r a t i o s  a ls o  r a p i d l y  a t t a i n e d  peak va lues and remained 
r e l a t i v e l y  constant  over the hour fo l l o w in g  i n j e c t i o n .  No s i g n i f i c a n t  
changes in tumour to  background r a t i o  were found in the 4 hour post in­
j e c t i o n  images compared to 1 hour post i n j e c t i o n  d a ta .  From the data I 
e s t a b l i s h  the t ime fo r  tumour imaging w ith  T I - 201  and is best  performed  
20 to  60 minutes post i n j e c t i o n .  M u l t i p l e  views can be ob ta ined  in 
t h i s  per io d  w it h  no s i g n i f i c a n t  loss o f  les ion  uptake.  I d id  not f in d  
any evidence  t h a t  the delayed (4  hour) imaging was advantageous because 
tumour to  background r a t i o  is not s i g n i f i c a n t l y  changed. The short  
w a i t i n g  per io d  a f t e r  i n j e c t i o n  w i th  T I -20 1  c l e a r l y  o f f e r s  a major poten­
t i a l  advantage over a l t e r n a t i v e  tumour imaging agents such as g a l l i u m - 6 7  
or r a d i o - l a b e l e d  monoclonal a n t ib o d ie s  which r e q u i r e  much longer delays  
from i n j e c t i o n  to image.
The mechanism o f  T I - 201  uptake in tumours has not been e s t a b l i s h e d .  In 
the present  study t h i s  mechanism was eva lu a ted  by comparison o f  the t ime  
course o f  T I -2 0 1  uptake in tumours and myocardium in 88 p a t i e n t s  with  
var io u s  mal ignant  d isease .  The t ime course o f  tumour uptake was found 
to  be s i m i l a r  and p a r a l l e l e d  myocardial  uptake w i th  almost id e n t i c a l  
t imes o f  peak uptake being obta ined  in tumours and myocardium. The
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range o f  t imes to  peak a c t i v i t y  th a t  I found in tumour and myocardium 
(between 8 -2 0  minutes)  was very s i m i l a r  to t h a t  repo r ted  by B r a d le y -  
Moore e t  a l ,  1975 ^48)  fo r  T I -201  myocardial  uptake in an animal model.  
The s i m i l a r i t y  in tumours and myocardial  T I -2 0 1  uptake may in d ic a t e  a 
s i m i l a r  mechanism o f  t r a c e r  uptake .  Myocardial  T I -2 0 1  uptake is 
g e n e r a l l y  accepted to  r e f l e c t  both b lo o d - f lo w  and sodium-potassium ATP- 
ase dependent pump a c t i v i t y .
Tumours o f t e n  have abnormal v a s c u l a r i t y  and T I -2 01  may accumulate  
r a p i d l y  in the e x t r a  c e l l u l a r  space e i t h e r  due to  the increased per­
m e a b i l i t y  o f  new vesse ls  w i th  large  i n t r a - c a p i l l a r y  p o r e s ^ 8 9  ^ or s imply  
due to  increased v a s c u l a r i t y .  I was ab le  to study in a s i n g l e  p a t i e n t  
the r o l e  o f  blood f low in the i n i t i a l  d i s t r i b u t i o n  o f  T I -20 1  by com­
par is on  r a t i o s  o f  uptake o f  T I -2 01  and T c " m microspheres In tumour and 
normal t i s s u e s  in a p a t i e n t  w i th  h ep a t ic  m etas tas is  from carcinoma 
colo n .  B iopsies  were taken and samples were analysed using the 3 chan­
nel gamma counter  and found th a t  the d i s t r i b u t i o n  o f  T I -201  in tumour 
t i s s u e s  is not p ro p o r t io n a l  to  the microspheres d i s t r i b u t i o n .  I con­
cluded t h a t  i n i t i a l  e x t r a c t i o n  o f  T I -201  by tumour c e l l s  is not p u re ly  a 
f lo w  dependent process.
I measured the T I -2 01  a c t i v i t y  under cont ro l  c o n d i t io n s  and a f t e r  c a r ­
d ia c  g lyco s id e  "d igoxln" in t e r v e n t io n  which ac ts  as a sodium-potassium 
pump b locker  In non-smal l  c e l l  lung cancer l i n e  SK-MES. The data ob­
ta in e d  In my in v i t r o  study showed a la rge decrease in e x t r a c t i o n  o f
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T I -2 0 1  by the tumour c e l l  l in e  f o l l o w in g  Incubat ion w i th  d ig o x in .  This  
suggests t h a t  d ig o x in  blocks the uptake o f  T I -201  by the squamous lung 
carcinoma c e l l s  SK-MES.
R esu lt s  o f  the s tu d ie s  in d ic a te  th a t  T I -2 01  uptake in tumours is not  
p u r e ly  a f lo w  dependent process.  The mechanism o f  i n t r a c e l l u l a r  uptake  
o f  T I -2 0 1  demonstrates the v i a b i l i t y  and m etabo l ic  a c t i v i t y  o f  the  
p a th o lo g ic a l  c e l l s .  I t  appears to  be s i m i l a r  to  the myocardium by sub­
s t i t u t i o n  o f  T I -2 0 1  fo r  potassium in the ATP-ase dependent sodium-  
potass I urn pump.
I e s t a b l i s h e d  the s e n s i t i v i t y  and s p e c i f i c i t y  o f  T I -201  uptake In a 
v a r i e t y  o f  tumours. I c a r r i e d  out a c l i n i c a l  e v a l u a t io n  o f  t h i s  
ra d i o n u c l id e  in the d iagnosis  and s ta g in g  o f  va r iou s  common mal ignanc ies  
in e v a l u a t i o n  o f  the T I - 201  c h l o r i d e  to  d e tec t  pr imary  lung cancer and 
to  demonstrate m ed ias t in a l  spread o f  the d isease .  Two groups of  
p a t i e n t s  w i th  h i s t o l o g i c a l l y  proven lung cancer were examined. Group A 
co ns is ted  o f  72 p a t i e n t s  w i th  a d iagnosis of  i r r e s e c t a b l e  lung cancer  
and group B co ns is ted  o f  75 p a t i e n t s  w ith  p o t e n t i a l l y  r e s e c ta b le  lung 
cancer .  In a d d i t i o n ,  10 p a t i e n t s  w i th  proven benign lung disease were 
examined.  F o r t y - f i v e  o f  the p a t i e n t s  in the ra d io th e ra p y  group A under­
went both t h a l l iu m - 2 0 1  and g a l l iu m - 6 7  c i t r a t e  imaging. T I -2 0 1  images 
were compared w i th  the r e s u l t s  o f  CT scanning and s u rg ic a l  m ed ia s t in a l  
e x p lo r a t  ion.
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T I -2 0 1  c h l o r i d e  was accurate  in lo ca t in g  126 out o f  147 (86%) p a t i e n t s
examined, but d is a p p o in t in g  in d e t e c t in g  m e d ias t in a l  tumour spread
(14%).  T I -2 0 1  c h l o r i d e  was a ls o  found to  concent ra te  in a c t i v e  s a r -
ft.
co id o s is  (1 case)  and a c t i v e  TB (2 cases)  I f  s p e c i f i c i t y  o f  70%. In 
the comparison study o f  T I -201  and g a l l i u m - 6 7  c i t r a t e ,  both 
r a d io n u c l id e s  showed n e a r ly  s i m i l a r  s e n s i t i v i t y  in d e t e c t in g  pr imary  
lung cancer but g a l l i u m - 6 7  showed higher s e n s i t i v i t y  (57%) in determin­
ing m e d ia s t in a l  spread o f  the d isease .  T I -2 01  scan does not de tec t  
pr imary tumours too small  to  be seen on chest  x - r a y .  I t  cannot p r e d ic t  
c e l l  type;  I t  is n o n - s p e c i f i c  in uptake and does not prove chest x - r a y  
shadow is m a l ig n a n t .  In a d d i t i o n ,  T I -2 01  scan is too i n s e n s i t i v e  in 
d e t e c t i n g  m e d ias t in a l  tumour spread.
I examined T I -2 0 1  c h lo r id e  in d e t e c t in g  pr imary  breast  cancer and tumour 
spread.
Twenty s ix  p a t i e n t s  w i th  h i s t o l o g i c a l l y  proven breast  cancer were ex­
amined. T I -2 0 1  scans were found to  be h ig h ly  s e n s i t i v e  in d e t e c t in g  the  
prim ary s i t e  o f  the breast  carcinoma, 20 out  o f  20 mal ignant  pr imary  
breas t  lesions took up T I -2 01  f o c a l l y  a t  the pr imary s i t e  w h i le  abnormal 
uptake was seen in 4 out o f  6 p a t i e n t s  in re c u r re n t  d isease .
In p a t i e n t s  s tu d ie d  be fo re  surgery the s e n s i t i v i t y  in p r e d i c t i n g  nodal  
Involvement was very  poor.  The s e n s i t i v i t y  o f  T I -2 0 1  scan was a ls o  very  
poor in comparison to  the r e s u l t s  o f  p a lp a t io n  in p a t i e n t s  who had 
c l i n i c a l  evidence o f  nodal spread o f  d isease .  I t  f a i l e d  to  d e te c t  any
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les ions  less than 2.5cm In d iam eter .  T I -2 0 1  scan was not s e n s i t i v e  in 
demonstra t ing smal l d i s t a n t  m etas ta s is  e s p e c i a l l y  in r i b s ,  lungs and 
m ed ia s t in a l  reg io n s .
The data  suggest t h a t  T I -20 1  scan has not proven use fu l  in the local  
s ta g in g  o f  breas t  cancer .
The a p p l i c a t i o n  o f  T I -2 0 1  c h l o r i d e  scans as a s ta g in g  tool  in lymphoma 
was d is a p p o in t in g  because not a l l  tumour s i t e s  were v i s u a l i z e d  w i th  t h i s  
techn iq ue .  The data ob ta ined  from the study shows t h a t  the s i z e  o f  the  
l e s io n  Is c r i t i c a l ,  the chances o f  lo c a t in g  a tumour less than 2 . 5  cm in 
diameter  a re  n e g l i g i b l e  even i f  i t  is in the s u p r a c la v i c u la r  or neck 
re g io n .
In p a t i e n t s  w i th  sub-d iaphragmat ic  ex tens ion  o f  the disease  the lo ca t io n  
of  the tumour is a lso  a problem due to  normal ly  high co n cen t ra t io n  of  
T I -2 0 1  in abdominal organs.
I e va lu a te d  T I -2 01  uptake in 18 p a t i e n t s  w i th  known b r a in  le s io n s ,  9 
p a t i e n t s  w i th  pr imary b r a in  tumour, 2 p a t i e n t s  w i th  cerebrovascu la r  ac­
c id e n t  and 7 p a t i e n t s  w i th  b r a in  m e ta s ta s is .  The s e n s i t i v i t y  o f  T I -2 01  
c h l o r i d e  in d e t e c t in g  b ra in  tumours was very high (100%).  The cerebra l  
les ions  were w el l  v i s u a l i z e d  w i th  T I -2 01  due to  high tumour uptake and 
low blood background le v e ls  In the b r a i n .  Using T I -2 0 1  c h l o r i d e  in im­
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aging b r a in  lesions we could d i f f e r e n t i a t e  between ce re b ra l  vascu la r  ac­
c id e n t  (CVA) which showed no abnormal T I -20 1  uptake from p a t i e n t s  who 
had b r a in  tumour which showed intense T I -20 1  uptake .
In two p a t i e n t s  s tu d ied  f o l l o w in g  s u rg ic a l  and r a d i a t i o n  th e ra p y ,  T I -201  
scan showed a s m al le r  and more focal  area o f  increased t r a c e r  uptake  
than CT scanning and Tc®®m HM-PAO SPECT s t u d ie s .  According to  o th er  in­
v e s t i g a t o r s  T I -2 0 1  scans showed the p re c is e  v i a b l e  re s id u a l  t i s s u e  b e t ­
t e r  than CT and o ther  r a d i o - n u c l i d e  s tu d ie s  ( 247) .  A l l  our p a t i e n t s  
w i t h  b r a i n  tumour were on s t e r o i d  therapy .  In s p i t e  o f  abnormal T I -201  
uptake seen In a l l  tumours, T I -2 0 1  images does not appear to  be a f f e c t e d  
by concomitant  s t e r o i d  a d m i n i s t r a t i o n .  I found T I -2 01  to  be usefu l  and 
h ig h ly  s e n s i t i v e  in d e t e c t in g  b r a in  tumours. I t  can be performed im­
m e d ia te ly  f o l l o w in g  i n j e c t i o n .  I t  r e f l e c t s  v i a b l e  tumour burden and 
does not appear to  be a f f e c t e d  by concomitant  s t e r o i d  a d m i n i s t r a t i o n .
I have ev a lu a ted  T I -2 0 1  c h l o r i d e  in d e t e c t i n g  bone and s o f t  t i s s u e  
tumours in 4 p a t i e n t s  w i th  pr imary bone tumour, two p a t i e n t s  w it h  
pr imary s o f t  t i s s u e  tumours, one p a t i e n t  w i th  bone m etas ta s is  and one 
p a t i e n t  w i th  ch ro nic  o s t e o m y e l i t i s .  T I -20 1  c h l o r i d e  scan was h ig h ly  
s e n s i t i v e  (100%) in d e t e c t in g  pr imary bone and s o f t  t i s s u e  sarcomas and 
provided  accura te  d e l i n e a t i o n  o f  tumour l i m i t s  as determined by CT scan­
n in g .  The s o f t  t i s s u e  tumours were a c c u r a t e ly  demonstrated by T I -201  
scans.  I concluded th a t  T I -201  scans are  h ig h ly  s e n s i t i v e  in d e t e c t in g  
pr imary  bone tumour, but not much use c l i n i c a l l y .  T I -2 0 1  scans may be 
o f  more va lu e  In lo c a t in g  s o f t  t i s s u e  sarcomas.
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I ev a lu a te d  T I -2 0 1  c h l o r i d e  in d e t e c t i n g  and c l a s s i f y i n g  mass lesions in 
the l i v e r  in twenty one p a t i e n t s  w i th  foca l  d e fe c ts  on the Tc®®m t i n -  
c o l l o i d  scan.  The h i s t o l o g i c a l  d iagnosis  was known in each p a t i e n t .  
With the  e xcept ion  o f  two p a t i e n t s  both w i th  hepatoma, a g a l l i u m - 6 7  
c i t r a t e  study was performed immediately f o l lo w i n g  the T I -2 0 1  s tudy .  The 
data ob ta in ed  from the study shows a l l  the hepatoma p a t i e n t s  had s i m i l a r  
appearance on T I -2 0 1  and Ga-67 imaging w i th  both t r a c e r s  showing s i g ­
n i f i c a n t  uptake in areas cold  on the Tc®®m c o l l o i d  scan. In four  o f  the  
f i v e  p a t i e n t s  w i th  m e tas tas is  s tu d ie d  the GA-67 and T I -2 01  images had 
s i m i l a r  appearances w i th  f a i l u r e  o f  the rad io p h arm aceu t ica ls  to  con­
c e n t r a t e  in the cold spot in the c o l l o i d  scan. In the remaining  
p a t i e n t s  the T I -2 0 1  d id  not show a c t i v e  uptake in the m e ta s ta s is ,  but  
the GA-67 was p o s i t i v e .
There was d iscordance between T I -201  images when compared w i th  GA-67 
Images. In 7 c i r r h o t i c  p a t i e n t s  s t u d ie d ,  the g a l l i u m - 6 7  uptake was 
homogenous in four p a t i e n t s  w i th  l i v e r  c i r r h o s i s  w i th  no foca l  d e fec t  
e v i d e n t .  In th re e  p a t i e n t s  the g a l l i u m - 6 7  uptake showed fo ca l  d e fec ts  
In the area  which was cold In T c ^ m T in  c o l l o i d  scan.
T I -2 0 1  images showed m u l t i p l e  foca l  d e fe c ts  and appearance was s i m i l a r  
to  t h a t  observed w i th  t i n  c o l l o i d  l i v e r  scan. I concluded t h a t  T I -201  
c h l o r i d e  is e q u a l l y  usefu l  to  GA-67 c i t r a t e  f o r  Imaging pr imary
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hepatoma. I t  surpasses g a l l iu m  imaging in d i s t i n c t i o n  o f  pseudotumours 
of  the l i v e r .  In a d d i t i o n  i t  has the advantage over GA-67 o f  e a r l y  im­
ag ing.
I in v e s t ig a t e d  the changes in tumour uptake f o l l o w in g  chemotherapy and
rad io th e ra p y  and to  determine whether such changes are  h e lp fu l  in
e v a l u a t i n g  tumour response therapy .  The r o l e  o f  T I -20 1  in p r e d i c t i n g  
tumour responsiveness to  an t i - tu m o u r  th e ra p ie s  has not been f u l l y  
e v a lu a te d  i f  a tumour s i t e  is cont inue to demonstrate uptake a f t e r
th e ra p y ,  in d i c a t i n g  the presence o f  metabo l ic  a c t i v e  t i s s u e  and pos­
s i b l e  evidence of  the presence of  re s idu a l  v i a b l e  tumours. A p o s i t i v e  
T I -2 0 1  scan f o l l o w i n g  t reatment  of  known tumour s i t e s  o f  disease may be 
used as an index of  p e rs is te n c e  or recurrence o f  t r e a t e d  d isease .  
T h i r t y - t h r e e  p a t i e n t s  w i th  lung carcinoma had rece iv e d  p r i o r  lung i r ­
r a d i a t i o n .  Eleven p a t i e n t s  had rece ived  p r i o r  chemotherapy and 16
p a t i e n t s  w i th  b r a in  tumours were r e c e iv in g  s t e r o i d  therapy  a t  the t ime  
of  imaging. Sequent ial  T I -201  images were performed p r i o r  to  th erapy ,  
w i t h i n  one week of  complet ion o f  therapy and in some p a t i e n t s  5 months 
a f t e r  therapy .  Ti —201 images were c o r r e l a t e d  w i th  r a d i o l o g i c a l  f i n d ­
ings.  Using the computer the mean counts in the tumour and background 
were recorded in p r e -  and post therapy images, from t h i s  data the t ru e  
counts in the tumour p r e -  and post therapy were o b ta in ed .  The perce n t ­
age o f  changes o f  a c t i v i t y  in the t ru e  counts o f  pr imary tumour was ob­
ta in e d  which represent  the degree o f  local  response a f t e r  t re a tm e n t .  
The r e s u l t s  o f  sequent ia l  T I - 201  scan were found to  be usefu l  in 
e v a l u a t in g  p a t i e n t s  w ith  mal ignant  d isease ,  e s p e c i a l l y  when the scan was
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p o s i t i v e  p r e - t r e a t m e n t .  There was a good c o r r e l a t i o n  between the change 
in T I -2 0 1  uptake and the change in the pr imary  tumour s i z e  a f t e r  t r e a t ­
ment as determined ra d io g ra p h ic a I  I y .
The a d m i n i s t r a t i o n  o f  a n t i n e o p l a s t i c  agents and s t e r o i d  therapy p r i o r  to  
i n j e c t i o n  o f  t h a l l iu m - 2 0 1  appeared not to  a f f e c t  the d i s t r i b u t i o n  of  
T I -2 0 1  in the tumour. The changes o f  uptake o f  T I -2 01  in the tumour 
s i t e  appear h ig h ly  s p e c i f i c  and T I -201  uptake may pro v id e  a usefu l  means 
o f  s tu dy ing  tumour v i a b i l i t y .  However, the use o f  T I -20 1  In measuring  
the e x t e n t  o f  the n e o p la s t i c  disease  has been d is a p p o in t in g  due to  in­
s e n s i t i v i t y  in d e t e c t i n g  m e d ias t in a l  and nodal spread o f  the d isease .
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